{
  "41": {
    "report_string": "# Genomic Variants and Their Impact on Adiposity and Type 2 Diabetes\n\nThe community revolves around genomic variants, particularly those associated with adiposity, type 2 diabetes (T2DM), and lipid metabolism. Key entities include genomic variants, SNPs, the FTO gene, and physiological processes like adiposity. These entities are interconnected through their roles in obesity risk, insulin secretion, and disease susceptibility.\n\n## Genomic variants and their association with adiposity\n\nGenomic variants are associated with adiposity, a measure of body fat. Specifically, variants in the FTO gene have been linked to obesity traits and LMI. This relationship highlights the role of genetics in body composition and disease risk.\n\n## Role of SNPs in T2DM and adiposity\n\nSNPs are a type of genomic variant associated with T2DM and adiposity. They are used to identify genetic associations with dietary intake and can influence physiological processes. For instance, SNPs in the FTO gene are linked to obesity and waist circumference.\n\n## FTO gene and its implications for obesity and LMI\n\nThe FTO gene contains genomic variants associated with obesity and LMI. Variants such as rs56137030 have been linked to increased BMI and obesity risk. This underscores the importance of genetic considerations in obesity management and prevention.\n\n## Genomic variants and their influence on dietary intake\n\nGenomic variants are associated with dietary intake, and SNPs are used to study these associations. This relationship between genetics and nutrition highlights the potential for personalized dietary recommendations based on genetic profiles.\n\n## Impact of genomic variants on disease susceptibility\n\nGenomic variants can influence disease susceptibility, including T2DM and colorectal cancer. For example, a genomic variant in the TCF7L2 gene has been associated with an increased risk of T2DM. This emphasizes the role of genetics in disease risk assessment and management.",
    "report_json": {
      "title": "Genomic Variants and Their Impact on Adiposity and Type 2 Diabetes",
      "summary": "The community revolves around genomic variants, particularly those associated with adiposity, type 2 diabetes (T2DM), and lipid metabolism. Key entities include genomic variants, SNPs, the FTO gene, and physiological processes like adiposity. These entities are interconnected through their roles in obesity risk, insulin secretion, and disease susceptibility.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genomic variants on adiposity and T2DM risk.",
      "findings": [
        {
          "summary": "Genomic variants and their association with adiposity",
          "explanation": "Genomic variants are associated with adiposity, a measure of body fat. Specifically, variants in the FTO gene have been linked to obesity traits and LMI. This relationship highlights the role of genetics in body composition and disease risk."
        },
        {
          "summary": "Role of SNPs in T2DM and adiposity",
          "explanation": "SNPs are a type of genomic variant associated with T2DM and adiposity. They are used to identify genetic associations with dietary intake and can influence physiological processes. For instance, SNPs in the FTO gene are linked to obesity and waist circumference."
        },
        {
          "summary": "FTO gene and its implications for obesity and LMI",
          "explanation": "The FTO gene contains genomic variants associated with obesity and LMI. Variants such as rs56137030 have been linked to increased BMI and obesity risk. This underscores the importance of genetic considerations in obesity management and prevention."
        },
        {
          "summary": "Genomic variants and their influence on dietary intake",
          "explanation": "Genomic variants are associated with dietary intake, and SNPs are used to study these associations. This relationship between genetics and nutrition highlights the potential for personalized dietary recommendations based on genetic profiles."
        },
        {
          "summary": "Impact of genomic variants on disease susceptibility",
          "explanation": "Genomic variants can influence disease susceptibility, including T2DM and colorectal cancer. For example, a genomic variant in the TCF7L2 gene has been associated with an increased risk of T2DM. This emphasizes the role of genetics in disease risk assessment and management."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 41",
    "edges": [
      [
        "\"GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LMI\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"SNPS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNPS\""
      ],
      [
        "\"FTO GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"FTO\"",
        "\"LMI\""
      ],
      [
        "\"DISEASE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GWAS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2DM\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"WALKING PACE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY\""
      ],
      [
        "\"EPIGENETIC MODIFICATION\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"SNPS\"",
        "\"T2DM\""
      ],
      [
        "\"BMI\"",
        "\"SNPS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNP\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"WALKING PACE\""
      ],
      [
        "\"FTO\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNPS\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MAF\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SELF-REPORTED WALKING PACE\""
      ]
    ],
    "nodes": [
      "\"ADIPOSITY\"",
      "\"SNPS\"",
      "\"LMI\"",
      "\"GENOMIC VARIANT\""
    ],
    "chunk_ids": [
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-70430b09782e1fdb643124aa15a06aae"
    ],
    "occurrence": 0.7037037037037037,
    "sub_communities": []
  },
  "45": {
    "report_string": "# Nutritional and Physiological Factors in Type2 Diabetes\n\nThe community revolves around Type2 diabetes, a disease influenced by nutritional factors such as protein intake and physiological processes like pancreatic function. Key entities include protein as a nutrient, Type2 diabetes as a disease, and the pancreas as a physiological process. These entities are interconnected through their roles in energy intake, digestion, and disease risk.\n\n## Protein intake and its association with Type2 diabetes risk\n\nProtein intake is positively associated with Type2 diabetes risk. This relationship suggests that dietary protein may play a role in the development or management of Type2 diabetes. The satiating properties of protein and its contribution to total energy intake may also influence this association.\n\n## The role of the pancreas in protein digestion and metabolism\n\nThe pancreas plays a crucial role in protein digestion and metabolism. This physiological process is essential for maintaining proper nutrient balance and may have implications for Type2 diabetes management. The pancreas's function in digestion and metabolism highlights the importance of considering physiological processes in understanding disease risk.\n\n## The relationship between BMI and Type2 diabetes\n\nBMI is associated with Type2 diabetes risk. This relationship indicates that body mass index is an important factor in the development of Type2 diabetes. The connection between BMI, protein intake, and Type2 diabetes suggests a complex interplay between nutritional factors, physiological processes, and disease risk.\n\n## Walking pace and its association with Type2 diabetes risk\n\nWalking pace is associated with lower risk of Type2 diabetes. This relationship highlights the importance of physical activity in managing disease risk. While not directly related to nutritional factors, walking pace and physical activity can interact with dietary components to influence overall health and disease susceptibility.\n\n## The impact of protein on energy intake and satiety\n\nProtein has satiating properties and its intake declines at higher levels of total energy intake. This relationship between protein, energy intake, and satiety may have implications for managing weight and reducing the risk of Type2 diabetes. The role of protein in energy balance and satiety underscores the importance of considering macronutrient composition in dietary recommendations.",
    "report_json": {
      "title": "Nutritional and Physiological Factors in Type2 Diabetes",
      "summary": "The community revolves around Type2 diabetes, a disease influenced by nutritional factors such as protein intake and physiological processes like pancreatic function. Key entities include protein as a nutrient, Type2 diabetes as a disease, and the pancreas as a physiological process. These entities are interconnected through their roles in energy intake, digestion, and disease risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of nutritional factors and physiological processes on Type2 diabetes risk and management.",
      "findings": [
        {
          "summary": "Protein intake and its association with Type2 diabetes risk",
          "explanation": "Protein intake is positively associated with Type2 diabetes risk. This relationship suggests that dietary protein may play a role in the development or management of Type2 diabetes. The satiating properties of protein and its contribution to total energy intake may also influence this association."
        },
        {
          "summary": "The role of the pancreas in protein digestion and metabolism",
          "explanation": "The pancreas plays a crucial role in protein digestion and metabolism. This physiological process is essential for maintaining proper nutrient balance and may have implications for Type2 diabetes management. The pancreas's function in digestion and metabolism highlights the importance of considering physiological processes in understanding disease risk."
        },
        {
          "summary": "The relationship between BMI and Type2 diabetes",
          "explanation": "BMI is associated with Type2 diabetes risk. This relationship indicates that body mass index is an important factor in the development of Type2 diabetes. The connection between BMI, protein intake, and Type2 diabetes suggests a complex interplay between nutritional factors, physiological processes, and disease risk."
        },
        {
          "summary": "Walking pace and its association with Type2 diabetes risk",
          "explanation": "Walking pace is associated with lower risk of Type2 diabetes. This relationship highlights the importance of physical activity in managing disease risk. While not directly related to nutritional factors, walking pace and physical activity can interact with dietary components to influence overall health and disease susceptibility."
        },
        {
          "summary": "The impact of protein on energy intake and satiety",
          "explanation": "Protein has satiating properties and its intake declines at higher levels of total energy intake. This relationship between protein, energy intake, and satiety may have implications for managing weight and reducing the risk of Type2 diabetes. The role of protein in energy balance and satiety underscores the importance of considering macronutrient composition in dietary recommendations."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 45",
    "edges": [
      [
        "\"PANCREAS\"",
        "\"PROTEIN\""
      ],
      [
        "\"TYPE 2 DIABETES\"",
        "\"WALKING PACE\""
      ],
      [
        "\"PROTEIN\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"OBESITY\"",
        "\"PROTEIN\""
      ],
      [
        "\"BMI\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"PROTEIN\""
      ]
    ],
    "nodes": [
      "\"PANCREAS\"",
      "\"TYPE 2 DIABETES\"",
      "\"PROTEIN\""
    ],
    "chunk_ids": [
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-2f2c90dea13e0dad5235137b025e03b7"
    ],
    "occurrence": 0.14814814814814814,
    "sub_communities": []
  },
  "44": {
    "report_string": "# Physical Activity and Nutrition Community\n\nThe community revolves around physical activity and its relationships with nutrition, genetic factors, and disease risk. Key entities include physiological processes like physical activity, energy intake, and VO2 max, as well as interventions like COSTRIDE and HW. These entities are interconnected through their roles in influencing obesity risk, energy intake, and cardiovascular health.\n\n## Physical activity's influence on obesity risk\n\nPhysical activity is an environmental factor that may influence obesity risk. This relationship highlights the importance of regular physical activity in maintaining a healthy weight and reducing the risk of obesity-related diseases.\n\n## Relationship between physical activity and energy intake\n\nPhysical activity influences energy intake, and this relationship is crucial for understanding how lifestyle factors impact overall energy balance. This connection underscores the need for comprehensive approaches to managing energy intake and expenditure.\n\n## Role of VO2 max in physical activity\n\nVO2 max is a measure of an individual's aerobic fitness, which is related to physical activity levels. This relationship emphasizes the importance of aerobic fitness in overall physical activity and health.\n\n## Impact of interventions on physical activity\n\nInterventions like COSTRIDE and HW aim to promote physical activity, highlighting the potential for targeted lifestyle interventions to improve physical activity levels and related health outcomes.\n\n## Epinephrine's role in physical activity\n\nEpinephrine levels may be influenced by physical activity, suggesting a physiological link between physical activity and hormonal responses.",
    "report_json": {
      "title": "Physical Activity and Nutrition Community",
      "summary": "The community revolves around physical activity and its relationships with nutrition, genetic factors, and disease risk. Key entities include physiological processes like physical activity, energy intake, and VO2 max, as well as interventions like COSTRIDE and HW. These entities are interconnected through their roles in influencing obesity risk, energy intake, and cardiovascular health.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of physical activity on obesity risk, energy intake, and overall cardiovascular health.",
      "findings": [
        {
          "summary": "Physical activity's influence on obesity risk",
          "explanation": "Physical activity is an environmental factor that may influence obesity risk. This relationship highlights the importance of regular physical activity in maintaining a healthy weight and reducing the risk of obesity-related diseases."
        },
        {
          "summary": "Relationship between physical activity and energy intake",
          "explanation": "Physical activity influences energy intake, and this relationship is crucial for understanding how lifestyle factors impact overall energy balance. This connection underscores the need for comprehensive approaches to managing energy intake and expenditure."
        },
        {
          "summary": "Role of VO2 max in physical activity",
          "explanation": "VO2 max is a measure of an individual's aerobic fitness, which is related to physical activity levels. This relationship emphasizes the importance of aerobic fitness in overall physical activity and health."
        },
        {
          "summary": "Impact of interventions on physical activity",
          "explanation": "Interventions like COSTRIDE and HW aim to promote physical activity, highlighting the potential for targeted lifestyle interventions to improve physical activity levels and related health outcomes."
        },
        {
          "summary": "Epinephrine's role in physical activity",
          "explanation": "Epinephrine levels may be influenced by physical activity, suggesting a physiological link between physical activity and hormonal responses."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 44",
    "edges": [
      [
        "\"OBESITY\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"BMI\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"COSTRIDE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"HW\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"VO2 MAX\""
      ],
      [
        "\"PAR ASSESSMENT\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"AGE\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"BMI\"",
        "\"ENERGY INTAKE\""
      ],
      [
        "\"EPINEPHRINE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"COSTRIDE\"",
        "\"HW\""
      ],
      [
        "\"AGE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"PROTEIN\""
      ]
    ],
    "nodes": [
      "\"PAR ASSESSMENT\"",
      "\"VO2 MAX\"",
      "\"COSTRIDE\"",
      "\"EPINEPHRINE\"",
      "\"PHYSICAL ACTIVITY\"",
      "\"RISK ESTIMATES\"",
      "\"HW\"",
      "\"ENERGY INTAKE\""
    ],
    "chunk_ids": [
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-90dc49ded987f15e0a9242fc9bb82297",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.25925925925925924,
    "sub_communities": []
  },
  "43": {
    "report_string": "# Genomic Variants and Their Associations with Diseases\n\nThe community revolves around genomic variants, particularly SNPs (Single Nucleotide Polymorphisms), and their associations with various diseases and physiological processes. Key entities include SNPs, the FTO gene, and diseases like cancer. These entities are interconnected through their roles in genetic variations, disease risk, and physiological processes.\n\n## SNPs and Their Associations with BMI and Obesity\n\nSNPs, including rs56137030, are associated with BMI and obesity risk. The FTO gene has SNPs, such as rs9922708 and rs17817449, that are linked to obesity. This highlights the importance of genetic variations in understanding disease risk.\n\n## Role of SNPs in Disease Associations\n\nSNPs are used to study associations with various diseases, including cancer. The dbSNP database catalogs known SNPs, which are crucial for understanding genetic variations. SNPs are also associated with skeletal robustness, a physiological process.\n\n## Genomic Variants and Physiological Processes\n\nSNPs are associated with skeletal robustness, a physiological process. The SOLiD system and UVAM are methods used to identify and validate SNPs, underscoring the importance of accurate genomic variant detection.\n\n## FTO Gene Variants and Obesity\n\nThe FTO gene has variants, such as rs8050136, that are associated with obesity. This highlights the role of specific genetic variants in disease risk.\n\n## SNPs and Their Role in Genomic Analysis\n\nSNPs are a type of genomic variant used to analyze genetic variations. The allele frequency distribution of SNPs in specific regions can provide insights into genetic associations with diseases.",
    "report_json": {
      "title": "Genomic Variants and Their Associations with Diseases",
      "summary": "The community revolves around genomic variants, particularly SNPs (Single Nucleotide Polymorphisms), and their associations with various diseases and physiological processes. Key entities include SNPs, the FTO gene, and diseases like cancer. These entities are interconnected through their roles in genetic variations, disease risk, and physiological processes.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genomic variants on disease risk and physiological processes.",
      "findings": [
        {
          "summary": "SNPs and Their Associations with BMI and Obesity",
          "explanation": "SNPs, including rs56137030, are associated with BMI and obesity risk. The FTO gene has SNPs, such as rs9922708 and rs17817449, that are linked to obesity. This highlights the importance of genetic variations in understanding disease risk."
        },
        {
          "summary": "Role of SNPs in Disease Associations",
          "explanation": "SNPs are used to study associations with various diseases, including cancer. The dbSNP database catalogs known SNPs, which are crucial for understanding genetic variations. SNPs are also associated with skeletal robustness, a physiological process."
        },
        {
          "summary": "Genomic Variants and Physiological Processes",
          "explanation": "SNPs are associated with skeletal robustness, a physiological process. The SOLiD system and UVAM are methods used to identify and validate SNPs, underscoring the importance of accurate genomic variant detection."
        },
        {
          "summary": "FTO Gene Variants and Obesity",
          "explanation": "The FTO gene has variants, such as rs8050136, that are associated with obesity. This highlights the role of specific genetic variants in disease risk."
        },
        {
          "summary": "SNPs and Their Role in Genomic Analysis",
          "explanation": "SNPs are a type of genomic variant used to analyze genetic variations. The allele frequency distribution of SNPs in specific regions can provide insights into genetic associations with diseases."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 43",
    "edges": [
      [
        "\"RS8050136\"",
        "\"SNP\""
      ],
      [
        "\"ALLELE FREQUENCY\"",
        "\"SNP\""
      ],
      [
        "\"SKELETAL ROBUSTNESS\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNP\""
      ],
      [
        "\"SNP\"",
        "\"UVAM\""
      ],
      [
        "\"CANCER\"",
        "\"SNP\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"SNP\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP\""
      ],
      [
        "\"GWAS\"",
        "\"SNP\""
      ],
      [
        "\"DBSNP\"",
        "\"SNP\""
      ],
      [
        "\"SNP\"",
        "\"SOLID SYSTEM\""
      ],
      [
        "\"BMI\"",
        "\"SNP\""
      ]
    ],
    "nodes": [
      "\"SNP\"",
      "\"CANCER\"",
      "\"ALLELE FREQUENCY\"",
      "\"SKELETAL ROBUSTNESS\"",
      "\"SOLID SYSTEM\"",
      "\"DBSNP\"",
      "\"UVAM\""
    ],
    "chunk_ids": [
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.4444444444444444,
    "sub_communities": []
  },
  "42": {
    "report_string": "# Disease and Environmental Interactions\n\nThe community consists of entities including DISEASE, ENVIRONMENTAL FACTOR, and their relationships. The DISEASE entity is connected to both ENVIRONMENTAL FACTOR and GENOMIC VARIANT, indicating that diseases can be influenced by both external environmental factors and internal genetic variations.\n\n## Relationship between Disease and Environmental Factors\n\nThe community highlights that environmental factors can contribute to the development of diseases. This relationship underscores the importance of considering external influences when assessing disease risk and management. Environmental factors can include a wide range of elements such as lifestyle, exposure to pollutants, and access to healthcare.\n\n## Role of Genomic Variants in Disease\n\nGenomic variants are associated with diseases, suggesting that genetic factors play a critical role in disease susceptibility and progression. This relationship emphasizes the need for personalized medicine approaches that take into account an individual's genetic makeup when assessing disease risk and treatment options.\n\n## Interconnection of Entities in Disease Etiology\n\nThe interconnection between disease, environmental factors, and genomic variants suggests a complex etiology for diseases. Understanding these relationships can help in developing comprehensive strategies for disease prevention and management that consider both genetic predispositions and environmental influences.",
    "report_json": {
      "title": "Disease and Environmental Interactions",
      "summary": "The community consists of entities including DISEASE, ENVIRONMENTAL FACTOR, and their relationships. The DISEASE entity is connected to both ENVIRONMENTAL FACTOR and GENOMIC VARIANT, indicating that diseases can be influenced by both external environmental factors and internal genetic variations.",
      "rating": 5.0,
      "rating_explanation": "The impact severity rating is moderate due to the general nature of the entities and relationships described, which are fundamental to understanding disease etiology.",
      "findings": [
        {
          "summary": "Relationship between Disease and Environmental Factors",
          "explanation": "The community highlights that environmental factors can contribute to the development of diseases. This relationship underscores the importance of considering external influences when assessing disease risk and management. Environmental factors can include a wide range of elements such as lifestyle, exposure to pollutants, and access to healthcare."
        },
        {
          "summary": "Role of Genomic Variants in Disease",
          "explanation": "Genomic variants are associated with diseases, suggesting that genetic factors play a critical role in disease susceptibility and progression. This relationship emphasizes the need for personalized medicine approaches that take into account an individual's genetic makeup when assessing disease risk and treatment options."
        },
        {
          "summary": "Interconnection of Entities in Disease Etiology",
          "explanation": "The interconnection between disease, environmental factors, and genomic variants suggests a complex etiology for diseases. Understanding these relationships can help in developing comprehensive strategies for disease prevention and management that consider both genetic predispositions and environmental influences."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 42",
    "edges": [
      [
        "\"DISEASE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"DISEASE\"",
        "\"ENVIRONMENTAL FACTOR\""
      ]
    ],
    "nodes": [
      "\"DISEASE\"",
      "\"ENVIRONMENTAL FACTOR\""
    ],
    "chunk_ids": [
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54"
    ],
    "occurrence": 0.037037037037037035,
    "sub_communities": []
  },
  "30": {
    "report_string": "# Genetic and Environmental Factors in Dietary Intake and Disease\n\nThe community revolves around the interplay between genetic factors, dietary intake, and disease, with a focus on GWAS, genomic variants, and environmental factors like UKB. Key entities include genes such as DRAM1, genomic variants like LEAD SNPS and GENOMIC LOCI, and environmental factors like UKB. These entities are interconnected through their roles in identifying genetic associations with dietary intake and disease.\n\n## GWAS and its role in identifying genetic associations\n\nGWAS is a method used to identify genetic variants associated with complex traits, including dietary intake and disease. It has identified genetic associations with the FTO gene and genomic loci associated with self-reported walking pace. This highlights the importance of GWAS in understanding the genetic basis of complex traits.\n\n## DRAM1 gene and dietary intake\n\nThe DRAM1 gene is associated with dietary intake, suggesting a potential link between genetic factors and nutritional behavior. This relationship highlights the need for further research into the genetic determinants of dietary intake.\n\n## Genomic variants and their association with dietary intake\n\nGenomic variants, including LEAD SNPS and GENOMIC LOCI, are associated with dietary intake. This suggests that genetic factors play a significant role in shaping nutritional behavior and potentially influencing disease risk.\n\n## UKB and its role in GWAS analyses\n\nThe UKB is a biobank that contains genetic and phenotypic data from a large cohort of individuals, making it a valuable resource for GWAS analyses. This highlights the importance of large-scale biobanks in understanding the relationships between genetic and environmental factors.\n\n## Relationship between dietary intake and genomic variants\n\nDietary intake is associated with genomic variants, including LEAD SNPS. This relationship suggests that genetic factors may influence nutritional behavior and potentially impact disease risk.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Dietary Intake and Disease",
      "summary": "The community revolves around the interplay between genetic factors, dietary intake, and disease, with a focus on GWAS, genomic variants, and environmental factors like UKB. Key entities include genes such as DRAM1, genomic variants like LEAD SNPS and GENOMIC LOCI, and environmental factors like UKB. These entities are interconnected through their roles in identifying genetic associations with dietary intake and disease.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the exploratory nature of the relationships between genetic and environmental factors in dietary intake and disease.",
      "findings": [
        {
          "summary": "GWAS and its role in identifying genetic associations",
          "explanation": "GWAS is a method used to identify genetic variants associated with complex traits, including dietary intake and disease. It has identified genetic associations with the FTO gene and genomic loci associated with self-reported walking pace. This highlights the importance of GWAS in understanding the genetic basis of complex traits."
        },
        {
          "summary": "DRAM1 gene and dietary intake",
          "explanation": "The DRAM1 gene is associated with dietary intake, suggesting a potential link between genetic factors and nutritional behavior. This relationship highlights the need for further research into the genetic determinants of dietary intake."
        },
        {
          "summary": "Genomic variants and their association with dietary intake",
          "explanation": "Genomic variants, including LEAD SNPS and GENOMIC LOCI, are associated with dietary intake. This suggests that genetic factors play a significant role in shaping nutritional behavior and potentially influencing disease risk."
        },
        {
          "summary": "UKB and its role in GWAS analyses",
          "explanation": "The UKB is a biobank that contains genetic and phenotypic data from a large cohort of individuals, making it a valuable resource for GWAS analyses. This highlights the importance of large-scale biobanks in understanding the relationships between genetic and environmental factors."
        },
        {
          "summary": "Relationship between dietary intake and genomic variants",
          "explanation": "Dietary intake is associated with genomic variants, including LEAD SNPS. This relationship suggests that genetic factors may influence nutritional behavior and potentially impact disease risk."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 30",
    "edges": [
      [
        "\"DIETARY INTAKE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GWAS\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"DRAM1\""
      ],
      [
        "\"GWAS\"",
        "\"UKB\""
      ],
      [
        "\"GWAS\"",
        "\"MO DISEASE\""
      ],
      [
        "\"FTO GENE\"",
        "\"GWAS\""
      ],
      [
        "\"FTO\"",
        "\"GWAS\""
      ],
      [
        "\"GWAS\"",
        "\"T2DM\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"LEAD SNPS\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"GWAS\""
      ],
      [
        "\"GWAS\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC LOCI\"",
        "\"GWAS\""
      ]
    ],
    "nodes": [
      "\"UKB\"",
      "\"GENOMIC LOCI\"",
      "\"DIETARY INTAKE\"",
      "\"DRAM1\"",
      "\"LEAD SNPS\"",
      "\"GWAS\""
    ],
    "chunk_ids": [
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.2962962962962963,
    "sub_communities": []
  },
  "27": {
    "report_string": "# Genomic Variants and Adiposity\n\nThe community revolves around genomic variants, particularly those associated with adiposity, obesity, and type 2 diabetes mellitus (T2DM). Key entities include genomic variants, SNPs, the FTO gene, and physiological processes like adiposity and walking pace. These entities are interconnected through their roles in obesity risk, insulin secretion, and disease susceptibility.\n\n## Genomic variants in the FTO gene and obesity risk\n\nThe FTO gene is associated with obesity traits, and genomic variants within this gene, such as rs56137030 and rs8050136, have been linked to increased BMI and obesity risk. These variants can influence adiposity and are used in studies to understand genetic associations with obesity.\n\n## SNPs and their role in disease susceptibility\n\nSNPs (Single Nucleotide Polymorphisms) are a type of genomic variant that can be associated with disease risk, including T2DM and obesity. They are used in genome-wide association studies (GWAS) to identify genetic associations with complex traits and dietary intake.\n\n## Relationship between genomic variants and adiposity\n\nGenomic variants are associated with adiposity, a measure of body fat. The relationship between genomic variants and adiposity highlights the importance of genetic factors in physiological processes related to obesity and metabolic health.\n\n## Impact of genomic variants on T2DM risk\n\nGenomic variants, particularly in genes like TCF7L2, have been linked to an increased risk of T2DM. These variants can influence insulin secretion and glucose metabolism, underscoring the role of genetics in diabetes susceptibility.\n\n## Genomic variants and dietary intake\n\nGenomic variants can influence dietary intake and macronutrient consumption. The interaction between genomic variants and dietary factors can impact obesity risk and metabolic health, suggesting a role for personalized nutrition based on genetic profiles.",
    "report_json": {
      "title": "Genomic Variants and Adiposity",
      "summary": "The community revolves around genomic variants, particularly those associated with adiposity, obesity, and type 2 diabetes mellitus (T2DM). Key entities include genomic variants, SNPs, the FTO gene, and physiological processes like adiposity and walking pace. These entities are interconnected through their roles in obesity risk, insulin secretion, and disease susceptibility.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genomic variants on obesity and T2DM risk.",
      "findings": [
        {
          "summary": "Genomic variants in the FTO gene and obesity risk",
          "explanation": "The FTO gene is associated with obesity traits, and genomic variants within this gene, such as rs56137030 and rs8050136, have been linked to increased BMI and obesity risk. These variants can influence adiposity and are used in studies to understand genetic associations with obesity."
        },
        {
          "summary": "SNPs and their role in disease susceptibility",
          "explanation": "SNPs (Single Nucleotide Polymorphisms) are a type of genomic variant that can be associated with disease risk, including T2DM and obesity. They are used in genome-wide association studies (GWAS) to identify genetic associations with complex traits and dietary intake."
        },
        {
          "summary": "Relationship between genomic variants and adiposity",
          "explanation": "Genomic variants are associated with adiposity, a measure of body fat. The relationship between genomic variants and adiposity highlights the importance of genetic factors in physiological processes related to obesity and metabolic health."
        },
        {
          "summary": "Impact of genomic variants on T2DM risk",
          "explanation": "Genomic variants, particularly in genes like TCF7L2, have been linked to an increased risk of T2DM. These variants can influence insulin secretion and glucose metabolism, underscoring the role of genetics in diabetes susceptibility."
        },
        {
          "summary": "Genomic variants and dietary intake",
          "explanation": "Genomic variants can influence dietary intake and macronutrient consumption. The interaction between genomic variants and dietary factors can impact obesity risk and metabolic health, suggesting a role for personalized nutrition based on genetic profiles."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 27",
    "edges": [
      [
        "\"DISEASE\"",
        "\"ENVIRONMENTAL FACTOR\""
      ],
      [
        "\"GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"SNP\"",
        "\"UVAM\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LMI\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"SNPS\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNPS\""
      ],
      [
        "\"FTO GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GWAS\"",
        "\"SNP\""
      ],
      [
        "\"FTO\"",
        "\"LMI\""
      ],
      [
        "\"DISEASE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GWAS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2DM\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"SKELETAL ROBUSTNESS\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"WALKING PACE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY\""
      ],
      [
        "\"EPIGENETIC MODIFICATION\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"SNPS\"",
        "\"T2DM\""
      ],
      [
        "\"BMI\"",
        "\"SNPS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNP\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"WALKING PACE\""
      ],
      [
        "\"FTO\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"DBSNP\"",
        "\"SNP\""
      ],
      [
        "\"SNP\"",
        "\"SOLID SYSTEM\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNPS\""
      ],
      [
        "\"RS8050136\"",
        "\"SNP\""
      ],
      [
        "\"ALLELE FREQUENCY\"",
        "\"SNP\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MAF\""
      ],
      [
        "\"CANCER\"",
        "\"SNP\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"SNP\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"SNP\""
      ]
    ],
    "nodes": [
      "\"DISEASE\"",
      "\"LMI\"",
      "\"GENOMIC VARIANT\"",
      "\"SNP\"",
      "\"CANCER\"",
      "\"SNPS\"",
      "\"ALLELE FREQUENCY\"",
      "\"SKELETAL ROBUSTNESS\"",
      "\"ENVIRONMENTAL FACTOR\"",
      "\"SOLID SYSTEM\"",
      "\"ADIPOSITY\"",
      "\"DBSNP\"",
      "\"UVAM\""
    ],
    "chunk_ids": [
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.8888888888888888,
    "sub_communities": [
      "43",
      "41",
      "42"
    ]
  },
  "35": {
    "report_string": "# Coronary Artery Disease and Macronutrient Interactions\n\nThe community revolves around coronary artery disease, a condition related to cardiovascular health, and its associations with the macronutrient fat, as well as physiological processes like walking pace and BMI. Key entities include coronary artery disease, fat, adrenals, BMI, and walking pace. These entities are interconnected through their roles in cardiovascular health, energy intake, and genetic correlations.\n\n## Coronary artery disease and fat intake relationship\n\nCoronary artery disease is positively associated with fat intake. Fat is a macronutrient that contributes to total energy intake and has a positive association with BMI. This relationship suggests that managing fat intake could be crucial in mitigating the risk of coronary artery disease.\n\n## Role of adrenals in fat metabolism\n\nThe adrenals play a role in lipid metabolism, and genetic variation related to adrenals affects fat intake. This connection implies that adrenal function could influence an individual's susceptibility to coronary artery disease through its impact on fat metabolism.\n\n## Walking pace and coronary artery disease association\n\nWalking pace is associated with a lower risk of coronary artery disease. This relationship highlights the importance of physical activity, specifically walking pace, in managing cardiovascular health and reducing the risk of coronary artery disease.\n\n## BMI and coronary artery disease link\n\nBMI is associated with coronary artery disease, suggesting that body mass index could be a risk factor for the disease. This association underscores the need for weight management in preventing or managing coronary artery disease.\n\n## Adrenals, fat intake, and genetic variation\n\nThe relationship between adrenals and fat intake is influenced by genetic variation. This suggests that individual genetic profiles could affect how dietary fat impacts coronary artery disease risk, potentially allowing for personalized dietary recommendations.",
    "report_json": {
      "title": "Coronary Artery Disease and Macronutrient Interactions",
      "summary": "The community revolves around coronary artery disease, a condition related to cardiovascular health, and its associations with the macronutrient fat, as well as physiological processes like walking pace and BMI. Key entities include coronary artery disease, fat, adrenals, BMI, and walking pace. These entities are interconnected through their roles in cardiovascular health, energy intake, and genetic correlations.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant associations between coronary artery disease and factors like fat intake, walking pace, and BMI.",
      "findings": [
        {
          "summary": "Coronary artery disease and fat intake relationship",
          "explanation": "Coronary artery disease is positively associated with fat intake. Fat is a macronutrient that contributes to total energy intake and has a positive association with BMI. This relationship suggests that managing fat intake could be crucial in mitigating the risk of coronary artery disease."
        },
        {
          "summary": "Role of adrenals in fat metabolism",
          "explanation": "The adrenals play a role in lipid metabolism, and genetic variation related to adrenals affects fat intake. This connection implies that adrenal function could influence an individual's susceptibility to coronary artery disease through its impact on fat metabolism."
        },
        {
          "summary": "Walking pace and coronary artery disease association",
          "explanation": "Walking pace is associated with a lower risk of coronary artery disease. This relationship highlights the importance of physical activity, specifically walking pace, in managing cardiovascular health and reducing the risk of coronary artery disease."
        },
        {
          "summary": "BMI and coronary artery disease link",
          "explanation": "BMI is associated with coronary artery disease, suggesting that body mass index could be a risk factor for the disease. This association underscores the need for weight management in preventing or managing coronary artery disease."
        },
        {
          "summary": "Adrenals, fat intake, and genetic variation",
          "explanation": "The relationship between adrenals and fat intake is influenced by genetic variation. This suggests that individual genetic profiles could affect how dietary fat impacts coronary artery disease risk, potentially allowing for personalized dietary recommendations."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 35",
    "edges": [
      [
        "\"CORONARY ARTERY DISEASE\"",
        "\"WALKING PACE\""
      ],
      [
        "\"CORONARY ARTERY DISEASE\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"ADRENALS\"",
        "\"FAT\""
      ],
      [
        "\"BMI\"",
        "\"CORONARY ARTERY DISEASE\""
      ],
      [
        "\"CORONARY ARTERY DISEASE\"",
        "\"FAT\""
      ]
    ],
    "nodes": [
      "\"ADRENALS\"",
      "\"FAT\"",
      "\"CORONARY ARTERY DISEASE\""
    ],
    "chunk_ids": [
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-b7e190953e4c769a8b651f251bf00588"
    ],
    "occurrence": 0.18518518518518517,
    "sub_communities": []
  },
  "34": {
    "report_string": "# Physical Activity and Nutrition in Type2 Diabetes\n\nThe community revolves around the interplay of physical activity, nutrition, and type2 diabetes. Key entities include physiological processes like physical activity and energy intake, nutrients such as protein, and diseases like type2 diabetes. These entities are interconnected through their roles in metabolic health, insulin function, and disease risk.\n\n## Physical activity's role in type2 diabetes and obesity risk\n\nPhysical activity is an environmental factor that may influence obesity risk and is associated with lower risk of type2 diabetes. It also interacts with genetic factors, such as the NRXN3 gene variant, in relation to colorectal cancer risk. Furthermore, physical activity levels can be influenced by age, with older adults potentially being less active.\n\n## Nutritional factors and type2 diabetes\n\nProtein intake is positively associated with type2 diabetes risk and obesity risk. Additionally, protein has satiating properties, and its intake declines at higher levels of total energy intake. The pancreas plays a role in protein digestion and metabolism, highlighting the complex interplay between nutrition and physiological processes.\n\n## Interventions promoting physical activity\n\nInterventions like COSTRIDE and HW aim to promote physical activity, but they differ in their approach. These interventions are crucial for improving physical activity outcomes and subsequently influencing metabolic health and disease risk.\n\n## The role of VO2 max in physical activity\n\nVO2 max is a measure of an individual's aerobic fitness, reflecting the body's ability to utilize oxygen during exercise. It is related to physical activity levels, underscoring the importance of aerobic fitness in overall health.\n\n## Energy intake and its relationship with physical activity and protein\n\nEnergy intake is influenced by physical activity levels, and it is also associated with BMI. Protein intake is positively correlated with BMI, particularly animal protein, highlighting the complex relationships between nutritional factors, physical activity, and metabolic health.",
    "report_json": {
      "title": "Physical Activity and Nutrition in Type2 Diabetes",
      "summary": "The community revolves around the interplay of physical activity, nutrition, and type2 diabetes. Key entities include physiological processes like physical activity and energy intake, nutrients such as protein, and diseases like type2 diabetes. These entities are interconnected through their roles in metabolic health, insulin function, and disease risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of physical activity and nutritional factors on type2 diabetes risk and management.",
      "findings": [
        {
          "summary": "Physical activity's role in type2 diabetes and obesity risk",
          "explanation": "Physical activity is an environmental factor that may influence obesity risk and is associated with lower risk of type2 diabetes. It also interacts with genetic factors, such as the NRXN3 gene variant, in relation to colorectal cancer risk. Furthermore, physical activity levels can be influenced by age, with older adults potentially being less active."
        },
        {
          "summary": "Nutritional factors and type2 diabetes",
          "explanation": "Protein intake is positively associated with type2 diabetes risk and obesity risk. Additionally, protein has satiating properties, and its intake declines at higher levels of total energy intake. The pancreas plays a role in protein digestion and metabolism, highlighting the complex interplay between nutrition and physiological processes."
        },
        {
          "summary": "Interventions promoting physical activity",
          "explanation": "Interventions like COSTRIDE and HW aim to promote physical activity, but they differ in their approach. These interventions are crucial for improving physical activity outcomes and subsequently influencing metabolic health and disease risk."
        },
        {
          "summary": "The role of VO2 max in physical activity",
          "explanation": "VO2 max is a measure of an individual's aerobic fitness, reflecting the body's ability to utilize oxygen during exercise. It is related to physical activity levels, underscoring the importance of aerobic fitness in overall health."
        },
        {
          "summary": "Energy intake and its relationship with physical activity and protein",
          "explanation": "Energy intake is influenced by physical activity levels, and it is also associated with BMI. Protein intake is positively correlated with BMI, particularly animal protein, highlighting the complex relationships between nutritional factors, physical activity, and metabolic health."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 34",
    "edges": [
      [
        "\"PANCREAS\"",
        "\"PROTEIN\""
      ],
      [
        "\"COSTRIDE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"AGE\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"VO2 MAX\""
      ],
      [
        "\"COSTRIDE\"",
        "\"HW\""
      ],
      [
        "\"BMI\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"BMI\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"HW\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"PAR ASSESSMENT\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"BMI\"",
        "\"ENERGY INTAKE\""
      ],
      [
        "\"EPINEPHRINE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"PROTEIN\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"OBESITY\"",
        "\"PROTEIN\""
      ],
      [
        "\"AGE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"PROTEIN\""
      ],
      [
        "\"TYPE 2 DIABETES\"",
        "\"WALKING PACE\""
      ],
      [
        "\"OBESITY\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"RISK ESTIMATES\""
      ]
    ],
    "nodes": [
      "\"PAR ASSESSMENT\"",
      "\"VO2 MAX\"",
      "\"PROTEIN\"",
      "\"COSTRIDE\"",
      "\"TYPE 2 DIABETES\"",
      "\"EPINEPHRINE\"",
      "\"PHYSICAL ACTIVITY\"",
      "\"RISK ESTIMATES\"",
      "\"HW\"",
      "\"ENERGY INTAKE\"",
      "\"PANCREAS\""
    ],
    "chunk_ids": [
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-90dc49ded987f15e0a9242fc9bb82297",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.3333333333333333,
    "sub_communities": [
      "44",
      "45"
    ]
  },
  "20": {
    "report_string": "# Genetic Factors in Type 2 Diabetes Mellitus (T2DM)\n\nThe community revolves around Type 2 Diabetes Mellitus (T2DM), a metabolic disorder influenced by genetic and environmental factors. Key entities include genes such as TCF7L2, ABCC8, and KCNJ11, environmental factors like diet and family history, and physiological processes such as β-cell impairment. These entities are interconnected through their roles in insulin secretion, glucose metabolism, and disease risk.\n\n## TCF7L2 gene and its association with T2DM\n\nThe TCF7L2 gene is significantly associated with an increased risk of T2DM. Variants in this gene, such as rs7903146, have been linked to T2DM susceptibility. This highlights the importance of genetic testing for T2DM risk assessment.\n\n## Role of diet in T2DM risk\n\nDiet is an environmental factor that modulates T2DM risk. The relationship between diet and T2DM suggests that personalized dietary recommendations could play a crucial role in disease management and prevention.\n\n## ABCC8 gene and its polymorphisms in T2DM\n\nThe ABCC8 gene has polymorphisms associated with T2DM in Nigerians. This underscores the importance of population-specific genetic studies for understanding T2DM genetics.\n\n## Family history and T2DM heritability\n\nFamily history is an environmental factor associated with T2DM heritability. This highlights the role of genetic factors in T2DM susceptibility and the importance of considering family history in risk assessment.\n\n## KCNJ11 gene and its polymorphism in T2DM\n\nThe KCNJ11 gene has a polymorphism (rs5219) associated with T2DM. This polymorphism affects insulin secretion and highlights the role of genetic variants in T2DM pathophysiology.\n\n## β-cell impairment in T2DM\n\nβ-cell impairment is a characteristic of T2DM. The ZRANB3 gene is involved in β-cell functional response to high glucose conditions, associated with T2DM. This highlights the importance of understanding β-cell biology in T2DM.\n\n## GWAS and T2DM genetic variants\n\nGenome-wide association studies (GWAS) have identified several genetic variants associated with T2DM. This approach has been instrumental in understanding the genetic architecture of T2DM.\n\n## PACAP gene and its association with T2DM\n\nThe PACAP gene is associated with T2DM. Located in 18p11, PACAP's role in T2DM highlights the importance of genetic studies in identifying novel T2DM susceptibility loci.",
    "report_json": {
      "title": "Genetic Factors in Type 2 Diabetes Mellitus (T2DM)",
      "summary": "The community revolves around Type 2 Diabetes Mellitus (T2DM), a metabolic disorder influenced by genetic and environmental factors. Key entities include genes such as TCF7L2, ABCC8, and KCNJ11, environmental factors like diet and family history, and physiological processes such as β-cell impairment. These entities are interconnected through their roles in insulin secretion, glucose metabolism, and disease risk.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic factors on T2DM risk and management.",
      "findings": [
        {
          "summary": "TCF7L2 gene and its association with T2DM",
          "explanation": "The TCF7L2 gene is significantly associated with an increased risk of T2DM. Variants in this gene, such as rs7903146, have been linked to T2DM susceptibility. This highlights the importance of genetic testing for T2DM risk assessment."
        },
        {
          "summary": "Role of diet in T2DM risk",
          "explanation": "Diet is an environmental factor that modulates T2DM risk. The relationship between diet and T2DM suggests that personalized dietary recommendations could play a crucial role in disease management and prevention."
        },
        {
          "summary": "ABCC8 gene and its polymorphisms in T2DM",
          "explanation": "The ABCC8 gene has polymorphisms associated with T2DM in Nigerians. This underscores the importance of population-specific genetic studies for understanding T2DM genetics."
        },
        {
          "summary": "Family history and T2DM heritability",
          "explanation": "Family history is an environmental factor associated with T2DM heritability. This highlights the role of genetic factors in T2DM susceptibility and the importance of considering family history in risk assessment."
        },
        {
          "summary": "KCNJ11 gene and its polymorphism in T2DM",
          "explanation": "The KCNJ11 gene has a polymorphism (rs5219) associated with T2DM. This polymorphism affects insulin secretion and highlights the role of genetic variants in T2DM pathophysiology."
        },
        {
          "summary": "β-cell impairment in T2DM",
          "explanation": "β-cell impairment is a characteristic of T2DM. The ZRANB3 gene is involved in β-cell functional response to high glucose conditions, associated with T2DM. This highlights the importance of understanding β-cell biology in T2DM."
        },
        {
          "summary": "GWAS and T2DM genetic variants",
          "explanation": "Genome-wide association studies (GWAS) have identified several genetic variants associated with T2DM. This approach has been instrumental in understanding the genetic architecture of T2DM."
        },
        {
          "summary": "PACAP gene and its association with T2DM",
          "explanation": "The PACAP gene is associated with T2DM. Located in 18p11, PACAP's role in T2DM highlights the importance of genetic studies in identifying novel T2DM susceptibility loci."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 20",
    "edges": [
      [
        "\"T2DM\"",
        "\"TCF7L2\""
      ],
      [
        "\"IDE\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"ZRANB3\""
      ],
      [
        "\"SCL40A1\"",
        "\"T2DM\""
      ],
      [
        "\"PPAR-Α\"",
        "\"T2DM\""
      ],
      [
        "\"PFH\"",
        "\"T2DM\""
      ],
      [
        "\"MEILOUD\"",
        "\"T2DM\""
      ],
      [
        "\"SSA\"",
        "\"T2DM\""
      ],
      [
        "\"FAMILY HISTORY\"",
        "\"T2DM\""
      ],
      [
        "\"ERASMUS\"",
        "\"T2DM\""
      ],
      [
        "\"C2D4B\"",
        "\"T2DM\""
      ],
      [
        "\"CHROMOSOMAL LOCATION\"",
        "\"PACAP\""
      ],
      [
        "\"CDKAL1\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"TNF-Α\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2DM\""
      ],
      [
        "\"HAPTOGLOBIN\"",
        "\"T2DM\""
      ],
      [
        "\"FTO\"",
        "\"T2DM\""
      ],
      [
        "\"PPP1R5\"",
        "\"T2DM\""
      ],
      [
        "\"KCNJ11\"",
        "\"T2DM\""
      ],
      [
        "\"AGMO\"",
        "\"T2DM\""
      ],
      [
        "\"DIET\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"SNPS\"",
        "\"T2DM\""
      ],
      [
        "\"CHEN\"",
        "\"T2DM\""
      ],
      [
        "\"PTEN\"",
        "\"T2DM\""
      ],
      [
        "\"SLC30A8\"",
        "\"T2DM\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FAMILY HISTORY\""
      ],
      [
        "\"POLYMORPHISMS\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"Β-CELL\""
      ],
      [
        "\"PSMD6\"",
        "\"T2DM\""
      ],
      [
        "\"DIET\"",
        "\"T2DM\""
      ],
      [
        "\"PACAP\"",
        "\"T2DM\""
      ],
      [
        "\"AGRP\"",
        "\"T2DM\""
      ],
      [
        "\"CAPN10\"",
        "\"T2DM\""
      ],
      [
        "\"ACDC\"",
        "\"T2DM\""
      ],
      [
        "\"ABCC8\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"TCF7L2-RS7903146\""
      ],
      [
        "\"ADEYEMO\"",
        "\"T2DM\""
      ],
      [
        "\"ENPP1\"",
        "\"T2DM\""
      ],
      [
        "\"GWAS\"",
        "\"T2DM\""
      ],
      [
        "\"PPAR-Γ\"",
        "\"T2DM\""
      ],
      [
        "\"LINKAGE ANALYSIS\"",
        "\"T2DM\""
      ],
      [
        "\"PPARGC1\"",
        "\"T2DM\""
      ],
      [
        "\"IRS-1\"",
        "\"T2DM\""
      ]
    ],
    "nodes": [
      "\"SLC30A8\"",
      "\"IRS-1\"",
      "\"PFH\"",
      "\"KCNJ11\"",
      "\"ADEYEMO\"",
      "\"LINKAGE ANALYSIS\"",
      "\"CHEN\"",
      "\"TNF-Α\"",
      "\"T2DM\"",
      "\"MEILOUD\"",
      "\"PPP1R5\"",
      "\"FAMILY HISTORY\"",
      "\"PSMD6\"",
      "\"ZRANB3\"",
      "\"PPAR-Α\"",
      "\"HAPTOGLOBIN\"",
      "\"SSA\"",
      "\"CDKAL1\"",
      "\"TCF7L2\"",
      "\"ACDC\"",
      "\"ENPP1\"",
      "\"C2D4B\"",
      "\"DIET\"",
      "\"SCL40A1\"",
      "\"POLYMORPHISMS\"",
      "\"PTEN\"",
      "\"PACAP\"",
      "\"IDE\"",
      "\"AGMO\"",
      "\"ERASMUS\"",
      "\"AGRP\"",
      "\"ABCC8\"",
      "\"CAPN10\"",
      "\"PPAR-Γ\""
    ],
    "chunk_ids": [
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.25925925925925924,
    "sub_communities": []
  },
  "38": {
    "report_string": "# Macronutrient Intake and Genetic Influences\n\nThe community revolves around macronutrient intake as a physiological process influenced by genetic and environmental factors. Key entities include macronutrient intake, dietary patterns, brain and central nervous system, and various studies like the Health and Retirement Study and the Rotterdam Study. These entities are interconnected through their roles in regulating and influencing macronutrient intake, health outcomes, and genetic variations.\n\n## Macronutrient intake as a physiological process\n\nMacronutrient intake is a physiological process influenced by dietary patterns and genetic factors. This process is crucial for maintaining metabolic health and is regulated by various physiological processes including those involving the brain and central nervous system.\n\n## Role of genetic variation in macronutrient intake\n\nGenetic variations are associated with macronutrient intake, influencing individual preferences and metabolic responses to diet. This highlights the importance of personalized nutrition based on genetic profiles.\n\n## Influence of dietary patterns on macronutrient intake\n\nDietary patterns significantly influence macronutrient intake and are linked to various health outcomes. Understanding the interaction between dietary patterns and genetic factors can provide insights into effective nutritional interventions.\n\n## The role of the brain in regulating macronutrient intake\n\nThe brain plays a critical role in regulating macronutrient intake through appetite regulation and food preferences. This process is influenced by both genetic and environmental factors, making it a key area of study for understanding metabolic health.\n\n## Impact of cohort studies on understanding macronutrient intake\n\nCohort studies such as the Health and Retirement Study and the Rotterdam Study provide valuable insights into the relationship between macronutrient intake and health outcomes in different populations. These studies help in understanding how genetic and environmental factors interact to influence health.",
    "report_json": {
      "title": "Macronutrient Intake and Genetic Influences",
      "summary": "The community revolves around macronutrient intake as a physiological process influenced by genetic and environmental factors. Key entities include macronutrient intake, dietary patterns, brain and central nervous system, and various studies like the Health and Retirement Study and the Rotterdam Study. These entities are interconnected through their roles in regulating and influencing macronutrient intake, health outcomes, and genetic variations.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and dietary factors on macronutrient intake and its implications for health outcomes.",
      "findings": [
        {
          "summary": "Macronutrient intake as a physiological process",
          "explanation": "Macronutrient intake is a physiological process influenced by dietary patterns and genetic factors. This process is crucial for maintaining metabolic health and is regulated by various physiological processes including those involving the brain and central nervous system."
        },
        {
          "summary": "Role of genetic variation in macronutrient intake",
          "explanation": "Genetic variations are associated with macronutrient intake, influencing individual preferences and metabolic responses to diet. This highlights the importance of personalized nutrition based on genetic profiles."
        },
        {
          "summary": "Influence of dietary patterns on macronutrient intake",
          "explanation": "Dietary patterns significantly influence macronutrient intake and are linked to various health outcomes. Understanding the interaction between dietary patterns and genetic factors can provide insights into effective nutritional interventions."
        },
        {
          "summary": "The role of the brain in regulating macronutrient intake",
          "explanation": "The brain plays a critical role in regulating macronutrient intake through appetite regulation and food preferences. This process is influenced by both genetic and environmental factors, making it a key area of study for understanding metabolic health."
        },
        {
          "summary": "Impact of cohort studies on understanding macronutrient intake",
          "explanation": "Cohort studies such as the Health and Retirement Study and the Rotterdam Study provide valuable insights into the relationship between macronutrient intake and health outcomes in different populations. These studies help in understanding how genetic and environmental factors interact to influence health."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 38",
    "edges": [
      [
        "\"GENETIC VARIATION\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"DIETARY PATTERN\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"DIETARY PATTERN\""
      ],
      [
        "\"MACRONUTRIENT INTAKE\"",
        "\"POLYGENIC SCORE\""
      ],
      [
        "\"BRAIN\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"HEALTH AND RETIREMENT STUDY\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"MACRONUTRIENT INTAKE\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"MACRONUTRIENT INTAKE\"",
        "\"ROTTERDAM STUDY\""
      ],
      [
        "\"FGF21\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"BRAIN\"",
        "\"MACRONUTRIENTS\""
      ],
      [
        "\"CENTRAL NERVOUS SYSTEM\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"BMI\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"DIET\"",
        "\"MACRONUTRIENT INTAKE\""
      ]
    ],
    "nodes": [
      "\"HEALTH AND RETIREMENT STUDY\"",
      "\"PHYSIOLOGICAL PROCESS\"",
      "\"ROTTERDAM STUDY\"",
      "\"MACRONUTRIENT INTAKE\"",
      "\"DIETARY PATTERN\"",
      "\"BRAIN\"",
      "\"CENTRAL NERVOUS SYSTEM\""
    ],
    "chunk_ids": [
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.2222222222222222,
    "sub_communities": []
  },
  "33": {
    "report_string": "# BMI and Associated Genetic and Nutritional Factors\n\nThe community revolves around Body Mass Index (BMI), a measure of body fatness associated with various health risks. Key entities include genetic variants such as FTO gene variants (rs56137030, rs7185735), nutrients like macronutrients, and physiological processes like weight gain and body fat. These entities are interconnected through their roles in obesity risk, energy intake, and disease susceptibility.\n\n## BMI and its association with genetic variants\n\nBMI is associated with several genetic variants, including those in the FTO gene (rs56137030, rs7185735). These variants have been linked to increased BMI and obesity risk. For instance, the rs56137030 variant is associated with increased BMI, highlighting the role of genetics in body mass index.\n\n## Role of macronutrients in BMI\n\nMacronutrient intake affects BMI, as these nutrients provide energy and support growth and maintenance of the body. The relationship between macronutrients and BMI underscores the importance of dietary considerations in managing body mass index.\n\n## BMI and its relationship with physiological processes\n\nBMI is associated with various physiological processes, including weight gain and body fat. For example, weight gain during pregnancy is a physiological process that can impact BMI. Additionally, BMI is a measure of body fat, highlighting its relevance to physiological assessments.\n\n## FTO gene variants and their impact on BMI\n\nThe FTO gene is associated with BMI and obesity risk, with variants like rs7185735 being significant. These genetic associations highlight the role of FTO in regulating body mass index and obesity susceptibility.\n\n## BMI and health implications\n\nBMI is associated with various health implications, including coronary artery disease, type2 diabetes, and obesity. For instance, BMI is a measure used to assess obesity, and high BMI values are linked to increased risks of these diseases.",
    "report_json": {
      "title": "BMI and Associated Genetic and Nutritional Factors",
      "summary": "The community revolves around Body Mass Index (BMI), a measure of body fatness associated with various health risks. Key entities include genetic variants such as FTO gene variants (rs56137030, rs7185735), nutrients like macronutrients, and physiological processes like weight gain and body fat. These entities are interconnected through their roles in obesity risk, energy intake, and disease susceptibility.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and nutritional factors on BMI and associated health risks.",
      "findings": [
        {
          "summary": "BMI and its association with genetic variants",
          "explanation": "BMI is associated with several genetic variants, including those in the FTO gene (rs56137030, rs7185735). These variants have been linked to increased BMI and obesity risk. For instance, the rs56137030 variant is associated with increased BMI, highlighting the role of genetics in body mass index."
        },
        {
          "summary": "Role of macronutrients in BMI",
          "explanation": "Macronutrient intake affects BMI, as these nutrients provide energy and support growth and maintenance of the body. The relationship between macronutrients and BMI underscores the importance of dietary considerations in managing body mass index."
        },
        {
          "summary": "BMI and its relationship with physiological processes",
          "explanation": "BMI is associated with various physiological processes, including weight gain and body fat. For example, weight gain during pregnancy is a physiological process that can impact BMI. Additionally, BMI is a measure of body fat, highlighting its relevance to physiological assessments."
        },
        {
          "summary": "FTO gene variants and their impact on BMI",
          "explanation": "The FTO gene is associated with BMI and obesity risk, with variants like rs7185735 being significant. These genetic associations highlight the role of FTO in regulating body mass index and obesity susceptibility."
        },
        {
          "summary": "BMI and health implications",
          "explanation": "BMI is associated with various health implications, including coronary artery disease, type2 diabetes, and obesity. For instance, BMI is a measure used to assess obesity, and high BMI values are linked to increased risks of these diseases."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 33",
    "edges": [
      [
        "\"BMI\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"BODY FAT\"",
        "\"FTO GENE\""
      ],
      [
        "\"BMI\"",
        "\"RS3751812\""
      ],
      [
        "\"BMI\"",
        "\"MACRONUTRIENTS\""
      ],
      [
        "\"BMI\"",
        "\"WOMEN\""
      ],
      [
        "\"BMI\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"BMI\"",
        "\"MEN\""
      ],
      [
        "\"PREGNANCY\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"FTO\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"BMI\"",
        "\"RS56137030\""
      ],
      [
        "\"BMI\"",
        "\"SNPS\""
      ],
      [
        "\"BMI\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"BMI\"",
        "\"ENERGY INTAKE\""
      ],
      [
        "\"BRAIN\"",
        "\"MACRONUTRIENTS\""
      ],
      [
        "\"BMI\"",
        "\"FTO\""
      ],
      [
        "\"BMI\"",
        "\"MC4R SNPS\""
      ],
      [
        "\"BMI\"",
        "\"WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"BMI\"",
        "\"FTO SNPS\""
      ],
      [
        "\"BMI\"",
        "\"RS7185735\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"RS8050136\""
      ],
      [
        "\"BMI\"",
        "\"CORONARY ARTERY DISEASE\""
      ],
      [
        "\"BMI\"",
        "\"BODY FAT\""
      ],
      [
        "\"BMI\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"BMI\"",
        "\"FTO GENE VARIANTS\""
      ],
      [
        "\"BMI\"",
        "\"SNP\""
      ]
    ],
    "nodes": [
      "\"MEN\"",
      "\"RS7185735\"",
      "\"BMI\"",
      "\"BODY FAT\"",
      "\"WEIGHT GAIN\"",
      "\"MC4R SNPS\"",
      "\"WOMEN\"",
      "\"RS56137030\"",
      "\"MACRONUTRIENTS\""
    ],
    "chunk_ids": [
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.8148148148148148,
    "sub_communities": []
  },
  "39": {
    "report_string": "# FGF21 and Taste Preference Regulation\n\nThe community centers around FGF21, a protein influencing sweet and alcohol taste preference. It interacts with genes KLB and MLXIPL, which code for essential cofactor and transcription factor, respectively. These interactions suggest a complex regulatory network involving genetic and nutritional factors.\n\n## FGF21's role in taste preference\n\nFGF21 is a protein involved in sweet and alcohol taste preference via the liver-brain-endocrine axis. This indicates that FGF21 plays a role in regulating taste preferences, which can significantly impact dietary choices and nutrient intake.\n\n## KLB gene's interaction with FGF21\n\nThe KLB gene codes for an essential cofactor to FGF21, suggesting that variations in KLB could affect FGF21's function in taste preference regulation. This interaction highlights the genetic component of taste perception and its potential influence on dietary behaviors.\n\n## MLXIPL gene's role in FGF21 regulation\n\nThe MLXIPL gene codes for a transcription factor to FGF21, implying that MLXIPL variations could impact FGF21 expression and, consequently, taste preference. This points to a complex regulatory mechanism involving multiple genetic factors.\n\n## FGF21 and macronutrient intake relationship\n\nFGF21 influences macronutrient intake, likely through its effects on taste preference. This relationship suggests that FGF21 could play a role in shaping dietary habits and, potentially, metabolic health outcomes.",
    "report_json": {
      "title": "FGF21 and Taste Preference Regulation",
      "summary": "The community centers around FGF21, a protein influencing sweet and alcohol taste preference. It interacts with genes KLB and MLXIPL, which code for essential cofactor and transcription factor, respectively. These interactions suggest a complex regulatory network involving genetic and nutritional factors.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific but significant influence of FGF21 and its interacting genes on taste preference and potential implications for dietary behaviors.",
      "findings": [
        {
          "summary": "FGF21's role in taste preference",
          "explanation": "FGF21 is a protein involved in sweet and alcohol taste preference via the liver-brain-endocrine axis. This indicates that FGF21 plays a role in regulating taste preferences, which can significantly impact dietary choices and nutrient intake."
        },
        {
          "summary": "KLB gene's interaction with FGF21",
          "explanation": "The KLB gene codes for an essential cofactor to FGF21, suggesting that variations in KLB could affect FGF21's function in taste preference regulation. This interaction highlights the genetic component of taste perception and its potential influence on dietary behaviors."
        },
        {
          "summary": "MLXIPL gene's role in FGF21 regulation",
          "explanation": "The MLXIPL gene codes for a transcription factor to FGF21, implying that MLXIPL variations could impact FGF21 expression and, consequently, taste preference. This points to a complex regulatory mechanism involving multiple genetic factors."
        },
        {
          "summary": "FGF21 and macronutrient intake relationship",
          "explanation": "FGF21 influences macronutrient intake, likely through its effects on taste preference. This relationship suggests that FGF21 could play a role in shaping dietary habits and, potentially, metabolic health outcomes."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 39",
    "edges": [
      [
        "\"FGF21\"",
        "\"MLXIPL\""
      ],
      [
        "\"FGF21\"",
        "\"KLB\""
      ],
      [
        "\"FGF21\"",
        "\"MACRONUTRIENT INTAKE\""
      ]
    ],
    "nodes": [
      "\"MLXIPL\"",
      "\"KLB\"",
      "\"FGF21\""
    ],
    "chunk_ids": [
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0"
    ],
    "occurrence": 0.037037037037037035,
    "sub_communities": []
  },
  "32": {
    "report_string": "# Obesity and Genetic Factors\n\nThe community revolves around obesity, a disease associated with genetic and environmental factors. Key entities include genes such as FTO, MC4R, PPARG, and BDNF, nutrients like calcium and dietary fiber, and diseases like diabetes and hypertension. These entities are interconnected through their roles in obesity risk, metabolic health, and disease susceptibility.\n\n## FTO gene and obesity risk\n\nThe FTO gene is strongly associated with obesity risk and maternal pre-pregnancy body weight. Variants in the FTO gene, such as rs9939609, have been linked to increased obesity risk and waist circumference. This highlights the importance of genetic considerations in obesity management.\n\n## MC4R gene and obesity\n\nThe MC4R gene is associated with obesity and has a strong effect size. It also plays a role in colorectal cancer risk. This underscores the potential for targeted interventions based on genetic profiles to mitigate obesity and related health risks.\n\n## Nutrient influences on obesity\n\nCalcium and dietary fiber are nutrients that may influence obesity risk. These dietary factors can interact with genetic predispositions to affect obesity susceptibility. For instance, adequate calcium intake may help mitigate obesity risk, especially in individuals with certain genetic variants.\n\n## Obesity and disease associations\n\nObesity is associated with an increased risk of various health conditions, including diabetes, hypertension, and colorectal cancer. These relationships highlight the need for comprehensive approaches to obesity management that consider both genetic and lifestyle factors.\n\n## Genetic and environmental interactions\n\nThe community highlights the interplay between genetic factors (e.g., FTO, MC4R, PPARG genes) and environmental factors (e.g., education, physical activity, smoking) in influencing obesity risk. Understanding these interactions is crucial for developing personalized interventions.",
    "report_json": {
      "title": "Obesity and Genetic Factors",
      "summary": "The community revolves around obesity, a disease associated with genetic and environmental factors. Key entities include genes such as FTO, MC4R, PPARG, and BDNF, nutrients like calcium and dietary fiber, and diseases like diabetes and hypertension. These entities are interconnected through their roles in obesity risk, metabolic health, and disease susceptibility.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on obesity risk and its associated health conditions.",
      "findings": [
        {
          "summary": "FTO gene and obesity risk",
          "explanation": "The FTO gene is strongly associated with obesity risk and maternal pre-pregnancy body weight. Variants in the FTO gene, such as rs9939609, have been linked to increased obesity risk and waist circumference. This highlights the importance of genetic considerations in obesity management."
        },
        {
          "summary": "MC4R gene and obesity",
          "explanation": "The MC4R gene is associated with obesity and has a strong effect size. It also plays a role in colorectal cancer risk. This underscores the potential for targeted interventions based on genetic profiles to mitigate obesity and related health risks."
        },
        {
          "summary": "Nutrient influences on obesity",
          "explanation": "Calcium and dietary fiber are nutrients that may influence obesity risk. These dietary factors can interact with genetic predispositions to affect obesity susceptibility. For instance, adequate calcium intake may help mitigate obesity risk, especially in individuals with certain genetic variants."
        },
        {
          "summary": "Obesity and disease associations",
          "explanation": "Obesity is associated with an increased risk of various health conditions, including diabetes, hypertension, and colorectal cancer. These relationships highlight the need for comprehensive approaches to obesity management that consider both genetic and lifestyle factors."
        },
        {
          "summary": "Genetic and environmental interactions",
          "explanation": "The community highlights the interplay between genetic factors (e.g., FTO, MC4R, PPARG genes) and environmental factors (e.g., education, physical activity, smoking) in influencing obesity risk. Understanding these interactions is crucial for developing personalized interventions."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 32",
    "edges": [
      [
        "\"FTO PROTEIN\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PPARG\""
      ],
      [
        "\"HYPERTENSION\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"PPARG\""
      ],
      [
        "\"EDUCATION\"",
        "\"OBESITY\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"MC4R\""
      ],
      [
        "\"FTO\"",
        "\"MC4R\""
      ],
      [
        "\"OBESITY\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY\""
      ],
      [
        "\"LEPR\"",
        "\"OBESITY\""
      ],
      [
        "\"DIABETES\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"OBESITY\""
      ],
      [
        "\"CTNNBL1\"",
        "\"OBESITY\""
      ],
      [
        "\"CALCIUM\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"SMOKING\""
      ],
      [
        "\"GWAS ANALYSIS\"",
        "\"OBESITY\""
      ],
      [
        "\"FISHER'S EXACT TEST\"",
        "\"OBESITY\""
      ],
      [
        "\"NEUROPEPTIDE Y GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PROTEIN\""
      ],
      [
        "\"MC4R\"",
        "\"OBESITY\""
      ],
      [
        "\"BDNF\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"QUANTITATIVE MEASURES\""
      ],
      [
        "\"OBESITY\"",
        "\"SH2B1\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"OBESITY\""
      ],
      [
        "\"DIETARY FIBER\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"KCTD15\"",
        "\"OBESITY\""
      ],
      [
        "\"MULTIVITAMINS\"",
        "\"OBESITY\""
      ]
    ],
    "nodes": [
      "\"FTO PROTEIN\"",
      "\"FISHER'S EXACT TEST\"",
      "\"DIETARY FIBER\"",
      "\"EDUCATION\"",
      "\"QUANTITATIVE MEASURES\"",
      "\"PPARG\"",
      "\"HYPERTENSION\"",
      "\"BDNF\"",
      "\"DIABETES\"",
      "\"NEUROPEPTIDE Y GENE\"",
      "\"MULTIVITAMINS\"",
      "\"KCTD15\"",
      "\"MC4R\"",
      "\"OBESITY\"",
      "\"SH2B1\"",
      "\"CALCIUM\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.6296296296296297,
    "sub_communities": []
  },
  "40": {
    "report_string": "# Polygenic Score Community Involving Macronutrient Intake\n\nThe community centers around the POLYGENIC SCORE, a measure of genetic risk for complex traits, and its relationships with MACRONUTRIENT INTAKE and the LDPRED metabolic pathway. The POLYGENIC SCORE is influenced by LDPRED, which constructs polygenic scores, and predicts MACRONUTRIENT INTAKE.\n\n## POLYGENIC SCORE and its role in genetic risk assessment\n\nThe POLYGENIC SCORE is a measure of an individual's genetic risk for complex traits. It is influenced by multiple genetic variants and can be used to predict disease susceptibility. The score's connection to MACRONUTRIENT INTAKE suggests that genetic factors may play a role in dietary choices and metabolic health.\n\n## LDPRED and polygenic score construction\n\nLDPRED is a method used to construct polygenic scores. It plays a crucial role in understanding the genetic architecture of complex traits. The relationship between LDPRED and POLYGENIC SCORE highlights the importance of accurate polygenic score construction in assessing genetic risk.\n\n## MACRONUTRIENT INTAKE prediction by POLYGENIC SCORE\n\nThe POLYGENIC SCORE predicts MACRONUTRIENT INTAKE, suggesting that genetic factors may influence dietary choices. This relationship has implications for personalized nutrition and metabolic health, as individuals with certain genetic profiles may require tailored dietary recommendations.",
    "report_json": {
      "title": "Polygenic Score Community Involving Macronutrient Intake",
      "summary": "The community centers around the POLYGENIC SCORE, a measure of genetic risk for complex traits, and its relationships with MACRONUTRIENT INTAKE and the LDPRED metabolic pathway. The POLYGENIC SCORE is influenced by LDPRED, which constructs polygenic scores, and predicts MACRONUTRIENT INTAKE.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the emerging role of polygenic scores in understanding genetic risk and their potential influence on macronutrient intake.",
      "findings": [
        {
          "summary": "POLYGENIC SCORE and its role in genetic risk assessment",
          "explanation": "The POLYGENIC SCORE is a measure of an individual's genetic risk for complex traits. It is influenced by multiple genetic variants and can be used to predict disease susceptibility. The score's connection to MACRONUTRIENT INTAKE suggests that genetic factors may play a role in dietary choices and metabolic health."
        },
        {
          "summary": "LDPRED and polygenic score construction",
          "explanation": "LDPRED is a method used to construct polygenic scores. It plays a crucial role in understanding the genetic architecture of complex traits. The relationship between LDPRED and POLYGENIC SCORE highlights the importance of accurate polygenic score construction in assessing genetic risk."
        },
        {
          "summary": "MACRONUTRIENT INTAKE prediction by POLYGENIC SCORE",
          "explanation": "The POLYGENIC SCORE predicts MACRONUTRIENT INTAKE, suggesting that genetic factors may influence dietary choices. This relationship has implications for personalized nutrition and metabolic health, as individuals with certain genetic profiles may require tailored dietary recommendations."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 40",
    "edges": [
      [
        "\"MACRONUTRIENT INTAKE\"",
        "\"POLYGENIC SCORE\""
      ],
      [
        "\"LDPRED\"",
        "\"POLYGENIC SCORE\""
      ]
    ],
    "nodes": [
      "\"POLYGENIC SCORE\"",
      "\"LDPRED\""
    ],
    "chunk_ids": [
      "chunk-2f2c90dea13e0dad5235137b025e03b7"
    ],
    "occurrence": 0.037037037037037035,
    "sub_communities": []
  },
  "15": {
    "report_string": "# FTO Gene and Obesity Risk\n\nThe community revolves around the FTO gene, which is associated with obesity risk, body mass index (BMI), and fat mass. Key entities include the FTO gene, genomic variants like rs3751812 and rs8050136, and physiological processes such as muscle development. These entities are interconnected through their roles in obesity, BMI, and gene-gene interactions.\n\n## FTO gene association with obesity\n\nThe FTO gene is strongly associated with obesity risk, BMI, and fat mass. Variants in the FTO gene, such as rs3751812 and rs8050136, have been linked to increased obesity risk. The gene's role in obesity is further supported by its association with maternal pre-pregnancy body weight and colorectal cancer risk.\n\n## Genomic variants in FTO and their effects\n\nGenomic variants in the FTO gene, such as rs3751812 and rs8050136, are associated with BMI and obesity. These variants are located within highly sequence-conserved elements among vertebrates, highlighting their potential functional significance. The rs17817964 SNP has a strong association with LMI and is located within a candidate intronic regulatory element of the FTO gene.\n\n## FTO interactions with other genes and proteins\n\nThe FTO gene interacts with other genes and proteins, including IGF-1, IRX3, MYF5, MYF6, MYOD1, and MYOG, in gene-gene interaction networks. These interactions suggest a complex regulatory network influencing obesity and related traits. RPGRIP1L, a gene located downstream of FTO on chromosome 16q12.2, has also been identified as a neighbor gene to FTO.\n\n## FTO expression in skeletal muscle\n\nThe FTO gene is expressed in skeletal muscle tissue, which is relevant given its association with muscle development and LMI. This expression suggests a potential role for FTO in regulating muscle-related traits.\n\n## Ethnic group-specific associations\n\nThe FTO gene association with obesity risk varies in different ethnic groups, including Hispanic-Americans and Caucasians. This highlights the importance of considering population-specific genetic associations when studying obesity.",
    "report_json": {
      "title": "FTO Gene and Obesity Risk",
      "summary": "The community revolves around the FTO gene, which is associated with obesity risk, body mass index (BMI), and fat mass. Key entities include the FTO gene, genomic variants like rs3751812 and rs8050136, and physiological processes such as muscle development. These entities are interconnected through their roles in obesity, BMI, and gene-gene interactions.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant association of the FTO gene with obesity risk and related traits.",
      "findings": [
        {
          "summary": "FTO gene association with obesity",
          "explanation": "The FTO gene is strongly associated with obesity risk, BMI, and fat mass. Variants in the FTO gene, such as rs3751812 and rs8050136, have been linked to increased obesity risk. The gene's role in obesity is further supported by its association with maternal pre-pregnancy body weight and colorectal cancer risk."
        },
        {
          "summary": "Genomic variants in FTO and their effects",
          "explanation": "Genomic variants in the FTO gene, such as rs3751812 and rs8050136, are associated with BMI and obesity. These variants are located within highly sequence-conserved elements among vertebrates, highlighting their potential functional significance. The rs17817964 SNP has a strong association with LMI and is located within a candidate intronic regulatory element of the FTO gene."
        },
        {
          "summary": "FTO interactions with other genes and proteins",
          "explanation": "The FTO gene interacts with other genes and proteins, including IGF-1, IRX3, MYF5, MYF6, MYOD1, and MYOG, in gene-gene interaction networks. These interactions suggest a complex regulatory network influencing obesity and related traits. RPGRIP1L, a gene located downstream of FTO on chromosome 16q12.2, has also been identified as a neighbor gene to FTO."
        },
        {
          "summary": "FTO expression in skeletal muscle",
          "explanation": "The FTO gene is expressed in skeletal muscle tissue, which is relevant given its association with muscle development and LMI. This expression suggests a potential role for FTO in regulating muscle-related traits."
        },
        {
          "summary": "Ethnic group-specific associations",
          "explanation": "The FTO gene association with obesity risk varies in different ethnic groups, including Hispanic-Americans and Caucasians. This highlights the importance of considering population-specific genetic associations when studying obesity."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 15",
    "edges": [
      [
        "\"FTO\"",
        "\"LEPR\""
      ],
      [
        "\"FTO\"",
        "\"SKELETAL MUSCLE\""
      ],
      [
        "\"CAUCASIANS\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"PPARG\""
      ],
      [
        "\"FTO\"",
        "\"MYF5\""
      ],
      [
        "\"FTO\"",
        "\"INTRON1\""
      ],
      [
        "\"FTO\"",
        "\"MUSCLE DEVELOPMENT\""
      ],
      [
        "\"FTO\"",
        "\"RS1421085\""
      ],
      [
        "\"FTO\"",
        "\"HISPANIC-AMERICANS\""
      ],
      [
        "\"FTO\"",
        "\"LMI\""
      ],
      [
        "\"FTO\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"BMI\"",
        "\"RS3751812\""
      ],
      [
        "\"FTO\"",
        "\"MC4R\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"MYF6\""
      ],
      [
        "\"FTO\"",
        "\"GWAS\""
      ],
      [
        "\"CTNNBL1\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"T2DM\""
      ],
      [
        "\"FTO INTRON1 REGION\"",
        "\"FTO\""
      ],
      [
        "\"EXONS\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"RS8051873\""
      ],
      [
        "\"FTO\"",
        "\"RS8050136\""
      ],
      [
        "\"FTO\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"RS3751812\"",
        "\"SEQUENCE-CONSERVED ELEMENT\""
      ],
      [
        "\"16Q12.2/FTO FINE-MAPPING REGION\"",
        "\"FTO\""
      ],
      [
        "\"BMI\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"FTO\"",
        "\"IGF-1\""
      ],
      [
        "\"FTO\"",
        "\"RS17817964\""
      ],
      [
        "\"FTO\"",
        "\"MYOD1\""
      ],
      [
        "\"BMI\"",
        "\"RS8050136\""
      ],
      [
        "\"RS8050136\"",
        "\"SNP\""
      ],
      [
        "\"FTO\"",
        "\"IRX3\""
      ],
      [
        "\"FTO\"",
        "\"RS3751812\""
      ],
      [
        "\"FTO\"",
        "\"MYOG\""
      ],
      [
        "\"FTO\"",
        "\"GENE/LOCUS\""
      ]
    ],
    "nodes": [
      "\"RS8050136\"",
      "\"GENE/LOCUS\"",
      "\"SEQUENCE-CONSERVED ELEMENT\"",
      "\"16Q12.2/FTO FINE-MAPPING REGION\"",
      "\"CAUCASIANS\"",
      "\"MUSCLE DEVELOPMENT\"",
      "\"SKELETAL MUSCLE\"",
      "\"FTO\"",
      "\"IGF-1\"",
      "\"MYOD1\"",
      "\"IRX3\"",
      "\"RS17817964\"",
      "\"RPGRIP1L\"",
      "\"MYOG\"",
      "\"RS3751812\"",
      "\"MYF6\"",
      "\"MYF5\"",
      "\"EXONS\"",
      "\"FTO INTRON1 REGION\"",
      "\"INTRON1\""
    ],
    "chunk_ids": [
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d"
    ],
    "occurrence": 0.6296296296296297,
    "sub_communities": []
  },
  "36": {
    "report_string": "# Physical Activity and Health Outcomes\n\nThe community revolves around self-reported walking pace and its associations with various physiological processes, diseases, and genetic factors. Key entities include self-reported walking pace, FEV1, FVC, depressive symptoms, and genetic variants. These entities are interconnected through their roles in physical activity, lung function, mental health, and disease susceptibility.\n\n## Association between self-reported walking pace and lung function\n\nSelf-reported walking pace is associated with lung function, as measured by FEV1 and FVC. This relationship suggests that physical activity, as reported by individuals, has a positive impact on respiratory health. The association is supported by the relationship between walking pace and FEV1, as well as FVC, which are both measures of lung function.\n\n## Relationship between self-reported walking pace and mental health\n\nSelf-reported walking pace is associated with depressive symptoms and psychiatric disease. This relationship highlights the importance of physical activity in maintaining mental health. The connection between walking pace and mental health outcomes suggests that regular physical activity may have a positive impact on reducing symptoms of depression and other psychiatric conditions.\n\n## Genetic variants and self-reported walking pace\n\nA genetic variant is associated with self-reported walking pace, suggesting that genetic factors may influence physical activity levels. This relationship highlights the complex interplay between genetic predispositions and lifestyle factors in determining health outcomes.\n\n## Self-reported walking pace and disease susceptibility\n\nSelf-reported walking pace is associated with various diseases, including coronary artery disease, adiposity, and insomnia. This relationship suggests that regular physical activity, as reported by individuals, may have a protective effect against certain diseases. The connections between walking pace and disease susceptibility emphasize the importance of physical activity in maintaining overall health.\n\n## Self-reported walking pace and cognitive function\n\nSelf-reported walking pace is associated with intelligence and years of schooling, suggesting a relationship between physical activity and cognitive function. This connection highlights the potential benefits of regular physical activity on cognitive health and educational attainment.",
    "report_json": {
      "title": "Physical Activity and Health Outcomes",
      "summary": "The community revolves around self-reported walking pace and its associations with various physiological processes, diseases, and genetic factors. Key entities include self-reported walking pace, FEV1, FVC, depressive symptoms, and genetic variants. These entities are interconnected through their roles in physical activity, lung function, mental health, and disease susceptibility.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant associations between self-reported walking pace and various health outcomes, including lung function, mental health, and disease susceptibility.",
      "findings": [
        {
          "summary": "Association between self-reported walking pace and lung function",
          "explanation": "Self-reported walking pace is associated with lung function, as measured by FEV1 and FVC. This relationship suggests that physical activity, as reported by individuals, has a positive impact on respiratory health. The association is supported by the relationship between walking pace and FEV1, as well as FVC, which are both measures of lung function."
        },
        {
          "summary": "Relationship between self-reported walking pace and mental health",
          "explanation": "Self-reported walking pace is associated with depressive symptoms and psychiatric disease. This relationship highlights the importance of physical activity in maintaining mental health. The connection between walking pace and mental health outcomes suggests that regular physical activity may have a positive impact on reducing symptoms of depression and other psychiatric conditions."
        },
        {
          "summary": "Genetic variants and self-reported walking pace",
          "explanation": "A genetic variant is associated with self-reported walking pace, suggesting that genetic factors may influence physical activity levels. This relationship highlights the complex interplay between genetic predispositions and lifestyle factors in determining health outcomes."
        },
        {
          "summary": "Self-reported walking pace and disease susceptibility",
          "explanation": "Self-reported walking pace is associated with various diseases, including coronary artery disease, adiposity, and insomnia. This relationship suggests that regular physical activity, as reported by individuals, may have a protective effect against certain diseases. The connections between walking pace and disease susceptibility emphasize the importance of physical activity in maintaining overall health."
        },
        {
          "summary": "Self-reported walking pace and cognitive function",
          "explanation": "Self-reported walking pace is associated with intelligence and years of schooling, suggesting a relationship between physical activity and cognitive function. This connection highlights the potential benefits of regular physical activity on cognitive health and educational attainment."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 36",
    "edges": [
      [
        "\"LONGEVITY\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"GLYCEMIC TRAITS\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"CORONARY ARTERY DISEASE\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"FVC\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"MUSCULAR STRENGTH\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"LUNG FUNCTION\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"DEPRESSIVE SYMPTOMS\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"PSYCHIATRIC DISEASE\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"GENETIC VARIANT\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"INSONNIA\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"SELF-REPORTED WALKING PACE\"",
        "\"YEARS OF SCHOOLING\""
      ],
      [
        "\"FEV1\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"INTELLIGENCE\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"FEV1\"",
        "\"WALKING PACE\""
      ]
    ],
    "nodes": [
      "\"YEARS OF SCHOOLING\"",
      "\"DEPRESSIVE SYMPTOMS\"",
      "\"GENETIC VARIANT\"",
      "\"INSONNIA\"",
      "\"FEV1\"",
      "\"GLYCEMIC TRAITS\"",
      "\"INTELLIGENCE\"",
      "\"LUNG FUNCTION\"",
      "\"PSYCHIATRIC DISEASE\"",
      "\"MUSCULAR STRENGTH\"",
      "\"FVC\"",
      "\"LONGEVITY\"",
      "\"SELF-REPORTED WALKING PACE\""
    ],
    "chunk_ids": [
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da"
    ],
    "occurrence": 0.14814814814814814,
    "sub_communities": []
  },
  "25": {
    "report_string": "# Genetic and Environmental Factors in Obesity\n\nThe community revolves around genetic and environmental factors influencing obesity, with key entities including FTO gene variants, age, sex, and physiological processes like fat mass (FM). These entities are interconnected through their roles in obesity traits, disease risk, and genetic associations.\n\n## FTO gene variants and obesity traits\n\nFTO gene variants, such as rs7185735, rs9922708, and rs17817449, are associated with obesity traits. The association of these variants with obesity varies among different ethnic groups, highlighting the importance of considering genetic and environmental factors in obesity risk assessment.\n\n## Age and obesity risk\n\nAge is an environmental factor that influences obesity risk, with older adults potentially being less active. The relationship between age and obesity highlights the need for age-specific interventions to manage obesity.\n\n## Sex and obesity risk\n\nSex is a biological factor that can influence the association between genetic variants and obesity. The association of FTO gene variants with obesity traits differs between males and females, underscoring the importance of considering sex in obesity risk assessment.\n\n## FTO gene variants and fat mass (FM)\n\nFTO gene variants are associated with FM values, which is a physiological process used to measure fat mass. This relationship highlights the role of genetic factors in obesity-related physiological processes.\n\n## Meta-analysis and FTO gene variants\n\nMeta-analysis is a statistical method used to combine results for FTO gene variants, which helps to identify significant associations between these variants and obesity traits.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Obesity",
      "summary": "The community revolves around genetic and environmental factors influencing obesity, with key entities including FTO gene variants, age, sex, and physiological processes like fat mass (FM). These entities are interconnected through their roles in obesity traits, disease risk, and genetic associations.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and environmental factors on obesity risk and management.",
      "findings": [
        {
          "summary": "FTO gene variants and obesity traits",
          "explanation": "FTO gene variants, such as rs7185735, rs9922708, and rs17817449, are associated with obesity traits. The association of these variants with obesity varies among different ethnic groups, highlighting the importance of considering genetic and environmental factors in obesity risk assessment."
        },
        {
          "summary": "Age and obesity risk",
          "explanation": "Age is an environmental factor that influences obesity risk, with older adults potentially being less active. The relationship between age and obesity highlights the need for age-specific interventions to manage obesity."
        },
        {
          "summary": "Sex and obesity risk",
          "explanation": "Sex is a biological factor that can influence the association between genetic variants and obesity. The association of FTO gene variants with obesity traits differs between males and females, underscoring the importance of considering sex in obesity risk assessment."
        },
        {
          "summary": "FTO gene variants and fat mass (FM)",
          "explanation": "FTO gene variants are associated with FM values, which is a physiological process used to measure fat mass. This relationship highlights the role of genetic factors in obesity-related physiological processes."
        },
        {
          "summary": "Meta-analysis and FTO gene variants",
          "explanation": "Meta-analysis is a statistical method used to combine results for FTO gene variants, which helps to identify significant associations between these variants and obesity traits."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 25",
    "edges": [
      [
        "\"ETHNICITY\"",
        "\"FTO GENE VARIANTS\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"SEX\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"META-ANALYSIS\""
      ],
      [
        "\"ETHNIC GROUP\"",
        "\"FTO GENE VARIANTS\""
      ],
      [
        "\"AGE\"",
        "\"COLORECTAL CANCER\""
      ],
      [
        "\"FM\"",
        "\"FTO GENE VARIANTS\""
      ],
      [
        "\"BMI\"",
        "\"FTO GENE VARIANTS\""
      ],
      [
        "\"AGE\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"SEX\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"SNP\""
      ],
      [
        "\"AGE\"",
        "\"GENDER\""
      ],
      [
        "\"AGE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"AGE\"",
        "\"SEX\""
      ]
    ],
    "nodes": [
      "\"FM\"",
      "\"ETHNIC GROUP\"",
      "\"AGE\"",
      "\"FTO GENE VARIANTS\"",
      "\"META-ANALYSIS\"",
      "\"GENDER\"",
      "\"SEX\""
    ],
    "chunk_ids": [
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-23f99f090070aea487163f2778574849",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.2962962962962963,
    "sub_communities": []
  },
  "37": {
    "report_string": "# Genetic and Physiological Associations with Walking Pace\n\nThe community revolves around walking pace, a physiological process genetically predicted and associated with various cardiometabolic, respiratory, psychiatric, and sleeping traits. Key entities include physiological processes like fasting insulin, HOMA-IR, and waist-to-hip ratio, as well as nutrient HDL cholesterol. These entities are interconnected through their associations with walking pace and its impact on health outcomes.\n\n## Walking Pace and Cardiometabolic Traits\n\nWalking pace is associated with cardiometabolic traits, including fasting insulin and HDL cholesterol levels. This relationship suggests that walking pace could be an important factor in managing metabolic health. For instance, a faster walking pace is linked to lower fasting insulin levels and higher HDL cholesterol levels, both of which are beneficial for reducing the risk of type2 diabetes and cardiovascular disease.\n\n## Impact of Walking Pace on Type2 Diabetes\n\nThere is evidence that walking pace is associated with a lower risk of type2 diabetes. This association highlights the potential for walking pace to serve as a modifiable risk factor for type2 diabetes. Individuals with a faster walking pace tend to have a lower risk of developing type2 diabetes, suggesting that promoting walking pace could be a useful strategy in diabetes prevention programs.\n\n## Walking Pace and Respiratory Traits\n\nWalking pace is associated with respiratory traits, as indicated by its relationship with FEV1. This connection implies that walking pace could influence or be a marker of respiratory health. A faster walking pace is linked to higher FEV1 values, which is indicative of better lung function.\n\n## Psychiatric and Sleeping Traits Associations\n\nWalking pace is associated with psychiatric and sleeping traits. This suggests that walking pace could have a broader impact on overall health, including mental health and sleep quality. The relationship between walking pace and these traits underscores the importance of considering physical activity in the management of psychiatric and sleep disorders.\n\n## Role of Multivariable MR in Understanding Causal Effects\n\nMultivariable MR is used to test the direct causal effect of walking pace on various health outcomes. This methodological approach helps in understanding the causal relationships between walking pace and health outcomes, providing insights into potential interventions.",
    "report_json": {
      "title": "Genetic and Physiological Associations with Walking Pace",
      "summary": "The community revolves around walking pace, a physiological process genetically predicted and associated with various cardiometabolic, respiratory, psychiatric, and sleeping traits. Key entities include physiological processes like fasting insulin, HOMA-IR, and waist-to-hip ratio, as well as nutrient HDL cholesterol. These entities are interconnected through their associations with walking pace and its impact on health outcomes.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant associations of walking pace with various health outcomes, including cardiometabolic traits, type2 diabetes, and psychiatric traits.",
      "findings": [
        {
          "summary": "Walking Pace and Cardiometabolic Traits",
          "explanation": "Walking pace is associated with cardiometabolic traits, including fasting insulin and HDL cholesterol levels. This relationship suggests that walking pace could be an important factor in managing metabolic health. For instance, a faster walking pace is linked to lower fasting insulin levels and higher HDL cholesterol levels, both of which are beneficial for reducing the risk of type2 diabetes and cardiovascular disease."
        },
        {
          "summary": "Impact of Walking Pace on Type2 Diabetes",
          "explanation": "There is evidence that walking pace is associated with a lower risk of type2 diabetes. This association highlights the potential for walking pace to serve as a modifiable risk factor for type2 diabetes. Individuals with a faster walking pace tend to have a lower risk of developing type2 diabetes, suggesting that promoting walking pace could be a useful strategy in diabetes prevention programs."
        },
        {
          "summary": "Walking Pace and Respiratory Traits",
          "explanation": "Walking pace is associated with respiratory traits, as indicated by its relationship with FEV1. This connection implies that walking pace could influence or be a marker of respiratory health. A faster walking pace is linked to higher FEV1 values, which is indicative of better lung function."
        },
        {
          "summary": "Psychiatric and Sleeping Traits Associations",
          "explanation": "Walking pace is associated with psychiatric and sleeping traits. This suggests that walking pace could have a broader impact on overall health, including mental health and sleep quality. The relationship between walking pace and these traits underscores the importance of considering physical activity in the management of psychiatric and sleep disorders."
        },
        {
          "summary": "Role of Multivariable MR in Understanding Causal Effects",
          "explanation": "Multivariable MR is used to test the direct causal effect of walking pace on various health outcomes. This methodological approach helps in understanding the causal relationships between walking pace and health outcomes, providing insights into potential interventions."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 37",
    "edges": [
      [
        "\"TYPE 2 DIABETES\"",
        "\"WALKING PACE\""
      ],
      [
        "\"CORONARY ARTERY DISEASE\"",
        "\"WALKING PACE\""
      ],
      [
        "\"SLEEPING TRAITS\"",
        "\"WALKING PACE\""
      ],
      [
        "\"HDL CHOLESTEROL\"",
        "\"WALKING PACE\""
      ],
      [
        "\"CARDIOMETABOLIC TRAITS\"",
        "\"WALKING PACE\""
      ],
      [
        "\"PSYCHIATRIC TRAITS\"",
        "\"WALKING PACE\""
      ],
      [
        "\"MULTIVARIABLE MR\"",
        "\"WALKING PACE\""
      ],
      [
        "\"FASTING INSULIN\"",
        "\"WALKING PACE\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"WALKING PACE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"WALKING PACE\""
      ],
      [
        "\"HOMA-IR\"",
        "\"WALKING PACE\""
      ],
      [
        "\"RESPIRATORY TRAITS\"",
        "\"WALKING PACE\""
      ],
      [
        "\"FEV1\"",
        "\"WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"WALKING PACE\""
      ],
      [
        "\"WAIST-TO-HIP RATIO\"",
        "\"WALKING PACE\""
      ]
    ],
    "nodes": [
      "\"FASTING INSULIN\"",
      "\"WAIST-TO-HIP RATIO\"",
      "\"WALKING PACE\"",
      "\"HOMA-IR\"",
      "\"RESPIRATORY TRAITS\"",
      "\"HDL CHOLESTEROL\"",
      "\"SLEEPING TRAITS\"",
      "\"MULTIVARIABLE MR\"",
      "\"PSYCHIATRIC TRAITS\"",
      "\"CARDIOMETABOLIC TRAITS\""
    ],
    "chunk_ids": [
      "chunk-b7e190953e4c769a8b651f251bf00588"
    ],
    "occurrence": 0.037037037037037035,
    "sub_communities": []
  },
  "28": {
    "report_string": "# FTO Gene and Obesity-Associated Genetic Variants\n\nThe community revolves around the FTO gene and its associations with obesity, body fat, and related genetic variants. Key entities include the FTO gene, genomic variants like SNP rs9939609 and rs116917414, and physiological processes such as anthropometric measures. These entities are interconnected through their roles in obesity risk, genetic associations, and molecular interactions.\n\n## FTO gene and obesity association\n\nThe FTO gene is strongly associated with obesity and waist circumference. This association is supported by multiple lines of evidence, including genetic studies and anthropometric measures. The FTO gene's role in body fat regulation and obesity risk is well-documented.\n\n## SNP rs9939609 and obesity\n\nSNP rs9939609 is a genomic variant associated with obesity and waist circumference. It has a p-value of 1.32×10−9 in joint analyses, indicating a significant association with obesity risk. This variant's impact on obesity highlights the importance of genetic factors in disease susceptibility.\n\n## FTO gene and colorectal cancer risk\n\nThe FTO gene is associated with an increased risk of colorectal cancer. This association suggests that the gene's influence extends beyond obesity and body fat regulation, potentially impacting other disease pathways.\n\n## Genetic variation and anthropometric measures\n\nGenetic variation, particularly in the FTO gene, is associated with anthropometric measures. This relationship underscores the importance of considering genetic factors in the assessment of body traits and disease risk.\n\n## Molecular interactions in FTO gene analysis\n\nThe analysis of the FTO gene involves various molecular interactions, including SOLID sequencing and iSelect genotyping. These techniques are used to sequence the FTO gene and surrounding sequence, and to analyze genetic associations with disease.",
    "report_json": {
      "title": "FTO Gene and Obesity-Associated Genetic Variants",
      "summary": "The community revolves around the FTO gene and its associations with obesity, body fat, and related genetic variants. Key entities include the FTO gene, genomic variants like SNP rs9939609 and rs116917414, and physiological processes such as anthropometric measures. These entities are interconnected through their roles in obesity risk, genetic associations, and molecular interactions.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of the FTO gene and associated genetic variants on obesity risk and related traits.",
      "findings": [
        {
          "summary": "FTO gene and obesity association",
          "explanation": "The FTO gene is strongly associated with obesity and waist circumference. This association is supported by multiple lines of evidence, including genetic studies and anthropometric measures. The FTO gene's role in body fat regulation and obesity risk is well-documented."
        },
        {
          "summary": "SNP rs9939609 and obesity",
          "explanation": "SNP rs9939609 is a genomic variant associated with obesity and waist circumference. It has a p-value of 1.32×10−9 in joint analyses, indicating a significant association with obesity risk. This variant's impact on obesity highlights the importance of genetic factors in disease susceptibility."
        },
        {
          "summary": "FTO gene and colorectal cancer risk",
          "explanation": "The FTO gene is associated with an increased risk of colorectal cancer. This association suggests that the gene's influence extends beyond obesity and body fat regulation, potentially impacting other disease pathways."
        },
        {
          "summary": "Genetic variation and anthropometric measures",
          "explanation": "Genetic variation, particularly in the FTO gene, is associated with anthropometric measures. This relationship underscores the importance of considering genetic factors in the assessment of body traits and disease risk."
        },
        {
          "summary": "Molecular interactions in FTO gene analysis",
          "explanation": "The analysis of the FTO gene involves various molecular interactions, including SOLID sequencing and iSelect genotyping. These techniques are used to sequence the FTO gene and surrounding sequence, and to analyze genetic associations with disease."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 28",
    "edges": [
      [
        "\"FTO GENE\"",
        "\"SNP RS116917414\""
      ],
      [
        "\"DNA\"",
        "\"FTO GENE\""
      ],
      [
        "\"ANTHROPOMETRIC MEASURES\"",
        "\"GENETIC VARIATION\""
      ],
      [
        "\"FTO GENE\"",
        "\"ISELECT GENOTYPING\""
      ],
      [
        "\"PCR ENRICHMENT\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO GENE\""
      ],
      [
        "\"FTO GENE\"",
        "\"GWAS\""
      ],
      [
        "\"OBESITY\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP\""
      ],
      [
        "\"MO DISEASE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"BODY FAT\"",
        "\"FTO GENE\""
      ],
      [
        "\"FTO GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"FTO GENE\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"FTO GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNPS\""
      ],
      [
        "\"ADIPOKINE LEVELS\"",
        "\"FTO GENE\""
      ],
      [
        "\"ANTHROPOMETRIC MEASURES\"",
        "\"FTO GENE\""
      ]
    ],
    "nodes": [
      "\"ISELECT GENOTYPING\"",
      "\"ANTHROPOMETRIC MEASURES\"",
      "\"FTO GENE\"",
      "\"SNP RS9939609\"",
      "\"SOLID SEQUENCING\"",
      "\"DNA\"",
      "\"SNP RS116917414\"",
      "\"PCR ENRICHMENT\"",
      "\"ADIPOKINE LEVELS\""
    ],
    "chunk_ids": [
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.25925925925925924,
    "sub_communities": []
  },
  "24": {
    "report_string": "# Colorectal Cancer Genetic and Environmental Factors\n\nThe community revolves around colorectal cancer, influenced by genetic variants, nutrients, and environmental factors. Key entities include colorectal cancer, FTO SNPs, adiponectin, leptin, and environmental factors like physical activity level and total energy intake. These entities interact through their roles in cancer risk, metabolism, and obesity.\n\n## FTO SNPs and colorectal cancer risk\n\nFTO SNPs are associated with an increased risk of colorectal cancer. They are also linked to BMI, suggesting a potential pathway through which obesity influences cancer risk. However, the relationship is complex and may involve interactions with dietary patterns and physical activity levels.\n\n## Adiponectin and leptin in colorectal cancer\n\nAdiponectin is inversely associated with the incidence of colorectal cancer, while leptin is positively associated. These adipokines play roles in metabolic processes and may interact with genetic variants to influence cancer risk. Their opposing effects highlight the complexity of metabolic factors in colorectal cancer.\n\n## Environmental factors and colorectal cancer risk\n\nEnvironmental factors such as physical activity level, total energy intake, and postmenopausal hormone treatment are associated with colorectal cancer risk. These factors may interact with genetic variants and nutrients to influence cancer development. For example, physical activity has been shown to reduce risk, while high energy intake may increase it.\n\n## MC4R and KCTD15 variants in colorectal cancer\n\nThe MC4R rs17782313 and KCTD15 rs29941 variants are associated with colorectal cancer risk. These genetic variants may influence metabolic pathways and interact with environmental factors to affect cancer susceptibility. Their study highlights the importance of genetic factors in colorectal cancer.\n\n## NRXN3 gene variant and colorectal cancer\n\nThe NRXN3 gene variant is associated with colorectal cancer risk. This variant may interact with dietary patterns and other genetic factors to influence cancer development. The NRXN3 gene's role in neurotransmission and potential effects on metabolism could underlie its association with cancer risk.",
    "report_json": {
      "title": "Colorectal Cancer Genetic and Environmental Factors",
      "summary": "The community revolves around colorectal cancer, influenced by genetic variants, nutrients, and environmental factors. Key entities include colorectal cancer, FTO SNPs, adiponectin, leptin, and environmental factors like physical activity level and total energy intake. These entities interact through their roles in cancer risk, metabolism, and obesity.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and environmental factors on colorectal cancer risk.",
      "findings": [
        {
          "summary": "FTO SNPs and colorectal cancer risk",
          "explanation": "FTO SNPs are associated with an increased risk of colorectal cancer. They are also linked to BMI, suggesting a potential pathway through which obesity influences cancer risk. However, the relationship is complex and may involve interactions with dietary patterns and physical activity levels."
        },
        {
          "summary": "Adiponectin and leptin in colorectal cancer",
          "explanation": "Adiponectin is inversely associated with the incidence of colorectal cancer, while leptin is positively associated. These adipokines play roles in metabolic processes and may interact with genetic variants to influence cancer risk. Their opposing effects highlight the complexity of metabolic factors in colorectal cancer."
        },
        {
          "summary": "Environmental factors and colorectal cancer risk",
          "explanation": "Environmental factors such as physical activity level, total energy intake, and postmenopausal hormone treatment are associated with colorectal cancer risk. These factors may interact with genetic variants and nutrients to influence cancer development. For example, physical activity has been shown to reduce risk, while high energy intake may increase it."
        },
        {
          "summary": "MC4R and KCTD15 variants in colorectal cancer",
          "explanation": "The MC4R rs17782313 and KCTD15 rs29941 variants are associated with colorectal cancer risk. These genetic variants may influence metabolic pathways and interact with environmental factors to affect cancer susceptibility. Their study highlights the importance of genetic factors in colorectal cancer."
        },
        {
          "summary": "NRXN3 gene variant and colorectal cancer",
          "explanation": "The NRXN3 gene variant is associated with colorectal cancer risk. This variant may interact with dietary patterns and other genetic factors to influence cancer development. The NRXN3 gene's role in neurotransmission and potential effects on metabolism could underlie its association with cancer risk."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 24",
    "edges": [
      [
        "\"COLORECTAL CANCER\"",
        "\"KCTD15 RS29941\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS8046502\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"SNPS\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"MC4R\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS10146997\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"LEPTIN\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"POSTMENOPAUSAL HORMONE TREATMENT\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS4784329\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"OBESITY\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO SNPS\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"PHYSICAL ACTIVITY LEVEL\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"MC4R RS17782313\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"SMOKING\""
      ],
      [
        "\"BMI\"",
        "\"FTO SNPS\""
      ],
      [
        "\"COLON CANCER\"",
        "\"COLORECTAL CANCER\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RECTAL CANCER\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"DIETARY PATTERN\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"SEX\""
      ],
      [
        "\"ADIPONECTIN\"",
        "\"COLORECTAL CANCER\""
      ],
      [
        "\"AGE\"",
        "\"COLORECTAL CANCER\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO GENE\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"TOTAL ENERGY INTAKE\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"NRXN3\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FAMILY HISTORY\""
      ]
    ],
    "nodes": [
      "\"PHYSICAL ACTIVITY LEVEL\"",
      "\"MC4R RS17782313\"",
      "\"POSTMENOPAUSAL HORMONE TREATMENT\"",
      "\"FTO SNPS\"",
      "\"RECTAL CANCER\"",
      "\"RS8046502\"",
      "\"LEPTIN\"",
      "\"COLON CANCER\"",
      "\"ADIPONECTIN\"",
      "\"COLORECTAL CANCER\"",
      "\"KCTD15 RS29941\"",
      "\"TOTAL ENERGY INTAKE\"",
      "\"RS4784329\""
    ],
    "chunk_ids": [
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.2222222222222222,
    "sub_communities": []
  },
  "18": {
    "report_string": "# LEPR Gene and Obesity Phenotypes in African-Americans\n\nThe community centers around the LEPR gene, which is associated with obesity phenotypes, particularly in African-Americans. The LEPR gene interacts with other entities such as FTO and obesity, highlighting its significance in obesity traits.\n\n## LEPR gene association with obesity phenotypes\n\nThe LEPR gene is directly associated with obesity phenotypes. This relationship is crucial as it underlines the genetic component of obesity, which is a significant risk factor for various metabolic disorders. The LEPR gene's role in obesity highlights the potential for targeted interventions based on genetic profiles.\n\n## LEPR gene significance in African-Americans\n\nThe LEPR gene's association with obesity phenotypes is significant in African-Americans. This population specificity suggests that genetic factors may play a varied role in obesity across different ethnic groups, emphasizing the need for personalized and population-tailored approaches to addressing obesity.\n\n## Interaction between FTO and LEPR genes\n\nThe FTO and LEPR genes are both associated with obesity traits. This interaction suggests a complex genetic landscape for obesity, where multiple genes contribute to the overall risk. Understanding the interplay between these genes can provide insights into the development of more effective obesity management strategies.\n\n## LEPR gene and obesity relationship\n\nThe LEPR gene is associated with obesity, indicating that genetic factors can significantly influence an individual's susceptibility to obesity. This relationship underscores the importance of considering genetic information in the prevention and treatment of obesity.",
    "report_json": {
      "title": "LEPR Gene and Obesity Phenotypes in African-Americans",
      "summary": "The community centers around the LEPR gene, which is associated with obesity phenotypes, particularly in African-Americans. The LEPR gene interacts with other entities such as FTO and obesity, highlighting its significance in obesity traits.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the LEPR gene's established association with obesity phenotypes and its significance in African-American populations.",
      "findings": [
        {
          "summary": "LEPR gene association with obesity phenotypes",
          "explanation": "The LEPR gene is directly associated with obesity phenotypes. This relationship is crucial as it underlines the genetic component of obesity, which is a significant risk factor for various metabolic disorders. The LEPR gene's role in obesity highlights the potential for targeted interventions based on genetic profiles."
        },
        {
          "summary": "LEPR gene significance in African-Americans",
          "explanation": "The LEPR gene's association with obesity phenotypes is significant in African-Americans. This population specificity suggests that genetic factors may play a varied role in obesity across different ethnic groups, emphasizing the need for personalized and population-tailored approaches to addressing obesity."
        },
        {
          "summary": "Interaction between FTO and LEPR genes",
          "explanation": "The FTO and LEPR genes are both associated with obesity traits. This interaction suggests a complex genetic landscape for obesity, where multiple genes contribute to the overall risk. Understanding the interplay between these genes can provide insights into the development of more effective obesity management strategies."
        },
        {
          "summary": "LEPR gene and obesity relationship",
          "explanation": "The LEPR gene is associated with obesity, indicating that genetic factors can significantly influence an individual's susceptibility to obesity. This relationship underscores the importance of considering genetic information in the prevention and treatment of obesity."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 18",
    "edges": [
      [
        "\"AFRICAN-AMERICANS\"",
        "\"LEPR\""
      ],
      [
        "\"FTO\"",
        "\"LEPR\""
      ],
      [
        "\"LEPR\"",
        "\"OBESITY\""
      ]
    ],
    "nodes": [
      "\"LEPR\"",
      "\"AFRICAN-AMERICANS\""
    ],
    "chunk_ids": [
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-84861a91f27adb095877d1a6ab6a6a69"
    ],
    "occurrence": 0.07407407407407407,
    "sub_communities": []
  },
  "19": {
    "report_string": "# Genetic Obesity Risk in Hispanic-Americans\n\nThe community revolves around the genetic factors influencing obesity traits in Hispanic-Americans. Key entities include the FTO gene, the genomic variant rs7201444, and the ethnic group Hispanic-Americans. These entities are interconnected through their roles in obesity risk and genetic association studies.\n\n## Association of FTO gene with obesity in Hispanic-Americans\n\nThe FTO gene has been associated with obesity traits, and this association varies in Hispanic-Americans. This variation is crucial for understanding genetic risk factors for obesity in this ethnic group.\n\n## Role of rs7201444 in obesity risk\n\nThe genomic variant rs7201444 in the FTO gene is specifically associated with obesity traits in Hispanic-Americans. This highlights the importance of genetic factors in obesity risk assessment and potential personalized interventions.\n\n## Importance of ethnic-specific genetic studies\n\nThe focus on Hispanic-Americans as an ethnic group in this study underscores the need for ethnic-specific genetic research. Such studies help in identifying unique genetic risk factors and tailoring interventions to specific populations.",
    "report_json": {
      "title": "Genetic Obesity Risk in Hispanic-Americans",
      "summary": "The community revolves around the genetic factors influencing obesity traits in Hispanic-Americans. Key entities include the FTO gene, the genomic variant rs7201444, and the ethnic group Hispanic-Americans. These entities are interconnected through their roles in obesity risk and genetic association studies.",
      "rating": 5.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific association of the FTO gene variant rs7201444 with obesity traits in Hispanic-Americans.",
      "findings": [
        {
          "summary": "Association of FTO gene with obesity in Hispanic-Americans",
          "explanation": "The FTO gene has been associated with obesity traits, and this association varies in Hispanic-Americans. This variation is crucial for understanding genetic risk factors for obesity in this ethnic group."
        },
        {
          "summary": "Role of rs7201444 in obesity risk",
          "explanation": "The genomic variant rs7201444 in the FTO gene is specifically associated with obesity traits in Hispanic-Americans. This highlights the importance of genetic factors in obesity risk assessment and potential personalized interventions."
        },
        {
          "summary": "Importance of ethnic-specific genetic studies",
          "explanation": "The focus on Hispanic-Americans as an ethnic group in this study underscores the need for ethnic-specific genetic research. Such studies help in identifying unique genetic risk factors and tailoring interventions to specific populations."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 19",
    "edges": [
      [
        "\"FTO\"",
        "\"HISPANIC-AMERICANS\""
      ],
      [
        "\"HISPANIC-AMERICANS\"",
        "\"RS7201444\""
      ]
    ],
    "nodes": [
      "\"RS7201444\"",
      "\"HISPANIC-AMERICANS\""
    ],
    "chunk_ids": [
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-84861a91f27adb095877d1a6ab6a6a69"
    ],
    "occurrence": 0.07407407407407407,
    "sub_communities": []
  },
  "26": {
    "report_string": "# NRXN3 and Associated Health Risks\n\nThe community centers around the NRXN3 gene, which is associated with obesity risk, waist to hip ratio, and colorectal cancer risk. The gene has a variant rs10146997 linked to colorectal cancer risk. The entity 'waist to hip ratio' is connected to NRXN3, indicating a relationship between genetic factors and body composition.\n\n## NRXN3 gene and its association with obesity risk\n\nThe NRXN3 gene is associated with obesity risk. This suggests that genetic factors play a role in the development of obesity, and understanding this relationship can inform targeted interventions for obesity prevention and management.\n\n## NRXN3 gene and waist to hip ratio\n\nThe NRXN3 gene is also associated with waist to hip ratio, a measure of body composition. This relationship highlights the potential for genetic factors to influence body shape and fat distribution, which are important for health risk assessments.\n\n## NRXN3 variant rs10146997 and colorectal cancer risk\n\nThe NRXN3 gene has a variant, rs10146997, which is associated with colorectal cancer risk. This finding underscores the importance of genetic screening for colorectal cancer risk and the potential for targeted prevention strategies.\n\n## Interconnectedness of NRXN3 with health conditions\n\nThe NRXN3 gene is connected to multiple health conditions, including obesity, colorectal cancer, and altered body composition. This interconnectedness suggests that interventions targeting NRXN3 or its pathways could have broad impacts on health risk management.",
    "report_json": {
      "title": "NRXN3 and Associated Health Risks",
      "summary": "The community centers around the NRXN3 gene, which is associated with obesity risk, waist to hip ratio, and colorectal cancer risk. The gene has a variant rs10146997 linked to colorectal cancer risk. The entity 'waist to hip ratio' is connected to NRXN3, indicating a relationship between genetic factors and body composition.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the NRXN3 gene's associations with multiple health risks, including obesity, colorectal cancer, and altered body composition.",
      "findings": [
        {
          "summary": "NRXN3 gene and its association with obesity risk",
          "explanation": "The NRXN3 gene is associated with obesity risk. This suggests that genetic factors play a role in the development of obesity, and understanding this relationship can inform targeted interventions for obesity prevention and management."
        },
        {
          "summary": "NRXN3 gene and waist to hip ratio",
          "explanation": "The NRXN3 gene is also associated with waist to hip ratio, a measure of body composition. This relationship highlights the potential for genetic factors to influence body shape and fat distribution, which are important for health risk assessments."
        },
        {
          "summary": "NRXN3 variant rs10146997 and colorectal cancer risk",
          "explanation": "The NRXN3 gene has a variant, rs10146997, which is associated with colorectal cancer risk. This finding underscores the importance of genetic screening for colorectal cancer risk and the potential for targeted prevention strategies."
        },
        {
          "summary": "Interconnectedness of NRXN3 with health conditions",
          "explanation": "The NRXN3 gene is connected to multiple health conditions, including obesity, colorectal cancer, and altered body composition. This interconnectedness suggests that interventions targeting NRXN3 or its pathways could have broad impacts on health risk management."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 26",
    "edges": [
      [
        "\"NRXN3\"",
        "\"WAIST TO HIP RATIO\""
      ],
      [
        "\"NRXN3\"",
        "\"RS10146997\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"NRXN3\""
      ]
    ],
    "nodes": [
      "\"NRXN3\"",
      "\"WAIST TO HIP RATIO\""
    ],
    "chunk_ids": [
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.1111111111111111,
    "sub_communities": []
  },
  "31": {
    "report_string": "# Epigenetic Modifications and Gene Expression in Metabolic Pathways\n\nThe community centers around epigenetic modifications, gene expression, and their influence on metabolic pathways. Key entities include epigenetic modifications, gene expression, and transcription factors. These entities are interconnected through their roles in regulating gene expression and responding to environmental factors such as dietary patterns.\n\n## Epigenetic Modifications Influence Gene Expression\n\nEpigenetic modifications play a crucial role in regulating gene expression. They can be influenced by environmental factors such as dietary patterns and, in turn, affect the metabolic pathway of nitric oxide synthesis. This relationship highlights the importance of considering epigenetic modifications in understanding gene expression and metabolic health.\n\n## Role of Transcription Factors in Gene Expression\n\nTranscription factors are essential for regulating gene expression by binding to specific DNA sequences. Their interaction with gene expression underscores the complex molecular mechanisms involved in responding to environmental cues, including dietary factors.\n\n## Genomic Variants and Epigenetic Modifications\n\nGenomic variants can influence epigenetic modifications, which in turn affect gene expression. This relationship suggests that genetic predispositions can be modulated by epigenetic changes, potentially impacting metabolic health and disease susceptibility.\n\n## Impact of Epigenetic Modifications on Metabolic Pathways\n\nEpigenetic modifications linked to poor dietary patterns can alter the metabolic pathway of nitric oxide synthesis. This highlights the potential for dietary interventions to mitigate adverse epigenetic changes and improve metabolic health.\n\n## Interconnectedness of Epigenetic Modifications, Gene Expression, and Transcription Factors\n\nThe community's entities are interconnected through their roles in regulating gene expression and responding to environmental factors. Understanding these relationships is crucial for developing personalized dietary recommendations and interventions aimed at improving metabolic health.",
    "report_json": {
      "title": "Epigenetic Modifications and Gene Expression in Metabolic Pathways",
      "summary": "The community centers around epigenetic modifications, gene expression, and their influence on metabolic pathways. Key entities include epigenetic modifications, gene expression, and transcription factors. These entities are interconnected through their roles in regulating gene expression and responding to environmental factors such as dietary patterns.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of epigenetic modifications and gene expression on metabolic health and disease susceptibility.",
      "findings": [
        {
          "summary": "Epigenetic Modifications Influence Gene Expression",
          "explanation": "Epigenetic modifications play a crucial role in regulating gene expression. They can be influenced by environmental factors such as dietary patterns and, in turn, affect the metabolic pathway of nitric oxide synthesis. This relationship highlights the importance of considering epigenetic modifications in understanding gene expression and metabolic health."
        },
        {
          "summary": "Role of Transcription Factors in Gene Expression",
          "explanation": "Transcription factors are essential for regulating gene expression by binding to specific DNA sequences. Their interaction with gene expression underscores the complex molecular mechanisms involved in responding to environmental cues, including dietary factors."
        },
        {
          "summary": "Genomic Variants and Epigenetic Modifications",
          "explanation": "Genomic variants can influence epigenetic modifications, which in turn affect gene expression. This relationship suggests that genetic predispositions can be modulated by epigenetic changes, potentially impacting metabolic health and disease susceptibility."
        },
        {
          "summary": "Impact of Epigenetic Modifications on Metabolic Pathways",
          "explanation": "Epigenetic modifications linked to poor dietary patterns can alter the metabolic pathway of nitric oxide synthesis. This highlights the potential for dietary interventions to mitigate adverse epigenetic changes and improve metabolic health."
        },
        {
          "summary": "Interconnectedness of Epigenetic Modifications, Gene Expression, and Transcription Factors",
          "explanation": "The community's entities are interconnected through their roles in regulating gene expression and responding to environmental factors. Understanding these relationships is crucial for developing personalized dietary recommendations and interventions aimed at improving metabolic health."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 31",
    "edges": [
      [
        "\"EPIGENETIC MODIFICATION\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"EPIGENETIC MODIFICATION\"",
        "\"GENE EXPRESSION\""
      ],
      [
        "\"GENE EXPRESSION\"",
        "\"TRANSCRIPTION FACTORS\""
      ]
    ],
    "nodes": [
      "\"TRANSCRIPTION FACTORS\"",
      "\"GENE EXPRESSION\"",
      "\"EPIGENETIC MODIFICATION\""
    ],
    "chunk_ids": [
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.1111111111111111,
    "sub_communities": []
  },
  "17": {
    "report_string": "# Genomic Variants and Regulatory Elements in Gene Expression\n\nThe community revolves around rs1421085, a genomic variant associated with the FTO gene and regulatory elements. Key entities include CUT-LIKE HOMEOBOX1 protein, INTRONIC REGULATORY ELEMENT, and the genomic variant rs1421085. These entities interact through their roles in gene expression and regulatory functions.\n\n## rs1421085 and its association with FTO gene\n\nThe rs1421085 genomic variant is associated with the FTO gene, suggesting a potential role in regulating gene expression related to FTO functions. However, specific details about FTO gene functions and their implications are not provided.\n\n## CUT-LIKE HOMEOBOX1 and rs1421085 interaction\n\nThe CUT-LIKE HOMEOBOX1 protein has a predicted reduced binding affinity for the C allele at rs1421085. This interaction suggests that rs1421085 may influence the regulation of gene expression by affecting transcription factor binding.\n\n## INTRONIC REGULATORY ELEMENT and rs1421085\n\nrs1421085 is located within a highly sequence-conserved element among vertebrates, indicating its potential importance in regulatory functions. The INTRONIC REGULATORY ELEMENT is associated with rs1421085, implying a role in the regulation of gene expression.",
    "report_json": {
      "title": "Genomic Variants and Regulatory Elements in Gene Expression",
      "summary": "The community revolves around rs1421085, a genomic variant associated with the FTO gene and regulatory elements. Key entities include CUT-LIKE HOMEOBOX1 protein, INTRONIC REGULATORY ELEMENT, and the genomic variant rs1421085. These entities interact through their roles in gene expression and regulatory functions.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific and localized effects of the genomic variant rs1421085 on gene expression and regulatory functions.",
      "findings": [
        {
          "summary": "rs1421085 and its association with FTO gene",
          "explanation": "The rs1421085 genomic variant is associated with the FTO gene, suggesting a potential role in regulating gene expression related to FTO functions. However, specific details about FTO gene functions and their implications are not provided."
        },
        {
          "summary": "CUT-LIKE HOMEOBOX1 and rs1421085 interaction",
          "explanation": "The CUT-LIKE HOMEOBOX1 protein has a predicted reduced binding affinity for the C allele at rs1421085. This interaction suggests that rs1421085 may influence the regulation of gene expression by affecting transcription factor binding."
        },
        {
          "summary": "INTRONIC REGULATORY ELEMENT and rs1421085",
          "explanation": "rs1421085 is located within a highly sequence-conserved element among vertebrates, indicating its potential importance in regulatory functions. The INTRONIC REGULATORY ELEMENT is associated with rs1421085, implying a role in the regulation of gene expression."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 17",
    "edges": [
      [
        "\"CUT-LIKE HOMEOBOX 1\"",
        "\"RS1421085\""
      ],
      [
        "\"INTRONIC REGULATORY ELEMENT\"",
        "\"RS1421085\""
      ],
      [
        "\"FTO\"",
        "\"RS1421085\""
      ]
    ],
    "nodes": [
      "\"CUT-LIKE HOMEOBOX 1\"",
      "\"INTRONIC REGULATORY ELEMENT\"",
      "\"RS1421085\""
    ],
    "chunk_ids": [
      "chunk-7d1efebc0446ed593d4a537624038948"
    ],
    "occurrence": 0.037037037037037035,
    "sub_communities": []
  },
  "16": {
    "report_string": "# Genomic Variant RS8051873 in FTO Gene\n\nThe community centers around the RS8051873 genomic variant located in the FTO gene, with a conditional p-value of 0.0011. This variant is significantly associated with the FTO gene, and the conditional p-value is a statistical measure used to determine the significance of this association.\n\n## RS8051873 Genomic Variant in FTO Gene\n\nThe RS8051873 genomic variant is located in intron 8 of the FTO gene. This information suggests that RS8051873 may have a regulatory or functional role in the expression or activity of the FTO gene. However, without further information on the FTO gene's function and the specific effects of RS8051873, the implications of this variant remain limited.\n\n## Conditional P-Value of RS8051873\n\nThe RS8051873 variant has a conditional p-value of 0.0011, indicating a statistically significant association with the FTO gene. The conditional p-value is a statistical measure used to determine the significance of a result while controlling for other variables. A p-value of 0.0011 suggests that the observed association is unlikely to occur by chance.\n\n## Relationship Between FTO Gene and RS8051873\n\nThe FTO gene is the source of the RS8051873 variant, and the variant is described as being located in intron 8 of the gene. This relationship highlights the direct connection between the RS8051873 variant and the FTO gene, suggesting that the variant may influence the gene's expression or function.\n\n## Limitations and Future Directions\n\nThe provided information is limited, and further research is needed to fully understand the implications of the RS8051873 variant and its association with the FTO gene. Additional studies could investigate the functional effects of RS8051873 on the FTO gene and its potential impact on human health.",
    "report_json": {
      "title": "Genomic Variant RS8051873 in FTO Gene",
      "summary": "The community centers around the RS8051873 genomic variant located in the FTO gene, with a conditional p-value of 0.0011. This variant is significantly associated with the FTO gene, and the conditional p-value is a statistical measure used to determine the significance of this association.",
      "rating": 2.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific and limited information provided about the RS8051873 variant and its association with the FTO gene.",
      "findings": [
        {
          "summary": "RS8051873 Genomic Variant in FTO Gene",
          "explanation": "The RS8051873 genomic variant is located in intron 8 of the FTO gene. This information suggests that RS8051873 may have a regulatory or functional role in the expression or activity of the FTO gene. However, without further information on the FTO gene's function and the specific effects of RS8051873, the implications of this variant remain limited."
        },
        {
          "summary": "Conditional P-Value of RS8051873",
          "explanation": "The RS8051873 variant has a conditional p-value of 0.0011, indicating a statistically significant association with the FTO gene. The conditional p-value is a statistical measure used to determine the significance of a result while controlling for other variables. A p-value of 0.0011 suggests that the observed association is unlikely to occur by chance."
        },
        {
          "summary": "Relationship Between FTO Gene and RS8051873",
          "explanation": "The FTO gene is the source of the RS8051873 variant, and the variant is described as being located in intron 8 of the gene. This relationship highlights the direct connection between the RS8051873 variant and the FTO gene, suggesting that the variant may influence the gene's expression or function."
        },
        {
          "summary": "Limitations and Future Directions",
          "explanation": "The provided information is limited, and further research is needed to fully understand the implications of the RS8051873 variant and its association with the FTO gene. Additional studies could investigate the functional effects of RS8051873 on the FTO gene and its potential impact on human health."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 16",
    "edges": [
      [
        "\"CONDITIONAL P-VALUE\"",
        "\"RS8051873\""
      ],
      [
        "\"FTO\"",
        "\"RS8051873\""
      ]
    ],
    "nodes": [
      "\"CONDITIONAL P-VALUE\"",
      "\"RS8051873\""
    ],
    "chunk_ids": [
      "chunk-7d1efebc0446ed593d4a537624038948"
    ],
    "occurrence": 0.037037037037037035,
    "sub_communities": []
  },
  "29": {
    "report_string": "# Genetic Factors in MO Disease\n\nThe community revolves around MO disease, a condition associated with various genetic variants. Key entities include genes such as RBFOX1, RP11-638 L3.1, and TMTC1, and genomic variants like SNP rs1421085 and SNP rs8050136. These entities are interconnected through their associations with MO disease, highlighting the genetic complexity of the condition.\n\n## Association of MO disease with genetic variants\n\nMO disease is associated with several genetic variants, including SNP rs1421085 and SNP rs8050136. These variants have been identified through genome-wide association studies (GWAS) and have significant p-values of 1.54×10−8 and 9.3×10−4, respectively. This highlights the importance of genetic factors in the susceptibility to MO disease.\n\n## Role of RBFOX1, RP11-638 L3.1, and TMTC1 in MO disease\n\nGenes such as RBFOX1, RP11-638 L3.1, and TMTC1 are associated with MO disease. These genes likely play critical roles in the biological pathways leading to the condition. Their association with MO disease underscores the genetic heterogeneity of the disease.\n\n## GWAS and genetic variant identification\n\nGenome-wide association studies (GWAS) have been instrumental in identifying genetic variants associated with MO disease. The use of GWAS has led to the discovery of several genomic variants, including SNP rs9939609, which is associated with MO disease with a p-value of 1.32×10−9. This approach has been crucial in understanding the genetic architecture of MO disease.\n\n## Genetic heterogeneity of MO disease\n\nThe association of multiple genes and genomic variants with MO disease highlights the genetic heterogeneity of the condition. This complexity suggests that MO disease is influenced by a multitude of genetic factors, each potentially contributing to the disease's pathogenesis.\n\n## Importance of genetic associations in MO disease\n\nThe identification of genetic associations with MO disease is crucial for understanding disease mechanisms and developing personalized treatment strategies. By elucidating the genetic underpinnings of MO disease, researchers can better understand how different genetic variants contribute to disease susceptibility and progression.",
    "report_json": {
      "title": "Genetic Factors in MO Disease",
      "summary": "The community revolves around MO disease, a condition associated with various genetic variants. Key entities include genes such as RBFOX1, RP11-638 L3.1, and TMTC1, and genomic variants like SNP rs1421085 and SNP rs8050136. These entities are interconnected through their associations with MO disease, highlighting the genetic complexity of the condition.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant association of genetic variants with MO disease susceptibility.",
      "findings": [
        {
          "summary": "Association of MO disease with genetic variants",
          "explanation": "MO disease is associated with several genetic variants, including SNP rs1421085 and SNP rs8050136. These variants have been identified through genome-wide association studies (GWAS) and have significant p-values of 1.54×10−8 and 9.3×10−4, respectively. This highlights the importance of genetic factors in the susceptibility to MO disease."
        },
        {
          "summary": "Role of RBFOX1, RP11-638 L3.1, and TMTC1 in MO disease",
          "explanation": "Genes such as RBFOX1, RP11-638 L3.1, and TMTC1 are associated with MO disease. These genes likely play critical roles in the biological pathways leading to the condition. Their association with MO disease underscores the genetic heterogeneity of the disease."
        },
        {
          "summary": "GWAS and genetic variant identification",
          "explanation": "Genome-wide association studies (GWAS) have been instrumental in identifying genetic variants associated with MO disease. The use of GWAS has led to the discovery of several genomic variants, including SNP rs9939609, which is associated with MO disease with a p-value of 1.32×10−9. This approach has been crucial in understanding the genetic architecture of MO disease."
        },
        {
          "summary": "Genetic heterogeneity of MO disease",
          "explanation": "The association of multiple genes and genomic variants with MO disease highlights the genetic heterogeneity of the condition. This complexity suggests that MO disease is influenced by a multitude of genetic factors, each potentially contributing to the disease's pathogenesis."
        },
        {
          "summary": "Importance of genetic associations in MO disease",
          "explanation": "The identification of genetic associations with MO disease is crucial for understanding disease mechanisms and developing personalized treatment strategies. By elucidating the genetic underpinnings of MO disease, researchers can better understand how different genetic variants contribute to disease susceptibility and progression."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 29",
    "edges": [
      [
        "\"MO DISEASE\"",
        "\"RP11-638 L3.1\""
      ],
      [
        "\"MO DISEASE\"",
        "\"SNP RS1421085\""
      ],
      [
        "\"GWAS\"",
        "\"MO DISEASE\""
      ],
      [
        "\"MO DISEASE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"MO DISEASE\"",
        "\"TMTC1\""
      ],
      [
        "\"MO DISEASE\"",
        "\"SNP RS8050136\""
      ],
      [
        "\"MO DISEASE\"",
        "\"RBFOX1\""
      ]
    ],
    "nodes": [
      "\"RP11-638 L3.1\"",
      "\"RBFOX1\"",
      "\"TMTC1\"",
      "\"MO DISEASE\"",
      "\"SNP RS8050136\"",
      "\"SNP RS1421085\""
    ],
    "chunk_ids": [
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed"
    ],
    "occurrence": 0.037037037037037035,
    "sub_communities": []
  },
  "23": {
    "report_string": "# β-Cell Impairment in Type 2 Diabetes\n\nThe community centers around β-cell impairment in Type 2 Diabetes (T2DM), with key entities including β-CELL, INSULIN, and their relationships. β-CELL is crucial for insulin production, and its impairment is a hallmark of T2DM.\n\n## β-CELL impairment in T2DM\n\nβ-CELL impairment is a characteristic of T2DM, affecting insulin production. This impairment is crucial in T2DM pathology.\n\n## Role of INSULIN in glucose regulation\n\nINSULIN, produced by β-CELLs, is vital for regulating blood sugar levels. Its production is impaired in T2DM patients.",
    "report_json": {
      "title": "β-Cell Impairment in Type 2 Diabetes",
      "summary": "The community centers around β-cell impairment in Type 2 Diabetes (T2DM), with key entities including β-CELL, INSULIN, and their relationships. β-CELL is crucial for insulin production, and its impairment is a hallmark of T2DM.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the critical role of β-cell impairment in T2DM pathology and the essential function of insulin in glucose regulation.",
      "findings": [
        {
          "summary": "β-CELL impairment in T2DM",
          "explanation": "β-CELL impairment is a characteristic of T2DM, affecting insulin production. This impairment is crucial in T2DM pathology."
        },
        {
          "summary": "Role of INSULIN in glucose regulation",
          "explanation": "INSULIN, produced by β-CELLs, is vital for regulating blood sugar levels. Its production is impaired in T2DM patients."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 23",
    "edges": [
      [
        "\"T2DM\"",
        "\"Β-CELL\""
      ],
      [
        "\"INSULIN\"",
        "\"Β-CELL\""
      ]
    ],
    "nodes": [
      "\"Β-CELL\"",
      "\"INSULIN\""
    ],
    "chunk_ids": [
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8"
    ],
    "occurrence": 0.037037037037037035,
    "sub_communities": []
  },
  "22": {
    "report_string": "# Genetic Factors in T2DM\n\nThe community revolves around genetic factors associated with Type 2 Diabetes Mellitus (T2DM). Key entities include the PPARGC1 gene, chromosomal locations such as 4p15 and 18p11, and an unknown entity PTEN/PPP1R5/IDE located in 10q23. These entities are interconnected through their roles in gene expression, chromosomal location, and association with T2DM.\n\n## PPARGC1 gene and its association with T2DM\n\nThe PPARGC1 gene, located in 4p15, is associated with T2DM. This gene plays a significant role in regulating glucose and lipid metabolism, which are critical factors in the development and management of T2DM. The association of PPARGC1 with T2DM underscores the importance of genetic factors in disease susceptibility.\n\n## Chromosomal locations and gene positioning\n\nThe chromosomal locations 4p15, 18p11, and 10q23 are mentioned in relation to various genes and entities. The location of PPARGC1 in 4p15 and its association with T2DM highlights the role of specific genetic loci in disease risk. Similarly, the positioning of other genes and entities on different chromosomes may influence their function and interaction with diseases like T2DM.\n\n## PTEN/PPP1R5/IDE entity and its chromosomal location\n\nThe entity PTEN/PPP1R5/IDE is located in 10q23. While the exact nature of this entity is unclear, its specific chromosomal location suggests a potential role in genetic regulation or disease association, possibly through interaction with other genes or factors influencing T2DM.\n\n## Limited scope and potential for further investigation\n\nThe current community of entities and relationships provides a snapshot of genetic factors associated with T2DM. However, the impact of these factors may be more comprehensive when considered alongside environmental and lifestyle factors. Further investigation into additional genes, entities, and relationships could provide a more detailed understanding of T2DM etiology and management.",
    "report_json": {
      "title": "Genetic Factors in T2DM",
      "summary": "The community revolves around genetic factors associated with Type 2 Diabetes Mellitus (T2DM). Key entities include the PPARGC1 gene, chromosomal locations such as 4p15 and 18p11, and an unknown entity PTEN/PPP1R5/IDE located in 10q23. These entities are interconnected through their roles in gene expression, chromosomal location, and association with T2DM.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific genetic associations with T2DM and the limited scope of entities and relationships provided.",
      "findings": [
        {
          "summary": "PPARGC1 gene and its association with T2DM",
          "explanation": "The PPARGC1 gene, located in 4p15, is associated with T2DM. This gene plays a significant role in regulating glucose and lipid metabolism, which are critical factors in the development and management of T2DM. The association of PPARGC1 with T2DM underscores the importance of genetic factors in disease susceptibility."
        },
        {
          "summary": "Chromosomal locations and gene positioning",
          "explanation": "The chromosomal locations 4p15, 18p11, and 10q23 are mentioned in relation to various genes and entities. The location of PPARGC1 in 4p15 and its association with T2DM highlights the role of specific genetic loci in disease risk. Similarly, the positioning of other genes and entities on different chromosomes may influence their function and interaction with diseases like T2DM."
        },
        {
          "summary": "PTEN/PPP1R5/IDE entity and its chromosomal location",
          "explanation": "The entity PTEN/PPP1R5/IDE is located in 10q23. While the exact nature of this entity is unclear, its specific chromosomal location suggests a potential role in genetic regulation or disease association, possibly through interaction with other genes or factors influencing T2DM."
        },
        {
          "summary": "Limited scope and potential for further investigation",
          "explanation": "The current community of entities and relationships provides a snapshot of genetic factors associated with T2DM. However, the impact of these factors may be more comprehensive when considered alongside environmental and lifestyle factors. Further investigation into additional genes, entities, and relationships could provide a more detailed understanding of T2DM etiology and management."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 22",
    "edges": [
      [
        "\"CHROMOSOMAL LOCATION\"",
        "\"PPARGC1\""
      ],
      [
        "\"CHROMOSOMAL LOCATION\"",
        "\"PACAP\""
      ],
      [
        "\"CHROMOSOMAL LOCATION\"",
        "\"PTEN/PPP1R5/IDE\""
      ],
      [
        "\"PPARGC1\"",
        "\"T2DM\""
      ]
    ],
    "nodes": [
      "\"PTEN/PPP1R5/IDE\"",
      "\"CHROMOSOMAL LOCATION\"",
      "\"PPARGC1\""
    ],
    "chunk_ids": [
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8"
    ],
    "occurrence": 0.07407407407407407,
    "sub_communities": []
  },
  "21": {
    "report_string": "# TCF7L2-rs7903146 and Type 2 Diabetes Risk\n\nThe community centers around the TCF7L2-rs7903146 genomic variant and its association with Type 2 Diabetes (T2DM). Key entities include genetic models such as additive, codominant, and recessive models, which assess the effect of TCF7L2-rs7903146 on T2DM risk. The relationships between these entities highlight the variant's impact on T2DM susceptibility.\n\n## TCF7L2-rs7903146 variant and T2DM risk\n\nThe TCF7L2-rs7903146 variant is associated with a moderate effect on T2DM risk. This is supported by its pooled odds ratios across different genetic models: 2.27 in the additive model, 6.17 in the codominant genetic model, and 1.75 in the recessive model. These statistics indicate a significant impact of the variant on T2DM susceptibility.\n\n## Genetic models for assessing TCF7L2-rs7903146 effect\n\nThe additive, codominant, and recessive genetic models provide a comprehensive assessment of TCF7L2-rs7903146's effect on T2DM risk. The codominant model shows the highest pooled odds ratio of 6.17, suggesting that this model may be particularly relevant for understanding the variant's impact.\n\n## Impact of TCF7L2-rs7903146 on T2DM risk across models\n\nThe TCF7L2-rs7903146 variant demonstrates varying degrees of association with T2DM risk across different genetic models. The additive model indicates a moderate increase in risk (OR=2.27), while the codominant model suggests a stronger association (OR=6.17). The recessive model shows a more modest effect (OR=1.75).",
    "report_json": {
      "title": "TCF7L2-rs7903146 and Type 2 Diabetes Risk",
      "summary": "The community centers around the TCF7L2-rs7903146 genomic variant and its association with Type 2 Diabetes (T2DM). Key entities include genetic models such as additive, codominant, and recessive models, which assess the effect of TCF7L2-rs7903146 on T2DM risk. The relationships between these entities highlight the variant's impact on T2DM susceptibility.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant association of TCF7L2-rs7903146 with T2DM risk across different genetic models.",
      "findings": [
        {
          "summary": "TCF7L2-rs7903146 variant and T2DM risk",
          "explanation": "The TCF7L2-rs7903146 variant is associated with a moderate effect on T2DM risk. This is supported by its pooled odds ratios across different genetic models: 2.27 in the additive model, 6.17 in the codominant genetic model, and 1.75 in the recessive model. These statistics indicate a significant impact of the variant on T2DM susceptibility."
        },
        {
          "summary": "Genetic models for assessing TCF7L2-rs7903146 effect",
          "explanation": "The additive, codominant, and recessive genetic models provide a comprehensive assessment of TCF7L2-rs7903146's effect on T2DM risk. The codominant model shows the highest pooled odds ratio of 6.17, suggesting that this model may be particularly relevant for understanding the variant's impact."
        },
        {
          "summary": "Impact of TCF7L2-rs7903146 on T2DM risk across models",
          "explanation": "The TCF7L2-rs7903146 variant demonstrates varying degrees of association with T2DM risk across different genetic models. The additive model indicates a moderate increase in risk (OR=2.27), while the codominant model suggests a stronger association (OR=6.17). The recessive model shows a more modest effect (OR=1.75)."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 21",
    "edges": [
      [
        "\"T2DM\"",
        "\"TCF7L2-RS7903146\""
      ],
      [
        "\"CODOMINANT GENETIC MODEL\"",
        "\"TCF7L2-RS7903146\""
      ],
      [
        "\"RECESSIVE MODEL\"",
        "\"TCF7L2-RS7903146\""
      ],
      [
        "\"ADDITIVE MODEL\"",
        "\"TCF7L2-RS7903146\""
      ]
    ],
    "nodes": [
      "\"ADDITIVE MODEL\"",
      "\"TCF7L2-RS7903146\"",
      "\"CODOMINANT GENETIC MODEL\"",
      "\"RECESSIVE MODEL\""
    ],
    "chunk_ids": [
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a"
    ],
    "occurrence": 0.037037037037037035,
    "sub_communities": []
  },
  "3": {
    "report_string": "# Genetic Variants and Obesity\n\nThe community revolves around genetic variants, particularly those associated with the FTO gene, and their impact on obesity and related diseases. Key entities include the FTO gene, genomic variants such as SNPs (e.g., rs9939609, rs8050136), and diseases like obesity and type 2 diabetes. These entities are interconnected through their roles in adiposity, insulin function, and disease risk.\n\n## The FTO gene and its association with obesity\n\nThe FTO gene is strongly associated with obesity and waist circumference. Variants in the FTO gene, such as rs9939609 and rs8050136, have been linked to increased obesity risk and related metabolic traits. This relationship highlights the importance of genetic factors in obesity.\n\n## Role of SNPs in obesity and disease\n\nSNPs, including those in the FTO gene (e.g., rs9939609, rs8050136), are associated with obesity, type 2 diabetes, and colorectal cancer. These genetic variants can influence adiposity, insulin function, and disease susceptibility, emphasizing the role of genetics in metabolic health.\n\n## GWAS and genetic associations\n\nGenome-Wide Association Studies (GWAS) have identified genetic associations with obesity and related diseases. The FTO gene was identified through GWAS analysis, and SNPs in this gene have been linked to obesity traits. GWAS is a powerful tool for uncovering genetic influences on complex traits.\n\n## Impact of genomic variants on dietary intake\n\nGenomic variants can influence dietary intake and macronutrient preferences. For example, variants in the FTO gene have been associated with dietary intake patterns. Understanding these relationships can help in developing personalized nutrition recommendations.\n\n## Epigenetic modifications and gene expression\n\nEpigenetic modifications, influenced by both genetic and environmental factors, play a role in gene expression and disease susceptibility. These modifications can affect how genes like FTO are expressed, potentially impacting obesity risk and metabolic health.",
    "report_json": {
      "title": "Genetic Variants and Obesity",
      "summary": "The community revolves around genetic variants, particularly those associated with the FTO gene, and their impact on obesity and related diseases. Key entities include the FTO gene, genomic variants such as SNPs (e.g., rs9939609, rs8050136), and diseases like obesity and type 2 diabetes. These entities are interconnected through their roles in adiposity, insulin function, and disease risk.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic variants, particularly in the FTO gene, on obesity and related metabolic disorders.",
      "findings": [
        {
          "summary": "The FTO gene and its association with obesity",
          "explanation": "The FTO gene is strongly associated with obesity and waist circumference. Variants in the FTO gene, such as rs9939609 and rs8050136, have been linked to increased obesity risk and related metabolic traits. This relationship highlights the importance of genetic factors in obesity."
        },
        {
          "summary": "Role of SNPs in obesity and disease",
          "explanation": "SNPs, including those in the FTO gene (e.g., rs9939609, rs8050136), are associated with obesity, type 2 diabetes, and colorectal cancer. These genetic variants can influence adiposity, insulin function, and disease susceptibility, emphasizing the role of genetics in metabolic health."
        },
        {
          "summary": "GWAS and genetic associations",
          "explanation": "Genome-Wide Association Studies (GWAS) have identified genetic associations with obesity and related diseases. The FTO gene was identified through GWAS analysis, and SNPs in this gene have been linked to obesity traits. GWAS is a powerful tool for uncovering genetic influences on complex traits."
        },
        {
          "summary": "Impact of genomic variants on dietary intake",
          "explanation": "Genomic variants can influence dietary intake and macronutrient preferences. For example, variants in the FTO gene have been associated with dietary intake patterns. Understanding these relationships can help in developing personalized nutrition recommendations."
        },
        {
          "summary": "Epigenetic modifications and gene expression",
          "explanation": "Epigenetic modifications, influenced by both genetic and environmental factors, play a role in gene expression and disease susceptibility. These modifications can affect how genes like FTO are expressed, potentially impacting obesity risk and metabolic health."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 3",
    "edges": [
      [
        "\"EPIGENETIC MODIFICATION\"",
        "\"GENE EXPRESSION\""
      ],
      [
        "\"DISEASE\"",
        "\"ENVIRONMENTAL FACTOR\""
      ],
      [
        "\"MO DISEASE\"",
        "\"SNP RS1421085\""
      ],
      [
        "\"GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"SNP\"",
        "\"UVAM\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LMI\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"SNPS\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNPS\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"GWAS\""
      ],
      [
        "\"FTO GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GWAS\"",
        "\"SNP\""
      ],
      [
        "\"BODY FAT\"",
        "\"FTO GENE\""
      ],
      [
        "\"FTO\"",
        "\"LMI\""
      ],
      [
        "\"MO DISEASE\"",
        "\"TMTC1\""
      ],
      [
        "\"DISEASE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"DNA\"",
        "\"FTO GENE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GWAS\""
      ],
      [
        "\"FTO GENE\"",
        "\"ISELECT GENOTYPING\""
      ],
      [
        "\"MO DISEASE\"",
        "\"RP11-638 L3.1\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"DRAM1\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2DM\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"FTO\"",
        "\"GWAS\""
      ],
      [
        "\"SKELETAL ROBUSTNESS\"",
        "\"SNP\""
      ],
      [
        "\"ANTHROPOMETRIC MEASURES\"",
        "\"FTO GENE\""
      ],
      [
        "\"OBESITY\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"WALKING PACE\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"LEAD SNPS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY\""
      ],
      [
        "\"MO DISEASE\"",
        "\"SNP RS8050136\""
      ],
      [
        "\"FTO GENE\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"EPIGENETIC MODIFICATION\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"SNPS\"",
        "\"T2DM\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP RS116917414\""
      ],
      [
        "\"ANTHROPOMETRIC MEASURES\"",
        "\"GENETIC VARIATION\""
      ],
      [
        "\"BMI\"",
        "\"SNPS\""
      ],
      [
        "\"PCR ENRICHMENT\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"GWAS\"",
        "\"UKB\""
      ],
      [
        "\"GWAS\"",
        "\"MO DISEASE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNP\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"WALKING PACE\""
      ],
      [
        "\"FTO\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"MO DISEASE\"",
        "\"RBFOX1\""
      ],
      [
        "\"DBSNP\"",
        "\"SNP\""
      ],
      [
        "\"SNP\"",
        "\"SOLID SYSTEM\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNPS\""
      ],
      [
        "\"ADIPOKINE LEVELS\"",
        "\"FTO GENE\""
      ],
      [
        "\"GENOMIC LOCI\"",
        "\"GWAS\""
      ],
      [
        "\"GENE EXPRESSION\"",
        "\"TRANSCRIPTION FACTORS\""
      ],
      [
        "\"RS8050136\"",
        "\"SNP\""
      ],
      [
        "\"ALLELE FREQUENCY\"",
        "\"SNP\""
      ],
      [
        "\"FTO GENE\"",
        "\"GWAS\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO GENE\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MAF\""
      ],
      [
        "\"GWAS\"",
        "\"T2DM\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"SNP\""
      ],
      [
        "\"CANCER\"",
        "\"SNP\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"MO DISEASE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"FTO GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"SNP\""
      ]
    ],
    "nodes": [
      "\"DISEASE\"",
      "\"GENOMIC VARIANT\"",
      "\"FTO GENE\"",
      "\"SNP RS9939609\"",
      "\"DIETARY INTAKE\"",
      "\"GENE EXPRESSION\"",
      "\"MO DISEASE\"",
      "\"SOLID SYSTEM\"",
      "\"LMI\"",
      "\"SNP\"",
      "\"EPIGENETIC MODIFICATION\"",
      "\"SNP RS116917414\"",
      "\"RBFOX1\"",
      "\"GENOMIC LOCI\"",
      "\"DRAM1\"",
      "\"SKELETAL ROBUSTNESS\"",
      "\"LEAD SNPS\"",
      "\"SNP RS8050136\"",
      "\"ISELECT GENOTYPING\"",
      "\"SOLID SEQUENCING\"",
      "\"DNA\"",
      "\"PCR ENRICHMENT\"",
      "\"ADIPOKINE LEVELS\"",
      "\"SNPS\"",
      "\"RP11-638 L3.1\"",
      "\"GWAS\"",
      "\"DBSNP\"",
      "\"UKB\"",
      "\"ANTHROPOMETRIC MEASURES\"",
      "\"TMTC1\"",
      "\"CANCER\"",
      "\"ALLELE FREQUENCY\"",
      "\"ENVIRONMENTAL FACTOR\"",
      "\"TRANSCRIPTION FACTORS\"",
      "\"ADIPOSITY\"",
      "\"SNP RS1421085\"",
      "\"UVAM\""
    ],
    "chunk_ids": [
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.9629629629629629,
    "sub_communities": [
      "31",
      "28",
      "29",
      "30",
      "27"
    ]
  },
  "8": {
    "report_string": "# Walking Pace and Cardiometabolic Health\n\nThe community revolves around walking pace, a physiological process genetically predicted and associated with various cardiometabolic, respiratory, psychiatric, and sleeping traits. Key entities include self-reported walking pace, cardiometabolic traits, coronary artery disease, and nutrients like fat. These entities are interconnected through their roles in physical activity, metabolic health, and disease risk.\n\n## Association between walking pace and cardiometabolic traits\n\nWalking pace is associated with various cardiometabolic traits, including BMI, fasting insulin, and glycemic traits. This suggests that walking pace is an important factor in metabolic health and may be a useful indicator for disease risk.\n\n## Walking pace and coronary artery disease risk\n\nSelf-reported walking pace is associated with coronary artery disease, and walking pace is associated with lower risk of coronary artery disease. This highlights the importance of physical activity in cardiovascular health.\n\n## Genetic variants and walking pace\n\nGenomic variants are associated with walking pace, suggesting a genetic component to physical activity. This has implications for understanding individual differences in walking pace and its relationship to health outcomes.\n\n## Relationship between fat intake and coronary artery disease\n\nFat intake is positively associated with coronary artery disease risk. This suggests that dietary fat intake is an important factor in cardiovascular health and may interact with walking pace in influencing disease risk.\n\n## Walking pace and mental health\n\nSelf-reported walking pace is associated with depressive symptoms, psychiatric traits, and insomnia. This highlights the importance of physical activity in mental health and well-being.\n\n## Lung function and walking pace\n\nFEV1 and FVC, measures of lung function, are associated with self-reported walking pace. This suggests that physical activity is related to respiratory health.\n\n## Educational attainment and walking pace\n\nSelf-reported walking pace is associated with years of schooling, suggesting a relationship between physical activity and educational attainment.\n\n## Waist-to-hip ratio and walking pace\n\nWaist-to-hip ratio is associated with walking pace, highlighting the importance of body composition in physical activity and health outcomes.",
    "report_json": {
      "title": "Walking Pace and Cardiometabolic Health",
      "summary": "The community revolves around walking pace, a physiological process genetically predicted and associated with various cardiometabolic, respiratory, psychiatric, and sleeping traits. Key entities include self-reported walking pace, cardiometabolic traits, coronary artery disease, and nutrients like fat. These entities are interconnected through their roles in physical activity, metabolic health, and disease risk.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of walking pace on various health outcomes, including cardiometabolic traits and disease risk.",
      "findings": [
        {
          "summary": "Association between walking pace and cardiometabolic traits",
          "explanation": "Walking pace is associated with various cardiometabolic traits, including BMI, fasting insulin, and glycemic traits. This suggests that walking pace is an important factor in metabolic health and may be a useful indicator for disease risk."
        },
        {
          "summary": "Walking pace and coronary artery disease risk",
          "explanation": "Self-reported walking pace is associated with coronary artery disease, and walking pace is associated with lower risk of coronary artery disease. This highlights the importance of physical activity in cardiovascular health."
        },
        {
          "summary": "Genetic variants and walking pace",
          "explanation": "Genomic variants are associated with walking pace, suggesting a genetic component to physical activity. This has implications for understanding individual differences in walking pace and its relationship to health outcomes."
        },
        {
          "summary": "Relationship between fat intake and coronary artery disease",
          "explanation": "Fat intake is positively associated with coronary artery disease risk. This suggests that dietary fat intake is an important factor in cardiovascular health and may interact with walking pace in influencing disease risk."
        },
        {
          "summary": "Walking pace and mental health",
          "explanation": "Self-reported walking pace is associated with depressive symptoms, psychiatric traits, and insomnia. This highlights the importance of physical activity in mental health and well-being."
        },
        {
          "summary": "Lung function and walking pace",
          "explanation": "FEV1 and FVC, measures of lung function, are associated with self-reported walking pace. This suggests that physical activity is related to respiratory health."
        },
        {
          "summary": "Educational attainment and walking pace",
          "explanation": "Self-reported walking pace is associated with years of schooling, suggesting a relationship between physical activity and educational attainment."
        },
        {
          "summary": "Waist-to-hip ratio and walking pace",
          "explanation": "Waist-to-hip ratio is associated with walking pace, highlighting the importance of body composition in physical activity and health outcomes."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 8",
    "edges": [
      [
        "\"GLYCEMIC TRAITS\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"FVC\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"SLEEPING TRAITS\"",
        "\"WALKING PACE\""
      ],
      [
        "\"CARDIOMETABOLIC TRAITS\"",
        "\"WALKING PACE\""
      ],
      [
        "\"PSYCHIATRIC TRAITS\"",
        "\"WALKING PACE\""
      ],
      [
        "\"FEV1\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"CORONARY ARTERY DISEASE\"",
        "\"WALKING PACE\""
      ],
      [
        "\"ADRENALS\"",
        "\"FAT\""
      ],
      [
        "\"MULTIVARIABLE MR\"",
        "\"WALKING PACE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"WALKING PACE\""
      ],
      [
        "\"LONGEVITY\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"FEV1\"",
        "\"WALKING PACE\""
      ],
      [
        "\"CORONARY ARTERY DISEASE\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"MUSCULAR STRENGTH\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"LUNG FUNCTION\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"DEPRESSIVE SYMPTOMS\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"FASTING INSULIN\"",
        "\"WALKING PACE\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"WALKING PACE\""
      ],
      [
        "\"GENETIC VARIANT\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"HOMA-IR\"",
        "\"WALKING PACE\""
      ],
      [
        "\"INSONNIA\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"RESPIRATORY TRAITS\"",
        "\"WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"WALKING PACE\""
      ],
      [
        "\"TYPE 2 DIABETES\"",
        "\"WALKING PACE\""
      ],
      [
        "\"HDL CHOLESTEROL\"",
        "\"WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"CORONARY ARTERY DISEASE\""
      ],
      [
        "\"PSYCHIATRIC DISEASE\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"CORONARY ARTERY DISEASE\"",
        "\"FAT\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"SELF-REPORTED WALKING PACE\"",
        "\"YEARS OF SCHOOLING\""
      ],
      [
        "\"INTELLIGENCE\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"WAIST-TO-HIP RATIO\"",
        "\"WALKING PACE\""
      ]
    ],
    "nodes": [
      "\"MUSCULAR STRENGTH\"",
      "\"WAIST-TO-HIP RATIO\"",
      "\"INSONNIA\"",
      "\"HDL CHOLESTEROL\"",
      "\"FVC\"",
      "\"ADRENALS\"",
      "\"PSYCHIATRIC TRAITS\"",
      "\"SELF-REPORTED WALKING PACE\"",
      "\"FAT\"",
      "\"FEV1\"",
      "\"GLYCEMIC TRAITS\"",
      "\"WALKING PACE\"",
      "\"INTELLIGENCE\"",
      "\"HOMA-IR\"",
      "\"LUNG FUNCTION\"",
      "\"PSYCHIATRIC DISEASE\"",
      "\"SLEEPING TRAITS\"",
      "\"CARDIOMETABOLIC TRAITS\"",
      "\"FASTING INSULIN\"",
      "\"YEARS OF SCHOOLING\"",
      "\"DEPRESSIVE SYMPTOMS\"",
      "\"GENETIC VARIANT\"",
      "\"RESPIRATORY TRAITS\"",
      "\"MULTIVARIABLE MR\"",
      "\"LONGEVITY\"",
      "\"CORONARY ARTERY DISEASE\""
    ],
    "chunk_ids": [
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-b7e190953e4c769a8b651f251bf00588"
    ],
    "occurrence": 0.25925925925925924,
    "sub_communities": [
      "35",
      "37",
      "36"
    ]
  },
  "4": {
    "report_string": "# Genetic and Environmental Factors in Obesity and Type2 Diabetes\n\nThe community revolves around obesity and type2 diabetes, influenced by genetic factors such as FTO, MC4R, and PPARG genes, and environmental factors like physical activity, dietary patterns, and nutrient intake. These entities interact to affect body mass index (BMI), body fat, and disease risk.\n\n## FTO gene and obesity risk\n\nThe FTO gene is associated with obesity risk, BMI, and body fat. Variants in the FTO gene, such as rs56137030 and rs7185735, have been linked to increased obesity risk. The FTO gene's role in obesity highlights the importance of genetic considerations in obesity management.\n\n## MC4R gene and obesity\n\nThe MC4R gene is associated with obesity and has a strong effect size. Variants in the MC4R gene have been linked to increased risk of obesity and colorectal cancer. The MC4R gene's role in obesity underscores the significance of genetic factors in disease risk.\n\n## Physical activity and obesity risk\n\nPhysical activity is an environmental factor that may influence obesity risk. Increased physical activity has been associated with lower BMI and reduced risk of obesity. Physical activity's impact on obesity risk highlights the importance of lifestyle interventions in disease prevention.\n\n## Dietary fiber and obesity risk\n\nDietary fiber may influence obesity risk. A diet rich in fiber has been associated with lower BMI and reduced risk of obesity. Dietary fiber's impact on obesity risk underscores the significance of dietary patterns in disease prevention.\n\n## PPARG gene and obesity\n\nThe PPARG gene is associated with obesity traits. Variants in the PPARG gene have been linked to increased risk of obesity. The PPARG gene's role in obesity highlights the importance of genetic factors in disease risk.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Obesity and Type2 Diabetes",
      "summary": "The community revolves around obesity and type2 diabetes, influenced by genetic factors such as FTO, MC4R, and PPARG genes, and environmental factors like physical activity, dietary patterns, and nutrient intake. These entities interact to affect body mass index (BMI), body fat, and disease risk.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on obesity and type2 diabetes risk and management.",
      "findings": [
        {
          "summary": "FTO gene and obesity risk",
          "explanation": "The FTO gene is associated with obesity risk, BMI, and body fat. Variants in the FTO gene, such as rs56137030 and rs7185735, have been linked to increased obesity risk. The FTO gene's role in obesity highlights the importance of genetic considerations in obesity management."
        },
        {
          "summary": "MC4R gene and obesity",
          "explanation": "The MC4R gene is associated with obesity and has a strong effect size. Variants in the MC4R gene have been linked to increased risk of obesity and colorectal cancer. The MC4R gene's role in obesity underscores the significance of genetic factors in disease risk."
        },
        {
          "summary": "Physical activity and obesity risk",
          "explanation": "Physical activity is an environmental factor that may influence obesity risk. Increased physical activity has been associated with lower BMI and reduced risk of obesity. Physical activity's impact on obesity risk highlights the importance of lifestyle interventions in disease prevention."
        },
        {
          "summary": "Dietary fiber and obesity risk",
          "explanation": "Dietary fiber may influence obesity risk. A diet rich in fiber has been associated with lower BMI and reduced risk of obesity. Dietary fiber's impact on obesity risk underscores the significance of dietary patterns in disease prevention."
        },
        {
          "summary": "PPARG gene and obesity",
          "explanation": "The PPARG gene is associated with obesity traits. Variants in the PPARG gene have been linked to increased risk of obesity. The PPARG gene's role in obesity highlights the importance of genetic factors in disease risk."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 4",
    "edges": [
      [
        "\"PANCREAS\"",
        "\"PROTEIN\""
      ],
      [
        "\"FTO PROTEIN\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PPARG\""
      ],
      [
        "\"BMI\"",
        "\"SELF-REPORTED WALKING PACE\""
      ],
      [
        "\"HYPERTENSION\"",
        "\"OBESITY\""
      ],
      [
        "\"COSTRIDE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"FTO\"",
        "\"PPARG\""
      ],
      [
        "\"AGE\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"EDUCATION\"",
        "\"OBESITY\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"MC4R\""
      ],
      [
        "\"BODY FAT\"",
        "\"FTO GENE\""
      ],
      [
        "\"BMI\"",
        "\"RS3751812\""
      ],
      [
        "\"FTO\"",
        "\"MC4R\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"VO2 MAX\""
      ],
      [
        "\"BMI\"",
        "\"MACRONUTRIENTS\""
      ],
      [
        "\"COSTRIDE\"",
        "\"HW\""
      ],
      [
        "\"OBESITY\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY\""
      ],
      [
        "\"LEPR\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"WOMEN\""
      ],
      [
        "\"DIABETES\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"BMI\"",
        "\"MEN\""
      ],
      [
        "\"FTO\"",
        "\"OBESITY\""
      ],
      [
        "\"CTNNBL1\"",
        "\"OBESITY\""
      ],
      [
        "\"CALCIUM\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"OBESITY\"",
        "\"SMOKING\""
      ],
      [
        "\"PREGNANCY\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"GWAS ANALYSIS\"",
        "\"OBESITY\""
      ],
      [
        "\"FISHER'S EXACT TEST\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"RS56137030\""
      ],
      [
        "\"BMI\"",
        "\"SNPS\""
      ],
      [
        "\"BMI\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"HW\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"KCTD15\"",
        "\"OBESITY\""
      ],
      [
        "\"PAR ASSESSMENT\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"NEUROPEPTIDE Y GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"ENERGY INTAKE\""
      ],
      [
        "\"EPINEPHRINE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"PROTEIN\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"OBESITY\"",
        "\"PROTEIN\""
      ],
      [
        "\"BRAIN\"",
        "\"MACRONUTRIENTS\""
      ],
      [
        "\"BMI\"",
        "\"FTO\""
      ],
      [
        "\"MC4R\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"WALKING PACE\""
      ],
      [
        "\"AGE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"PROTEIN\""
      ],
      [
        "\"BMI\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"BMI\"",
        "\"FTO SNPS\""
      ],
      [
        "\"BMI\"",
        "\"MC4R SNPS\""
      ],
      [
        "\"OBESITY\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"BDNF\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"RS7185735\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"QUANTITATIVE MEASURES\""
      ],
      [
        "\"BMI\"",
        "\"RS8050136\""
      ],
      [
        "\"TYPE 2 DIABETES\"",
        "\"WALKING PACE\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"BMI\"",
        "\"CORONARY ARTERY DISEASE\""
      ],
      [
        "\"BMI\"",
        "\"BODY FAT\""
      ],
      [
        "\"BMI\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"OBESITY\"",
        "\"SH2B1\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"OBESITY\""
      ],
      [
        "\"DIETARY FIBER\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"FTO GENE VARIANTS\""
      ],
      [
        "\"MULTIVITAMINS\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"SNP\""
      ]
    ],
    "nodes": [
      "\"RS7185735\"",
      "\"BMI\"",
      "\"BODY FAT\"",
      "\"HYPERTENSION\"",
      "\"WEIGHT GAIN\"",
      "\"KCTD15\"",
      "\"RISK ESTIMATES\"",
      "\"DIABETES\"",
      "\"OBESITY\"",
      "\"ENERGY INTAKE\"",
      "\"MEN\"",
      "\"PAR ASSESSMENT\"",
      "\"EDUCATION\"",
      "\"TYPE 2 DIABETES\"",
      "\"EPINEPHRINE\"",
      "\"BDNF\"",
      "\"NEUROPEPTIDE Y GENE\"",
      "\"MULTIVITAMINS\"",
      "\"MC4R\"",
      "\"PROTEIN\"",
      "\"PANCREAS\"",
      "\"DIETARY FIBER\"",
      "\"CALCIUM\"",
      "\"VO2 MAX\"",
      "\"PPARG\"",
      "\"RS56137030\"",
      "\"MACRONUTRIENTS\"",
      "\"FISHER'S EXACT TEST\"",
      "\"COSTRIDE\"",
      "\"QUANTITATIVE MEASURES\"",
      "\"MC4R SNPS\"",
      "\"WOMEN\"",
      "\"PHYSICAL ACTIVITY\"",
      "\"HW\"",
      "\"FTO PROTEIN\"",
      "\"SH2B1\""
    ],
    "chunk_ids": [
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-90dc49ded987f15e0a9242fc9bb82297",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 1.0,
    "sub_communities": [
      "34",
      "32",
      "33"
    ]
  },
  "1": {
    "report_string": "# Type2 Diabetes Mellitus (T2DM) Genetic and Environmental Factors\n\nThe community revolves around Type2 Diabetes Mellitus (T2DM), a metabolic disorder influenced by genetic and environmental factors. Key entities include genes such as TCF7L2, PPARGC1, and SLC30A8, environmental factors like diet and family history, and physiological processes such as β-cell function. These entities are interconnected through their roles in insulin secretion, glucose metabolism, and disease risk.\n\n## TCF7L2 gene and its association with T2DM\n\nThe TCF7L2 gene is significantly associated with an increased risk of T2DM. Variants such as rs7903146 have been linked to T2DM susceptibility. This gene's impact on T2DM risk is well-documented, making it a crucial factor in understanding the genetic underpinnings of the disease.\n\n## Diet and its role in T2DM risk modulation\n\nDiet is a critical environmental factor that modulates T2DM risk. The relationship between diet and T2DM is complex, involving interactions with genetic variants to influence disease susceptibility. Dietary patterns can either mitigate or exacerbate the risk of developing T2DM.\n\n## β-cell impairment in T2DM\n\nβ-cell impairment is a hallmark of T2DM, characterized by reduced insulin secretion and increased glucose levels. Genes such as ZRANB3 are involved in β-cell functional response to high glucose conditions, highlighting the importance of β-cell health in T2DM management.\n\n## PPARGC1 gene and its association with T2DM\n\nPPARGC1 is a gene associated with T2DM, involved in glucose metabolism and insulin sensitivity. Its location in 4p15 and potential interactions with environmental factors like diet make it a relevant entity in T2DM research.\n\n## Family history and T2DM heritability\n\nFamily history is an environmental factor associated with T2DM heritability. The presence of T2DM in family members increases an individual's risk, underscoring the importance of genetic factors in disease susceptibility.",
    "report_json": {
      "title": "Type2 Diabetes Mellitus (T2DM) Genetic and Environmental Factors",
      "summary": "The community revolves around Type2 Diabetes Mellitus (T2DM), a metabolic disorder influenced by genetic and environmental factors. Key entities include genes such as TCF7L2, PPARGC1, and SLC30A8, environmental factors like diet and family history, and physiological processes such as β-cell function. These entities are interconnected through their roles in insulin secretion, glucose metabolism, and disease risk.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on T2DM risk and management.",
      "findings": [
        {
          "summary": "TCF7L2 gene and its association with T2DM",
          "explanation": "The TCF7L2 gene is significantly associated with an increased risk of T2DM. Variants such as rs7903146 have been linked to T2DM susceptibility. This gene's impact on T2DM risk is well-documented, making it a crucial factor in understanding the genetic underpinnings of the disease."
        },
        {
          "summary": "Diet and its role in T2DM risk modulation",
          "explanation": "Diet is a critical environmental factor that modulates T2DM risk. The relationship between diet and T2DM is complex, involving interactions with genetic variants to influence disease susceptibility. Dietary patterns can either mitigate or exacerbate the risk of developing T2DM."
        },
        {
          "summary": "β-cell impairment in T2DM",
          "explanation": "β-cell impairment is a hallmark of T2DM, characterized by reduced insulin secretion and increased glucose levels. Genes such as ZRANB3 are involved in β-cell functional response to high glucose conditions, highlighting the importance of β-cell health in T2DM management."
        },
        {
          "summary": "PPARGC1 gene and its association with T2DM",
          "explanation": "PPARGC1 is a gene associated with T2DM, involved in glucose metabolism and insulin sensitivity. Its location in 4p15 and potential interactions with environmental factors like diet make it a relevant entity in T2DM research."
        },
        {
          "summary": "Family history and T2DM heritability",
          "explanation": "Family history is an environmental factor associated with T2DM heritability. The presence of T2DM in family members increases an individual's risk, underscoring the importance of genetic factors in disease susceptibility."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 1",
    "edges": [
      [
        "\"T2DM\"",
        "\"TCF7L2\""
      ],
      [
        "\"IDE\"",
        "\"T2DM\""
      ],
      [
        "\"ADDITIVE MODEL\"",
        "\"TCF7L2-RS7903146\""
      ],
      [
        "\"T2DM\"",
        "\"ZRANB3\""
      ],
      [
        "\"SCL40A1\"",
        "\"T2DM\""
      ],
      [
        "\"PPAR-Α\"",
        "\"T2DM\""
      ],
      [
        "\"PFH\"",
        "\"T2DM\""
      ],
      [
        "\"MEILOUD\"",
        "\"T2DM\""
      ],
      [
        "\"INSULIN\"",
        "\"Β-CELL\""
      ],
      [
        "\"SSA\"",
        "\"T2DM\""
      ],
      [
        "\"FAMILY HISTORY\"",
        "\"T2DM\""
      ],
      [
        "\"ERASMUS\"",
        "\"T2DM\""
      ],
      [
        "\"C2D4B\"",
        "\"T2DM\""
      ],
      [
        "\"CHROMOSOMAL LOCATION\"",
        "\"PACAP\""
      ],
      [
        "\"CDKAL1\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"TNF-Α\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2DM\""
      ],
      [
        "\"HAPTOGLOBIN\"",
        "\"T2DM\""
      ],
      [
        "\"FTO\"",
        "\"T2DM\""
      ],
      [
        "\"PPP1R5\"",
        "\"T2DM\""
      ],
      [
        "\"KCNJ11\"",
        "\"T2DM\""
      ],
      [
        "\"AGMO\"",
        "\"T2DM\""
      ],
      [
        "\"DIET\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"CODOMINANT GENETIC MODEL\"",
        "\"TCF7L2-RS7903146\""
      ],
      [
        "\"SNPS\"",
        "\"T2DM\""
      ],
      [
        "\"CHEN\"",
        "\"T2DM\""
      ],
      [
        "\"CHROMOSOMAL LOCATION\"",
        "\"PPARGC1\""
      ],
      [
        "\"PTEN\"",
        "\"T2DM\""
      ],
      [
        "\"SLC30A8\"",
        "\"T2DM\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FAMILY HISTORY\""
      ],
      [
        "\"POLYMORPHISMS\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"Β-CELL\""
      ],
      [
        "\"PSMD6\"",
        "\"T2DM\""
      ],
      [
        "\"DIET\"",
        "\"T2DM\""
      ],
      [
        "\"PACAP\"",
        "\"T2DM\""
      ],
      [
        "\"AGRP\"",
        "\"T2DM\""
      ],
      [
        "\"CAPN10\"",
        "\"T2DM\""
      ],
      [
        "\"ACDC\"",
        "\"T2DM\""
      ],
      [
        "\"ABCC8\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"TCF7L2-RS7903146\""
      ],
      [
        "\"RECESSIVE MODEL\"",
        "\"TCF7L2-RS7903146\""
      ],
      [
        "\"ADEYEMO\"",
        "\"T2DM\""
      ],
      [
        "\"ENPP1\"",
        "\"T2DM\""
      ],
      [
        "\"GWAS\"",
        "\"T2DM\""
      ],
      [
        "\"PPAR-Γ\"",
        "\"T2DM\""
      ],
      [
        "\"LINKAGE ANALYSIS\"",
        "\"T2DM\""
      ],
      [
        "\"CHROMOSOMAL LOCATION\"",
        "\"PTEN/PPP1R5/IDE\""
      ],
      [
        "\"PPARGC1\"",
        "\"T2DM\""
      ],
      [
        "\"IRS-1\"",
        "\"T2DM\""
      ]
    ],
    "nodes": [
      "\"PTEN/PPP1R5/IDE\"",
      "\"SLC30A8\"",
      "\"IRS-1\"",
      "\"PFH\"",
      "\"KCNJ11\"",
      "\"CODOMINANT GENETIC MODEL\"",
      "\"ADEYEMO\"",
      "\"LINKAGE ANALYSIS\"",
      "\"CHEN\"",
      "\"TNF-Α\"",
      "\"T2DM\"",
      "\"MEILOUD\"",
      "\"PPARGC1\"",
      "\"PPP1R5\"",
      "\"TCF7L2-RS7903146\"",
      "\"FAMILY HISTORY\"",
      "\"PSMD6\"",
      "\"ZRANB3\"",
      "\"PPAR-Α\"",
      "\"CHROMOSOMAL LOCATION\"",
      "\"HAPTOGLOBIN\"",
      "\"SSA\"",
      "\"CDKAL1\"",
      "\"TCF7L2\"",
      "\"ACDC\"",
      "\"ENPP1\"",
      "\"ADDITIVE MODEL\"",
      "\"RECESSIVE MODEL\"",
      "\"C2D4B\"",
      "\"DIET\"",
      "\"SCL40A1\"",
      "\"POLYMORPHISMS\"",
      "\"PTEN\"",
      "\"PACAP\"",
      "\"INSULIN\"",
      "\"IDE\"",
      "\"AGMO\"",
      "\"ERASMUS\"",
      "\"AGRP\"",
      "\"ABCC8\"",
      "\"CAPN10\"",
      "\"PPAR-Γ\"",
      "\"Β-CELL\""
    ],
    "chunk_ids": [
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.25925925925925924,
    "sub_communities": [
      "20",
      "22",
      "21",
      "23"
    ]
  },
  "9": {
    "report_string": "# Macronutrient Intake and Genetic Influences\n\nThe community revolves around macronutrient intake, a physiological process influenced by genetic and environmental factors. Key entities include genes such as FGF21, KLB, and MLXIPL, physiological processes like brain function and central nervous system activity, and environmental factors such as dietary patterns. These entities are interconnected through their roles in regulating macronutrient intake, sweet and alcohol taste preference, and metabolic health.\n\n## FGF21 and its role in macronutrient intake\n\nThe FGF21 protein is involved in sweet and alcohol taste preference via the liver-brain-endocrine axis. It interacts with KLB and MLXIPL to influence metabolic processes. This highlights the importance of considering genetic factors in dietary recommendations for personalized nutrition.\n\n## Genetic variation and macronutrient intake\n\nGenetic variation affects macronutrient intake, and genomic variants are associated with macronutrient intake. This suggests that genetic factors play a crucial role in shaping individual differences in dietary preferences and metabolic health.\n\n## Dietary patterns and macronutrient intake\n\nDietary patterns influence macronutrient intake and are associated with various genes. This highlights the importance of considering both genetic and environmental factors in understanding metabolic health and developing personalized dietary recommendations.\n\n## Brain function and macronutrient intake\n\nThe brain is involved in regulating macronutrient intake, and macronutrient intake affects brain function and behavior. This underscores the complex interplay between genetic, environmental, and physiological factors in shaping metabolic health.\n\n## Polygenic scores and macronutrient intake\n\nPolygenic scores predict macronutrient intake and are constructed using methods like LDpred. This highlights the potential for using genetic information to inform personalized dietary recommendations and improve metabolic health outcomes.",
    "report_json": {
      "title": "Macronutrient Intake and Genetic Influences",
      "summary": "The community revolves around macronutrient intake, a physiological process influenced by genetic and environmental factors. Key entities include genes such as FGF21, KLB, and MLXIPL, physiological processes like brain function and central nervous system activity, and environmental factors such as dietary patterns. These entities are interconnected through their roles in regulating macronutrient intake, sweet and alcohol taste preference, and metabolic health.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and dietary factors on macronutrient intake and metabolic health.",
      "findings": [
        {
          "summary": "FGF21 and its role in macronutrient intake",
          "explanation": "The FGF21 protein is involved in sweet and alcohol taste preference via the liver-brain-endocrine axis. It interacts with KLB and MLXIPL to influence metabolic processes. This highlights the importance of considering genetic factors in dietary recommendations for personalized nutrition."
        },
        {
          "summary": "Genetic variation and macronutrient intake",
          "explanation": "Genetic variation affects macronutrient intake, and genomic variants are associated with macronutrient intake. This suggests that genetic factors play a crucial role in shaping individual differences in dietary preferences and metabolic health."
        },
        {
          "summary": "Dietary patterns and macronutrient intake",
          "explanation": "Dietary patterns influence macronutrient intake and are associated with various genes. This highlights the importance of considering both genetic and environmental factors in understanding metabolic health and developing personalized dietary recommendations."
        },
        {
          "summary": "Brain function and macronutrient intake",
          "explanation": "The brain is involved in regulating macronutrient intake, and macronutrient intake affects brain function and behavior. This underscores the complex interplay between genetic, environmental, and physiological factors in shaping metabolic health."
        },
        {
          "summary": "Polygenic scores and macronutrient intake",
          "explanation": "Polygenic scores predict macronutrient intake and are constructed using methods like LDpred. This highlights the potential for using genetic information to inform personalized dietary recommendations and improve metabolic health outcomes."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 9",
    "edges": [
      [
        "\"GENETIC VARIATION\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"DIETARY PATTERN\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"FGF21\"",
        "\"KLB\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"DIETARY PATTERN\""
      ],
      [
        "\"MACRONUTRIENT INTAKE\"",
        "\"POLYGENIC SCORE\""
      ],
      [
        "\"FGF21\"",
        "\"MLXIPL\""
      ],
      [
        "\"BRAIN\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"HEALTH AND RETIREMENT STUDY\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"MACRONUTRIENT INTAKE\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"MACRONUTRIENT INTAKE\"",
        "\"ROTTERDAM STUDY\""
      ],
      [
        "\"LDPRED\"",
        "\"POLYGENIC SCORE\""
      ],
      [
        "\"FGF21\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"BRAIN\"",
        "\"MACRONUTRIENTS\""
      ],
      [
        "\"CENTRAL NERVOUS SYSTEM\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"BMI\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"DIET\"",
        "\"MACRONUTRIENT INTAKE\""
      ]
    ],
    "nodes": [
      "\"HEALTH AND RETIREMENT STUDY\"",
      "\"PHYSIOLOGICAL PROCESS\"",
      "\"POLYGENIC SCORE\"",
      "\"ROTTERDAM STUDY\"",
      "\"LDPRED\"",
      "\"KLB\"",
      "\"MLXIPL\"",
      "\"MACRONUTRIENT INTAKE\"",
      "\"DIETARY PATTERN\"",
      "\"BRAIN\"",
      "\"FGF21\"",
      "\"CENTRAL NERVOUS SYSTEM\""
    ],
    "chunk_ids": [
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.2222222222222222,
    "sub_communities": [
      "39",
      "38",
      "40"
    ]
  },
  "13": {
    "report_string": "# Genetic Analysis Community with MAGMA\n\nThe community revolves around genetic analysis and its applications, with a central focus on MAGMA, a bioinformatic tool used for gene-based analyses. Key entities include GENE, GENE FUNCTION, GENE-BASED ANALYSIS, and MAGMA, which are interconnected through their roles in genetic association studies, gene function prediction, and analysis of GWAS summary statistics.\n\n## Role of MAGMA in Gene-Based Analyses\n\nMAGMA is a bioinformatic tool used for gene-based analyses of GWAS summary statistics. It helps identify genetic associations with dietary intake and complex traits. This highlights the importance of MAGMA in understanding the genetic architecture of traits influenced by diet.\n\n## Relationship Between GENE and Genomic Variants\n\nGenes can have genomic variants, which is a fundamental concept in genetics. This relationship is crucial for understanding how genetic variations influence traits and disease susceptibility.\n\n## MAGMA's Role in Predicting Gene Function\n\nMAGMA is used to predict the functions of genes. This is significant because understanding gene function is essential for elucidating the biological mechanisms underlying genetic associations with dietary intake and complex traits.\n\n## Connection Between GENE-BASED ANALYSIS and MAGMA\n\nMAGMA is used for gene-based analyses of GWAS summary statistics. This demonstrates the tool's utility in integrating genetic data with analysis frameworks to uncover insights into complex traits.\n\n## Importance of MAGMA in Genetic Association Studies\n\nMAGMA's role in identifying genetic associations with dietary intake underscores its relevance in nutritional genetics. This can inform personalized dietary recommendations based on genetic profiles.",
    "report_json": {
      "title": "Genetic Analysis Community with MAGMA",
      "summary": "The community revolves around genetic analysis and its applications, with a central focus on MAGMA, a bioinformatic tool used for gene-based analyses. Key entities include GENE, GENE FUNCTION, GENE-BASED ANALYSIS, and MAGMA, which are interconnected through their roles in genetic association studies, gene function prediction, and analysis of GWAS summary statistics.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the relevance of MAGMA and related entities in understanding genetic associations with dietary intake and complex traits.",
      "findings": [
        {
          "summary": "Role of MAGMA in Gene-Based Analyses",
          "explanation": "MAGMA is a bioinformatic tool used for gene-based analyses of GWAS summary statistics. It helps identify genetic associations with dietary intake and complex traits. This highlights the importance of MAGMA in understanding the genetic architecture of traits influenced by diet."
        },
        {
          "summary": "Relationship Between GENE and Genomic Variants",
          "explanation": "Genes can have genomic variants, which is a fundamental concept in genetics. This relationship is crucial for understanding how genetic variations influence traits and disease susceptibility."
        },
        {
          "summary": "MAGMA's Role in Predicting Gene Function",
          "explanation": "MAGMA is used to predict the functions of genes. This is significant because understanding gene function is essential for elucidating the biological mechanisms underlying genetic associations with dietary intake and complex traits."
        },
        {
          "summary": "Connection Between GENE-BASED ANALYSIS and MAGMA",
          "explanation": "MAGMA is used for gene-based analyses of GWAS summary statistics. This demonstrates the tool's utility in integrating genetic data with analysis frameworks to uncover insights into complex traits."
        },
        {
          "summary": "Importance of MAGMA in Genetic Association Studies",
          "explanation": "MAGMA's role in identifying genetic associations with dietary intake underscores its relevance in nutritional genetics. This can inform personalized dietary recommendations based on genetic profiles."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 13",
    "edges": [
      [
        "\"GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENE-BASED ANALYSIS\"",
        "\"MAGMA\""
      ],
      [
        "\"GENE FUNCTION\"",
        "\"MAGMA\""
      ],
      [
        "\"GENE\"",
        "\"MAGMA\""
      ]
    ],
    "nodes": [
      "\"GENE FUNCTION\"",
      "\"GENE\"",
      "\"GENE-BASED ANALYSIS\"",
      "\"MAGMA\""
    ],
    "chunk_ids": [
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-2f2c90dea13e0dad5235137b025e03b7"
    ],
    "occurrence": 0.14814814814814814,
    "sub_communities": []
  },
  "14": {
    "report_string": "# Genetic Variation and Genotyping Quality in Nutritional Genomics\n\nThe community revolves around genetic variation, genotyping quality, and their impacts on nutritional genomics. Key entities include GENETIC VARIATION, GENOTYPING QUALITY, MAF, HWE, and LD PLOT. These entities are interconnected through their roles in genetic associations, genotyping accuracy, and metabolic processes.\n\n## Relationship between Genetic Variation and Macronutrient Intake\n\nGenetic variation affects macronutrient intake, which is crucial for understanding personalized nutrition. This relationship highlights the importance of considering genetic factors in dietary recommendations.\n\n## Genotyping Quality and MAF\n\nGenotyping quality is measured by MAF, which is a critical aspect of genetic analysis. Accurate genotyping is essential for reliable genetic associations and subsequent nutritional interventions.\n\n## Hardy-Weinberg Equilibrium (HWE) and Genotyping Quality\n\nHWE is a principle used to test for deviations in genetic associations, and genotyping quality is measured by HWE. Deviations from HWE can indicate genotyping errors or population stratification.\n\n## LD Plot and MAF\n\nLD plots are used to visualize genetic associations, and MAF is used to interpret LD plots. This highlights the importance of MAF in understanding genetic linkage and its implications for nutritional genomics.\n\n## Genetic Variation and Anthropometric Measures\n\nGenetic variation is associated with anthropometric measures, which are critical in nutritional genomics. Understanding this relationship can help in developing personalized dietary plans based on genetic profiles.",
    "report_json": {
      "title": "Genetic Variation and Genotyping Quality in Nutritional Genomics",
      "summary": "The community revolves around genetic variation, genotyping quality, and their impacts on nutritional genomics. Key entities include GENETIC VARIATION, GENOTYPING QUALITY, MAF, HWE, and LD PLOT. These entities are interconnected through their roles in genetic associations, genotyping accuracy, and metabolic processes.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic variation on genotyping quality and its implications for nutritional genomics.",
      "findings": [
        {
          "summary": "Relationship between Genetic Variation and Macronutrient Intake",
          "explanation": "Genetic variation affects macronutrient intake, which is crucial for understanding personalized nutrition. This relationship highlights the importance of considering genetic factors in dietary recommendations."
        },
        {
          "summary": "Genotyping Quality and MAF",
          "explanation": "Genotyping quality is measured by MAF, which is a critical aspect of genetic analysis. Accurate genotyping is essential for reliable genetic associations and subsequent nutritional interventions."
        },
        {
          "summary": "Hardy-Weinberg Equilibrium (HWE) and Genotyping Quality",
          "explanation": "HWE is a principle used to test for deviations in genetic associations, and genotyping quality is measured by HWE. Deviations from HWE can indicate genotyping errors or population stratification."
        },
        {
          "summary": "LD Plot and MAF",
          "explanation": "LD plots are used to visualize genetic associations, and MAF is used to interpret LD plots. This highlights the importance of MAF in understanding genetic linkage and its implications for nutritional genomics."
        },
        {
          "summary": "Genetic Variation and Anthropometric Measures",
          "explanation": "Genetic variation is associated with anthropometric measures, which are critical in nutritional genomics. Understanding this relationship can help in developing personalized dietary plans based on genetic profiles."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 14",
    "edges": [
      [
        "\"GENETIC VARIATION\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"CR\"",
        "\"GENOTYPING QUALITY\""
      ],
      [
        "\"ANTHROPOMETRIC MEASURES\"",
        "\"GENETIC VARIATION\""
      ],
      [
        "\"GENOTYPING QUALITY\"",
        "\"MAF\""
      ],
      [
        "\"GENETIC VARIATION\"",
        "\"LDSC-SEG\""
      ],
      [
        "\"GENETIC VARIATION\"",
        "\"HWE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MAF\""
      ],
      [
        "\"GENOTYPING QUALITY\"",
        "\"HWE\""
      ],
      [
        "\"LD PLOT\"",
        "\"MAF\""
      ]
    ],
    "nodes": [
      "\"GENOTYPING QUALITY\"",
      "\"CR\"",
      "\"MAF\"",
      "\"HWE\"",
      "\"GENETIC VARIATION\"",
      "\"LDSC-SEG\"",
      "\"LD PLOT\""
    ],
    "chunk_ids": [
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-23f99f090070aea487163f2778574849",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-2f2c90dea13e0dad5235137b025e03b7"
    ],
    "occurrence": 0.14814814814814814,
    "sub_communities": []
  },
  "6": {
    "report_string": "# Lifestyle Factors and Genetic Associations in Pregnancy and Disease\n\nThe community revolves around lifestyle factors such as smoking and alcohol consumption, and their genetic associations with pregnancy outcomes and disease risks. Key entities include genes like ACTN1, ADH1C, CHRND, DBH, GRM8, and PDYN, environmental factors like smoking and alcohol consumption, and physiological processes like pregnancy.\n\n## Smoking and its genetic associations\n\nSmoking is an environmental factor that may influence obesity and colorectal cancer risk. Genes like ACTN1, CHRND, and DBH are associated with smoking during pregnancy, highlighting the complex interplay between genetic and environmental factors in pregnancy outcomes.\n\n## Alcohol consumption and its genetic associations\n\nAlcohol consumption is a lifestyle factor that may influence obesity and colorectal cancer risk. Genes like ADH1C, GRM8, and PDYN are associated with alcohol consumption during pregnancy, underscoring the importance of genetic considerations in assessing pregnancy risks.\n\n## Pregnancy and lifestyle factors\n\nPregnancy is a physiological process that can be affected by lifestyle factors like smoking and alcohol consumption. These factors can impact pregnancy outcomes, and genetic associations with these factors can provide insights into individual susceptibility to pregnancy complications.\n\n## Smoking and disease risk\n\nSmoking is a risk factor for colorectal cancer and may influence obesity risk. The genetic associations with smoking, such as ACTN1, CHRND, and DBH, highlight the potential for targeted interventions to mitigate disease risk.\n\n## Alcohol consumption and disease risk\n\nAlcohol consumption may influence obesity and colorectal cancer risk. The genetic associations with alcohol consumption, such as ADH1C, GRM8, and PDYN, suggest that personalized dietary recommendations could optimize disease prevention strategies.",
    "report_json": {
      "title": "Lifestyle Factors and Genetic Associations in Pregnancy and Disease",
      "summary": "The community revolves around lifestyle factors such as smoking and alcohol consumption, and their genetic associations with pregnancy outcomes and disease risks. Key entities include genes like ACTN1, ADH1C, CHRND, DBH, GRM8, and PDYN, environmental factors like smoking and alcohol consumption, and physiological processes like pregnancy.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of lifestyle factors and genetic associations on pregnancy outcomes and disease risks.",
      "findings": [
        {
          "summary": "Smoking and its genetic associations",
          "explanation": "Smoking is an environmental factor that may influence obesity and colorectal cancer risk. Genes like ACTN1, CHRND, and DBH are associated with smoking during pregnancy, highlighting the complex interplay between genetic and environmental factors in pregnancy outcomes."
        },
        {
          "summary": "Alcohol consumption and its genetic associations",
          "explanation": "Alcohol consumption is a lifestyle factor that may influence obesity and colorectal cancer risk. Genes like ADH1C, GRM8, and PDYN are associated with alcohol consumption during pregnancy, underscoring the importance of genetic considerations in assessing pregnancy risks."
        },
        {
          "summary": "Pregnancy and lifestyle factors",
          "explanation": "Pregnancy is a physiological process that can be affected by lifestyle factors like smoking and alcohol consumption. These factors can impact pregnancy outcomes, and genetic associations with these factors can provide insights into individual susceptibility to pregnancy complications."
        },
        {
          "summary": "Smoking and disease risk",
          "explanation": "Smoking is a risk factor for colorectal cancer and may influence obesity risk. The genetic associations with smoking, such as ACTN1, CHRND, and DBH, highlight the potential for targeted interventions to mitigate disease risk."
        },
        {
          "summary": "Alcohol consumption and disease risk",
          "explanation": "Alcohol consumption may influence obesity and colorectal cancer risk. The genetic associations with alcohol consumption, such as ADH1C, GRM8, and PDYN, suggest that personalized dietary recommendations could optimize disease prevention strategies."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 6",
    "edges": [
      [
        "\"OBESITY\"",
        "\"SMOKING\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"PREGNANCY\""
      ],
      [
        "\"CHRND\"",
        "\"SMOKING\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"SMOKING\""
      ],
      [
        "\"ACTN1\"",
        "\"SMOKING\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"GRM8\""
      ],
      [
        "\"PREGNANCY\"",
        "\"SMOKING\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"PDYN\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"OBESITY\""
      ],
      [
        "\"DBH\"",
        "\"SMOKING\""
      ],
      [
        "\"PREGNANCY\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"ADH1C\"",
        "\"ALCOHOL CONSUMPTION\""
      ]
    ],
    "nodes": [
      "\"PREGNANCY\"",
      "\"ADH1C\"",
      "\"DBH\"",
      "\"GRM8\"",
      "\"ALCOHOL CONSUMPTION\"",
      "\"ACTN1\"",
      "\"CHRND\"",
      "\"SMOKING\"",
      "\"PDYN\""
    ],
    "chunk_ids": [
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.14814814814814814,
    "sub_communities": []
  },
  "5": {
    "report_string": "# Genetic Factors Influencing Waist Circumference\n\nThe community centers around waist circumference, a measure of central obesity, and its genetic determinants. Key entities include genes such as PPARΓ, MELANOCORTIN4 RECEPTOR GENE, NCAM2, and TRANSMEMBRANE PROTEIN18 GENE, as well as genetic variants like SNP RS1801282 and SNP RS9941349. These entities are interconnected through their roles in glucose and lipid metabolism, energy homeostasis, and body fat distribution.\n\n## PPARΓ gene and waist circumference\n\nThe PPARγ gene plays a crucial role in glucose and lipid metabolism, and its variant rs1801282 has a protective effect against increased waist circumference. This suggests that genetic variations in PPARγ can influence body fat distribution and metabolic health.\n\n## MELANOCORTIN4 RECEPTOR GENE and energy homeostasis\n\nThe melanocortin4 receptor gene (MC4R) is involved in energy homeostasis, and its variants have been associated with waist circumference. This highlights the importance of MC4R in regulating body weight and fat distribution.\n\n## NCAM2 gene and waist circumference\n\nThe NCAM2 gene is associated with waist circumference, suggesting its potential role in body fat distribution. Further research is needed to understand the mechanisms underlying this association.\n\n## SNP RS9941349 and waist circumference\n\nSNP rs9941349 is associated with waist circumference, with a p-value of 9.05 × 10^−8 in joint analyses. This indicates a significant genetic contribution to variation in waist circumference.\n\n## TRANSMEMBRANE PROTEIN18 GENE and energy homeostasis\n\nThe transmembrane protein18 gene (TMEM18) is involved in energy homeostasis, and its variants have been linked to waist circumference. This suggests that TMEM18 may play a role in regulating body weight and metabolic health.",
    "report_json": {
      "title": "Genetic Factors Influencing Waist Circumference",
      "summary": "The community centers around waist circumference, a measure of central obesity, and its genetic determinants. Key entities include genes such as PPARΓ, MELANOCORTIN4 RECEPTOR GENE, NCAM2, and TRANSMEMBRANE PROTEIN18 GENE, as well as genetic variants like SNP RS1801282 and SNP RS9941349. These entities are interconnected through their roles in glucose and lipid metabolism, energy homeostasis, and body fat distribution.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic factors on waist circumference, a key indicator of obesity and metabolic health.",
      "findings": [
        {
          "summary": "PPARΓ gene and waist circumference",
          "explanation": "The PPARγ gene plays a crucial role in glucose and lipid metabolism, and its variant rs1801282 has a protective effect against increased waist circumference. This suggests that genetic variations in PPARγ can influence body fat distribution and metabolic health."
        },
        {
          "summary": "MELANOCORTIN4 RECEPTOR GENE and energy homeostasis",
          "explanation": "The melanocortin4 receptor gene (MC4R) is involved in energy homeostasis, and its variants have been associated with waist circumference. This highlights the importance of MC4R in regulating body weight and fat distribution."
        },
        {
          "summary": "NCAM2 gene and waist circumference",
          "explanation": "The NCAM2 gene is associated with waist circumference, suggesting its potential role in body fat distribution. Further research is needed to understand the mechanisms underlying this association."
        },
        {
          "summary": "SNP RS9941349 and waist circumference",
          "explanation": "SNP rs9941349 is associated with waist circumference, with a p-value of 9.05 × 10^−8 in joint analyses. This indicates a significant genetic contribution to variation in waist circumference."
        },
        {
          "summary": "TRANSMEMBRANE PROTEIN18 GENE and energy homeostasis",
          "explanation": "The transmembrane protein18 gene (TMEM18) is involved in energy homeostasis, and its variants have been linked to waist circumference. This suggests that TMEM18 may play a role in regulating body weight and metabolic health."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 5",
    "edges": [
      [
        "\"TRANSMEMBRANE PROTEIN18 GENE\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"PPARΓ GENE\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"PPARΓ GENE\"",
        "\"SNP RS1801282\""
      ],
      [
        "\"NCAM2\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"MELANOCORTIN4 RECEPTOR GENE\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"OBESITY\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"GENETIC MODEL\"",
        "\"PPARΓ GENE\""
      ],
      [
        "\"SNP RS9941349\"",
        "\"WAIST CIRCUMFERENCE\""
      ]
    ],
    "nodes": [
      "\"GENETIC MODEL\"",
      "\"NCAM2\"",
      "\"WAIST CIRCUMFERENCE\"",
      "\"PPARΓ GENE\"",
      "\"TRANSMEMBRANE PROTEIN18 GENE\"",
      "\"SNP RS1801282\"",
      "\"SNP RS9941349\"",
      "\"MELANOCORTIN4 RECEPTOR GENE\""
    ],
    "chunk_ids": [
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.18518518518518517,
    "sub_communities": []
  },
  "0": {
    "report_string": "# FTO Gene and Obesity Risk\n\nThe community revolves around the FTO gene, which is associated with obesity risk, body mass index (BMI), and fat mass. The FTO gene interacts with various entities, including genomic variants, proteins, and ethnic groups, to influence obesity traits and related physiological processes.\n\n## FTO gene and obesity risk\n\nThe FTO gene is strongly associated with obesity risk, BMI, and fat mass. Variants in the FTO gene, such as rs3751812 and rs8050136, have been linked to obesity traits. The FTO gene is also associated with maternal pre-pregnancy body weight and colorectal cancer risk.\n\n## FTO gene and genomic variants\n\nThe FTO gene is associated with various genomic variants, including rs1421085, rs3751812, and rs8050136. These variants are located within highly sequence-conserved elements among vertebrates and have been predicted to have allele-specific binding affinities for different transcription factors.\n\n## FTO gene and protein interactions\n\nThe FTO gene interacts with various proteins, including IGF-1, IRX3, MYF5, MYF6, MYOD1, and MYOG. These interactions suggest a complex network of gene-gene interactions that influence obesity traits and related physiological processes.\n\n## FTO gene and ethnic group associations\n\nThe FTO gene association varies in different ethnic groups, including Hispanic-Americans, African-Americans, and Caucasians. The FTO gene association is significant in Caucasians and Hispanic-Americans.\n\n## FTO gene and physiological processes\n\nThe FTO gene plays a role in muscle development and is expressed in skeletal muscle tissue. The FTO gene is also associated with LMI and impulsivity traits.",
    "report_json": {
      "title": "FTO Gene and Obesity Risk",
      "summary": "The community revolves around the FTO gene, which is associated with obesity risk, body mass index (BMI), and fat mass. The FTO gene interacts with various entities, including genomic variants, proteins, and ethnic groups, to influence obesity traits and related physiological processes.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant association of the FTO gene with obesity risk and related traits.",
      "findings": [
        {
          "summary": "FTO gene and obesity risk",
          "explanation": "The FTO gene is strongly associated with obesity risk, BMI, and fat mass. Variants in the FTO gene, such as rs3751812 and rs8050136, have been linked to obesity traits. The FTO gene is also associated with maternal pre-pregnancy body weight and colorectal cancer risk."
        },
        {
          "summary": "FTO gene and genomic variants",
          "explanation": "The FTO gene is associated with various genomic variants, including rs1421085, rs3751812, and rs8050136. These variants are located within highly sequence-conserved elements among vertebrates and have been predicted to have allele-specific binding affinities for different transcription factors."
        },
        {
          "summary": "FTO gene and protein interactions",
          "explanation": "The FTO gene interacts with various proteins, including IGF-1, IRX3, MYF5, MYF6, MYOD1, and MYOG. These interactions suggest a complex network of gene-gene interactions that influence obesity traits and related physiological processes."
        },
        {
          "summary": "FTO gene and ethnic group associations",
          "explanation": "The FTO gene association varies in different ethnic groups, including Hispanic-Americans, African-Americans, and Caucasians. The FTO gene association is significant in Caucasians and Hispanic-Americans."
        },
        {
          "summary": "FTO gene and physiological processes",
          "explanation": "The FTO gene plays a role in muscle development and is expressed in skeletal muscle tissue. The FTO gene is also associated with LMI and impulsivity traits."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 0",
    "edges": [
      [
        "\"HISPANIC-AMERICANS\"",
        "\"RS7201444\""
      ],
      [
        "\"FTO\"",
        "\"LEPR\""
      ],
      [
        "\"FTO\"",
        "\"SKELETAL MUSCLE\""
      ],
      [
        "\"CAUCASIANS\"",
        "\"FTO\""
      ],
      [
        "\"CUT-LIKE HOMEOBOX 1\"",
        "\"RS1421085\""
      ],
      [
        "\"FTO\"",
        "\"PPARG\""
      ],
      [
        "\"FTO\"",
        "\"MYF5\""
      ],
      [
        "\"FTO\"",
        "\"INTRON1\""
      ],
      [
        "\"FTO\"",
        "\"MUSCLE DEVELOPMENT\""
      ],
      [
        "\"FTO\"",
        "\"RS1421085\""
      ],
      [
        "\"FTO\"",
        "\"HISPANIC-AMERICANS\""
      ],
      [
        "\"FTO\"",
        "\"LMI\""
      ],
      [
        "\"FTO\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"BMI\"",
        "\"RS3751812\""
      ],
      [
        "\"FTO\"",
        "\"MC4R\""
      ],
      [
        "\"AFRICAN-AMERICANS\"",
        "\"LEPR\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"MYF6\""
      ],
      [
        "\"FTO\"",
        "\"GWAS\""
      ],
      [
        "\"CTNNBL1\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"T2DM\""
      ],
      [
        "\"FTO INTRON1 REGION\"",
        "\"FTO\""
      ],
      [
        "\"LEPR\"",
        "\"OBESITY\""
      ],
      [
        "\"EXONS\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"RS8051873\""
      ],
      [
        "\"FTO\"",
        "\"RS8050136\""
      ],
      [
        "\"FTO\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"RS3751812\"",
        "\"SEQUENCE-CONSERVED ELEMENT\""
      ],
      [
        "\"CONDITIONAL P-VALUE\"",
        "\"RS8051873\""
      ],
      [
        "\"16Q12.2/FTO FINE-MAPPING REGION\"",
        "\"FTO\""
      ],
      [
        "\"BMI\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"FTO\"",
        "\"IGF-1\""
      ],
      [
        "\"FTO\"",
        "\"RS17817964\""
      ],
      [
        "\"FTO\"",
        "\"MYOD1\""
      ],
      [
        "\"BMI\"",
        "\"RS8050136\""
      ],
      [
        "\"RS8050136\"",
        "\"SNP\""
      ],
      [
        "\"INTRONIC REGULATORY ELEMENT\"",
        "\"RS1421085\""
      ],
      [
        "\"FTO\"",
        "\"IRX3\""
      ],
      [
        "\"FTO\"",
        "\"RS3751812\""
      ],
      [
        "\"FTO\"",
        "\"MYOG\""
      ],
      [
        "\"FTO\"",
        "\"GENE/LOCUS\""
      ]
    ],
    "nodes": [
      "\"RS8051873\"",
      "\"RS1421085\"",
      "\"LEPR\"",
      "\"RS8050136\"",
      "\"GENE/LOCUS\"",
      "\"SEQUENCE-CONSERVED ELEMENT\"",
      "\"RS7201444\"",
      "\"INTRONIC REGULATORY ELEMENT\"",
      "\"16Q12.2/FTO FINE-MAPPING REGION\"",
      "\"CAUCASIANS\"",
      "\"MUSCLE DEVELOPMENT\"",
      "\"SKELETAL MUSCLE\"",
      "\"FTO\"",
      "\"IGF-1\"",
      "\"MYOD1\"",
      "\"IRX3\"",
      "\"AFRICAN-AMERICANS\"",
      "\"RS17817964\"",
      "\"RPGRIP1L\"",
      "\"HISPANIC-AMERICANS\"",
      "\"CONDITIONAL P-VALUE\"",
      "\"MYOG\"",
      "\"RS3751812\"",
      "\"MYF6\"",
      "\"MYF5\"",
      "\"CUT-LIKE HOMEOBOX 1\"",
      "\"EXONS\"",
      "\"FTO INTRON1 REGION\"",
      "\"INTRON1\""
    ],
    "chunk_ids": [
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d"
    ],
    "occurrence": 0.6296296296296297,
    "sub_communities": [
      "15",
      "17",
      "19",
      "16",
      "18"
    ]
  },
  "2": {
    "report_string": "# Genetic and Environmental Factors in Colorectal Cancer\n\nThe community revolves around colorectal cancer, influenced by genetic and environmental factors. Key entities include genes (NRXN3, FTO), genomic variants (FTO GENE VARIANTS, KCTD15 RS29941), nutrients (adiponectin, leptin), and environmental factors (age, sex, physical activity level). These entities interact through complex relationships affecting disease risk and metabolic health.\n\n## NRXN3 gene and colorectal cancer risk\n\nThe NRXN3 gene is associated with colorectal cancer risk, with variant rs10146997 being inversely associated with disease risk in whites. This suggests a potential genetic link between NRXN3 and colorectal cancer, which may be influenced by ethnic group.\n\n## FTO gene variants and obesity\n\nFTO gene variants, such as rs7185735, rs9922708, and rs17817449, are associated with obesity traits. The association of these variants with obesity risk highlights the importance of genetic factors in metabolic health.\n\n## Adiponectin and colorectal cancer\n\nAdiponectin is inversely associated with the incidence of colorectal cancer. This suggests that adiponectin may play a protective role in colorectal cancer development, potentially through its anti-inflammatory effects.\n\n## Environmental factors and colorectal cancer risk\n\nEnvironmental factors such as age, sex, physical activity level, and total energy intake are associated with colorectal cancer risk. These factors interact with genetic variants to influence disease susceptibility.\n\n## FTO SNPs and colorectal cancer\n\nFTO SNPs are associated with an increased risk of colorectal cancer, although the significance may vary depending on the study population and genetic background.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Colorectal Cancer",
      "summary": "The community revolves around colorectal cancer, influenced by genetic and environmental factors. Key entities include genes (NRXN3, FTO), genomic variants (FTO GENE VARIANTS, KCTD15 RS29941), nutrients (adiponectin, leptin), and environmental factors (age, sex, physical activity level). These entities interact through complex relationships affecting disease risk and metabolic health.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and environmental factors on colorectal cancer risk.",
      "findings": [
        {
          "summary": "NRXN3 gene and colorectal cancer risk",
          "explanation": "The NRXN3 gene is associated with colorectal cancer risk, with variant rs10146997 being inversely associated with disease risk in whites. This suggests a potential genetic link between NRXN3 and colorectal cancer, which may be influenced by ethnic group."
        },
        {
          "summary": "FTO gene variants and obesity",
          "explanation": "FTO gene variants, such as rs7185735, rs9922708, and rs17817449, are associated with obesity traits. The association of these variants with obesity risk highlights the importance of genetic factors in metabolic health."
        },
        {
          "summary": "Adiponectin and colorectal cancer",
          "explanation": "Adiponectin is inversely associated with the incidence of colorectal cancer. This suggests that adiponectin may play a protective role in colorectal cancer development, potentially through its anti-inflammatory effects."
        },
        {
          "summary": "Environmental factors and colorectal cancer risk",
          "explanation": "Environmental factors such as age, sex, physical activity level, and total energy intake are associated with colorectal cancer risk. These factors interact with genetic variants to influence disease susceptibility."
        },
        {
          "summary": "FTO SNPs and colorectal cancer",
          "explanation": "FTO SNPs are associated with an increased risk of colorectal cancer, although the significance may vary depending on the study population and genetic background."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 2",
    "edges": [
      [
        "\"COLORECTAL CANCER\"",
        "\"KCTD15 RS29941\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS8046502\""
      ],
      [
        "\"FM\"",
        "\"FTO GENE VARIANTS\""
      ],
      [
        "\"AGE\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"SEX\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"SNPS\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"MC4R\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS10146997\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"LEPTIN\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"POSTMENOPAUSAL HORMONE TREATMENT\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS4784329\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"OBESITY\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO SNPS\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"PHYSICAL ACTIVITY LEVEL\""
      ],
      [
        "\"AGE\"",
        "\"GENDER\""
      ],
      [
        "\"ETHNICITY\"",
        "\"FTO GENE VARIANTS\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"MC4R RS17782313\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"SMOKING\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"META-ANALYSIS\""
      ],
      [
        "\"ETHNIC GROUP\"",
        "\"FTO GENE VARIANTS\""
      ],
      [
        "\"NRXN3\"",
        "\"RS10146997\""
      ],
      [
        "\"AGE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"AGE\"",
        "\"SEX\""
      ],
      [
        "\"BMI\"",
        "\"FTO SNPS\""
      ],
      [
        "\"COLON CANCER\"",
        "\"COLORECTAL CANCER\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RECTAL CANCER\""
      ],
      [
        "\"NRXN3\"",
        "\"WAIST TO HIP RATIO\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"SEX\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"DIETARY PATTERN\""
      ],
      [
        "\"ADIPONECTIN\"",
        "\"COLORECTAL CANCER\""
      ],
      [
        "\"AGE\"",
        "\"COLORECTAL CANCER\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO GENE\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"SNP\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"TOTAL ENERGY INTAKE\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"NRXN3\""
      ],
      [
        "\"BMI\"",
        "\"FTO GENE VARIANTS\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FAMILY HISTORY\""
      ]
    ],
    "nodes": [
      "\"PHYSICAL ACTIVITY LEVEL\"",
      "\"RS8046502\"",
      "\"LEPTIN\"",
      "\"ETHNIC GROUP\"",
      "\"KCTD15 RS29941\"",
      "\"COLON CANCER\"",
      "\"AGE\"",
      "\"COLORECTAL CANCER\"",
      "\"GENDER\"",
      "\"NRXN3\"",
      "\"FM\"",
      "\"MC4R RS17782313\"",
      "\"FTO SNPS\"",
      "\"ADIPONECTIN\"",
      "\"FTO GENE VARIANTS\"",
      "\"RS4784329\"",
      "\"WAIST TO HIP RATIO\"",
      "\"RECTAL CANCER\"",
      "\"POSTMENOPAUSAL HORMONE TREATMENT\"",
      "\"META-ANALYSIS\"",
      "\"TOTAL ENERGY INTAKE\"",
      "\"SEX\""
    ],
    "chunk_ids": [
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-23f99f090070aea487163f2778574849",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.4444444444444444,
    "sub_communities": [
      "24",
      "25",
      "26"
    ]
  },
  "10": {
    "report_string": "# CTNNBL1 and Obesity Phenotypes\n\nThe community centers around the CTNNBL1 gene, which is associated with obesity phenotypes. The CTNNBL1 gene interacts with other entities such as FTO and obesity, and is also linked to the Chinese ethnic group through a specific SNP. This community highlights the genetic factors influencing obesity traits.\n\n## CTNNBL1 gene and obesity phenotypes\n\nThe CTNNBL1 gene is directly associated with obesity phenotypes. This association is significant as it highlights the genetic component of obesity. The gene's interaction with other obesity-related genes like FTO further emphasizes its role in obesity.\n\n## CTNNBL1 and ethnic group specificity\n\nThe CTNNBL1 gene has a specific association with obesity traits in the Chinese ethnic group, as indicated by the SNP rs45500793. This suggests that genetic factors influencing obesity may vary between ethnic groups, highlighting the importance of personalized genetic screening in obesity management.\n\n## CTNNBL1 and FTO interaction\n\nThe interaction between CTNNBL1 and FTO, another gene associated with obesity, suggests a complex genetic network influencing obesity phenotypes. Understanding these interactions can provide insights into the multifactorial causes of obesity.\n\n## CTNNBL1 and obesity\n\nThe direct association of CTNNBL1 with obesity underscores the gene's potential as a target for therapeutic interventions or preventive measures against obesity. Further research into the mechanisms by which CTNNBL1 influences obesity could lead to novel treatments.",
    "report_json": {
      "title": "CTNNBL1 and Obesity Phenotypes",
      "summary": "The community centers around the CTNNBL1 gene, which is associated with obesity phenotypes. The CTNNBL1 gene interacts with other entities such as FTO and obesity, and is also linked to the Chinese ethnic group through a specific SNP. This community highlights the genetic factors influencing obesity traits.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific association of CTNNBL1 with obesity phenotypes and its interaction with other relevant genes and ethnic groups.",
      "findings": [
        {
          "summary": "CTNNBL1 gene and obesity phenotypes",
          "explanation": "The CTNNBL1 gene is directly associated with obesity phenotypes. This association is significant as it highlights the genetic component of obesity. The gene's interaction with other obesity-related genes like FTO further emphasizes its role in obesity."
        },
        {
          "summary": "CTNNBL1 and ethnic group specificity",
          "explanation": "The CTNNBL1 gene has a specific association with obesity traits in the Chinese ethnic group, as indicated by the SNP rs45500793. This suggests that genetic factors influencing obesity may vary between ethnic groups, highlighting the importance of personalized genetic screening in obesity management."
        },
        {
          "summary": "CTNNBL1 and FTO interaction",
          "explanation": "The interaction between CTNNBL1 and FTO, another gene associated with obesity, suggests a complex genetic network influencing obesity phenotypes. Understanding these interactions can provide insights into the multifactorial causes of obesity."
        },
        {
          "summary": "CTNNBL1 and obesity",
          "explanation": "The direct association of CTNNBL1 with obesity underscores the gene's potential as a target for therapeutic interventions or preventive measures against obesity. Further research into the mechanisms by which CTNNBL1 influences obesity could lead to novel treatments."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 10",
    "edges": [
      [
        "\"CHINESE\"",
        "\"CTNNBL1\""
      ],
      [
        "\"CTNNBL1\"",
        "\"OBESITY\""
      ],
      [
        "\"CTNNBL1\"",
        "\"FTO\""
      ]
    ],
    "nodes": [
      "\"CHINESE\"",
      "\"CTNNBL1\""
    ],
    "chunk_ids": [
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-84861a91f27adb095877d1a6ab6a6a69"
    ],
    "occurrence": 0.07407407407407407,
    "sub_communities": []
  },
  "12": {
    "report_string": "# Linkage Disequilibrium in Genetic Variants\n\nThe community centers around linkage disequilibrium, a molecular interaction between genetic variants that are inherited together. Key entities include linkage disequilibrium, FTO gene variants, and genetic variants. These entities are interconnected through their roles in genetic associations and correlations.\n\n## Linkage disequilibrium and its role in genetic associations\n\nLinkage disequilibrium (LD) is a physiological process used to analyze genetic associations. It measures the correlation between genetic variants that are inherited together. LD is observed among SNPs in the FTO gene, indicating its importance in understanding genetic correlations.\n\n## Relationship between FTO gene variants and linkage disequilibrium\n\nFTO gene variants are in linkage disequilibrium with each other, suggesting that these variants are inherited together and may contribute to similar biological effects. This relationship highlights the significance of considering LD in genetic studies.\n\n## Linkage disequilibrium as a measure of genetic correlation\n\nLinkage disequilibrium serves as a measure of genetic correlation between variants. This correlation can influence the risk of diseases and traits. Understanding LD helps researchers to identify genetic associations and their potential impact on health.\n\n## Genetic variants and their interaction with linkage disequilibrium\n\nGenetic variants interact with linkage disequilibrium to influence genetic associations. This interaction is crucial for understanding the genetic basis of diseases and developing personalized medicine approaches.\n\n## Implications of linkage disequilibrium for disease susceptibility\n\nThe study of linkage disequilibrium has implications for understanding disease susceptibility. By identifying genetic variants in LD, researchers can better understand the genetic factors contributing to disease risk and develop targeted interventions.",
    "report_json": {
      "title": "Linkage Disequilibrium in Genetic Variants",
      "summary": "The community centers around linkage disequilibrium, a molecular interaction between genetic variants that are inherited together. Key entities include linkage disequilibrium, FTO gene variants, and genetic variants. These entities are interconnected through their roles in genetic associations and correlations.",
      "rating": 5.0,
      "rating_explanation": "The impact severity rating is moderate due to the significant role of linkage disequilibrium in understanding genetic associations and its implications for disease susceptibility.",
      "findings": [
        {
          "summary": "Linkage disequilibrium and its role in genetic associations",
          "explanation": "Linkage disequilibrium (LD) is a physiological process used to analyze genetic associations. It measures the correlation between genetic variants that are inherited together. LD is observed among SNPs in the FTO gene, indicating its importance in understanding genetic correlations."
        },
        {
          "summary": "Relationship between FTO gene variants and linkage disequilibrium",
          "explanation": "FTO gene variants are in linkage disequilibrium with each other, suggesting that these variants are inherited together and may contribute to similar biological effects. This relationship highlights the significance of considering LD in genetic studies."
        },
        {
          "summary": "Linkage disequilibrium as a measure of genetic correlation",
          "explanation": "Linkage disequilibrium serves as a measure of genetic correlation between variants. This correlation can influence the risk of diseases and traits. Understanding LD helps researchers to identify genetic associations and their potential impact on health."
        },
        {
          "summary": "Genetic variants and their interaction with linkage disequilibrium",
          "explanation": "Genetic variants interact with linkage disequilibrium to influence genetic associations. This interaction is crucial for understanding the genetic basis of diseases and developing personalized medicine approaches."
        },
        {
          "summary": "Implications of linkage disequilibrium for disease susceptibility",
          "explanation": "The study of linkage disequilibrium has implications for understanding disease susceptibility. By identifying genetic variants in LD, researchers can better understand the genetic factors contributing to disease risk and develop targeted interventions."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 12",
    "edges": [
      [
        "\"GENETIC VARIANTS\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"FTO GENE VARIANTS\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ]
    ],
    "nodes": [
      "\"LINKAGE DISEQUILIBRIUM\"",
      "\"GENETIC VARIANTS\""
    ],
    "chunk_ids": [
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478"
    ],
    "occurrence": 0.18518518518518517,
    "sub_communities": []
  },
  "11": {
    "report_string": "# Ethnicity and Genetic Associations with Obesity and Colorectal Cancer\n\nThe community revolves around the interplay between ethnicity, genetic variants, and their associations with obesity and colorectal cancer. Key entities include ethnic groups like Whites and Roma, genetic variants such as rs10146997 in the NRXN3 gene, and metabolic pathways influenced by these factors. The relationships highlight how ethnicity influences genetic associations with disease risk.\n\n## Influence of Ethnicity on Genetic Associations\n\nEthnicity plays a crucial role in modifying the associations between genetic variants and disease risk. For instance, the association of FTO gene variants with obesity traits varies among different ethnic groups. This variability underscores the importance of considering ethnicity in genetic studies and personalized medicine approaches.\n\n## Role of rs10146997 in Colorectal Cancer Risk\n\nThe rs10146997 variant in the NRXN3 gene is associated with colorectal cancer risk, and this association varies by ethnicity. Specifically, the variant is inversely associated with colorectal cancer risk in Whites. This highlights the need for ethnic-specific studies to understand genetic risk factors for diseases.\n\n## Ethnic Differences in Disease Frequency\n\nThere are significant differences in disease frequency among various ethnic groups. For example, the Roma ethnic group has a significantly higher frequency of certain outcomes. Understanding these differences is crucial for targeted public health interventions and personalized medicine.\n\n## Importance of Statistical Analysis in Genetic Associations\n\nStatistical measures such as odds ratio (OR) and 95% confidence interval (CI) are essential in assessing the reliability of genetic associations with disease risk. These tools help in understanding the strength and significance of the associations, which can vary by ethnicity and other factors.\n\n## Impact of Ethnicity on Outcome\n\nEthnicity status is considered an outcome in this context, and it influences the association between genetic variants and disease risk. This highlights the complex interplay between genetic, environmental, and ethnic factors in determining health outcomes.",
    "report_json": {
      "title": "Ethnicity and Genetic Associations with Obesity and Colorectal Cancer",
      "summary": "The community revolves around the interplay between ethnicity, genetic variants, and their associations with obesity and colorectal cancer. Key entities include ethnic groups like Whites and Roma, genetic variants such as rs10146997 in the NRXN3 gene, and metabolic pathways influenced by these factors. The relationships highlight how ethnicity influences genetic associations with disease risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of ethnicity on genetic associations with obesity and colorectal cancer risk.",
      "findings": [
        {
          "summary": "Influence of Ethnicity on Genetic Associations",
          "explanation": "Ethnicity plays a crucial role in modifying the associations between genetic variants and disease risk. For instance, the association of FTO gene variants with obesity traits varies among different ethnic groups. This variability underscores the importance of considering ethnicity in genetic studies and personalized medicine approaches."
        },
        {
          "summary": "Role of rs10146997 in Colorectal Cancer Risk",
          "explanation": "The rs10146997 variant in the NRXN3 gene is associated with colorectal cancer risk, and this association varies by ethnicity. Specifically, the variant is inversely associated with colorectal cancer risk in Whites. This highlights the need for ethnic-specific studies to understand genetic risk factors for diseases."
        },
        {
          "summary": "Ethnic Differences in Disease Frequency",
          "explanation": "There are significant differences in disease frequency among various ethnic groups. For example, the Roma ethnic group has a significantly higher frequency of certain outcomes. Understanding these differences is crucial for targeted public health interventions and personalized medicine."
        },
        {
          "summary": "Importance of Statistical Analysis in Genetic Associations",
          "explanation": "Statistical measures such as odds ratio (OR) and 95% confidence interval (CI) are essential in assessing the reliability of genetic associations with disease risk. These tools help in understanding the strength and significance of the associations, which can vary by ethnicity and other factors."
        },
        {
          "summary": "Impact of Ethnicity on Outcome",
          "explanation": "Ethnicity status is considered an outcome in this context, and it influences the association between genetic variants and disease risk. This highlights the complex interplay between genetic, environmental, and ethnic factors in determining health outcomes."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 11",
    "edges": [
      [
        "\"ETHNICITY\"",
        "\"FTO GENE VARIANTS\""
      ],
      [
        "\"OUTCOME\"",
        "\"ROMA\""
      ],
      [
        "\"ETHNICITY\"",
        "\"ROMA\""
      ],
      [
        "\"ETHNICITY\"",
        "\"RS10146997\""
      ],
      [
        "\"ETHNICITY\"",
        "\"OUTCOME\""
      ],
      [
        "\"RS10146997\"",
        "\"WHITES\""
      ],
      [
        "\"NRXN3\"",
        "\"RS10146997\""
      ],
      [
        "\"ETHNICITY\"",
        "\"GENETIC ASSOCIATION\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS10146997\""
      ],
      [
        "\"FREQUENCY\"",
        "\"OR\""
      ],
      [
        "\"FREQUENCY\"",
        "\"ROMA\""
      ],
      [
        "\"95% CI\"",
        "\"OR\""
      ]
    ],
    "nodes": [
      "\"OUTCOME\"",
      "\"FREQUENCY\"",
      "\"RS10146997\"",
      "\"WHITES\"",
      "\"95% CI\"",
      "\"ROMA\"",
      "\"GENETIC ASSOCIATION\"",
      "\"OR\"",
      "\"ETHNICITY\""
    ],
    "chunk_ids": [
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-7d164d6337b8cd1db04bea036fc75fac",
      "chunk-841b239f43a16869c8effff2954c615d"
    ],
    "occurrence": 0.2222222222222222,
    "sub_communities": []
  },
  "7": {
    "report_string": "# GWAS Analysis Community\n\nThe community revolves around GWAS analysis, which is used to identify genetic associations with disease. Key entities include GWAS analysis, binary traits, genotype data, and Manhattan plots. These entities are interconnected through their roles in genetic association studies.\n\n## GWAS analysis and its role in identifying genetic associations\n\nGWAS analysis is a method used to identify genetic associations with disease. It relies on genotype data and binary traits to analyze genetic associations. The results of GWAS analysis are often represented graphically using Manhattan plots.\n\n## Binary traits in GWAS analysis\n\nBinary traits are used in GWAS analysis to identify genetic associations with disease. They are a type of physiological process used to analyze genetic associations.\n\n## Genotype data and its role in GWAS analysis\n\nGenotype data is used in GWAS analysis to identify genetic associations with disease. It provides the genetic information necessary for analyzing associations between genetic variants and disease.\n\n## Manhattan plots and their role in GWAS analysis\n\nManhattan plots are a graphical representation of the results of GWAS analysis. They are used to visualize the association between genetic variants and disease.\n\n## Relationship between GWAS analysis and obesity\n\nGWAS analysis is used to identify genetic associations with obesity. This highlights the significance of GWAS analysis in understanding the genetic factors contributing to obesity.",
    "report_json": {
      "title": "GWAS Analysis Community",
      "summary": "The community revolves around GWAS analysis, which is used to identify genetic associations with disease. Key entities include GWAS analysis, binary traits, genotype data, and Manhattan plots. These entities are interconnected through their roles in genetic association studies.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the significance of GWAS analysis in understanding genetic associations with disease.",
      "findings": [
        {
          "summary": "GWAS analysis and its role in identifying genetic associations",
          "explanation": "GWAS analysis is a method used to identify genetic associations with disease. It relies on genotype data and binary traits to analyze genetic associations. The results of GWAS analysis are often represented graphically using Manhattan plots."
        },
        {
          "summary": "Binary traits in GWAS analysis",
          "explanation": "Binary traits are used in GWAS analysis to identify genetic associations with disease. They are a type of physiological process used to analyze genetic associations."
        },
        {
          "summary": "Genotype data and its role in GWAS analysis",
          "explanation": "Genotype data is used in GWAS analysis to identify genetic associations with disease. It provides the genetic information necessary for analyzing associations between genetic variants and disease."
        },
        {
          "summary": "Manhattan plots and their role in GWAS analysis",
          "explanation": "Manhattan plots are a graphical representation of the results of GWAS analysis. They are used to visualize the association between genetic variants and disease."
        },
        {
          "summary": "Relationship between GWAS analysis and obesity",
          "explanation": "GWAS analysis is used to identify genetic associations with obesity. This highlights the significance of GWAS analysis in understanding the genetic factors contributing to obesity."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 7",
    "edges": [
      [
        "\"GENOTYPE DATA\"",
        "\"GWAS ANALYSIS\""
      ],
      [
        "\"GWAS ANALYSIS\"",
        "\"OBESITY\""
      ],
      [
        "\"GWAS ANALYSIS\"",
        "\"MANHATTAN PLOT\""
      ],
      [
        "\"BINARY TRAIT\"",
        "\"GWAS ANALYSIS\""
      ]
    ],
    "nodes": [
      "\"GENOTYPE DATA\"",
      "\"BINARY TRAIT\"",
      "\"MANHATTAN PLOT\"",
      "\"GWAS ANALYSIS\""
    ],
    "chunk_ids": [
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-1cc1bb385b2030b386679b552c606643"
    ],
    "occurrence": 0.07407407407407407,
    "sub_communities": []
  }
}